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Chapter 1 
GENERAL INTRODUCTION 

GENERAL INTRODUCTION 
Introduction 
Ro RNPs are a class of small cytoplasmic RNA-protein complexes of unknown function, 
which are present in cells of all species studied so far. The RNA component of these 
Ro RNPs consists of one of the Y RNAs. In human cells four different Y RNAs, which 
are approximately 100 nucleotides long, have been identified: hYl, hY3, hY4 and hY5 
(Hendrick et al., 1981). Furthermore, three different proteins have been reported to be 
associated with Ro RNPs in humans: the La protein, the 60 kDa Ro protein (Ro60) and 
the 52 kDa Ro protein (Ro52) (Hendrick et al., 1981; Wolin and Steitz, 1984; Ben 
Chetrit et al., 1988) (see Fig. 1). Calreticulin has also been reported to be part of the Ro 
RNP complex (Lieu et al., 1988; McCauliffe et al., 1990), but more recent experiments 
indicated that this association is highly doubtful (Rokeach et ai, 1991; Pruijn étal., 
1992). The Ro RNPs were initially discovered using autoantibodies against the Ro/SS-A 
antigens (both Ro52 and Ro60) and the La/SS-B antigen, produced by patients suffering 
from systemic lupus erythematosus (and related disorderc) or Sjogren's syndrome 
(reviewed in: Tan, 1989). These autoantibodies have been of great value for the further 
characterization of Ro RNPs. In this chapter our current knowledge on structure, 
evolutionary conservation, function and intracellular transport of the different components 
of Ro RNPs will be reviewed. 
Figure 1. Model for the human Yl RNP. 
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Y RN As 
All four human Y RNAs (hYl, hY3, hY4 and hY5 RNA) have been sequenced (Kato 
et al, 1982; Wolin and Steitz, 1983; O'Brien and Harley, 1990) and found to be 84, 93, 
101 and 112 nucleotides long, respectively, although some heterogeneity at their 3'-ends 
has been observed. The initially identified hY2 RNA turned out to be a degradation 
product of hYl RNA (Wolin and Steitz, 1983). The hY RNAs are transcribed by RNA 
polymerase III (Hendrick et al., 1981). There appears to be some variation in the relative 
amount of Y RNAs present in different human cells. While four h Y RNAs are expressed 
in human lymphocytes and other nucleated cells, erythrocytes mainly contain hYl and 
hY4 RNA (Rader étal., 1989; O'Brien and Harley, 1990; Pruijn et al., 1993) and 
thrombocytes only hY3 and hY4 RNA (Itoh and Reichlin, 1991). 
Genes encoding hYl, hY3 and hY4 RNA have been cloned (Wolin and Steitz, 1983; 
Maraia et al., 1994b) and appear to be single copy in the human genome. All four hY 
genes are located on human chromosome 7 and preliminary data suggest that, besides the 
hYl and hY3 gene which have been shown to be clustered (Wolin and Steitz, 1983), all 
four h Y genes are tightly linked to each other (Maraia et al., 1994b). Besides these 
authentic genes the human genome contains multiple hY-like sequences (O'Brien and 
Harley, 1992; Farris et al., 1995), which appeared to be pseudogenes. Pseudogenes have 
been reported for human Y3 and Y4 RNA (Jurka et al., 1988; O'Brien and Harley, 1992; 
Maraia et al., 1994b) as well as for mouse (Crouch and Liebke, 1989) and rat Yl RNA 
(Pruijn et al., 1993). 
hY1 hY3 hY4 hY5 
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Figure 2. Secondary structure model for the human Y RNAs. Sructures were obtained using chemical 
modification techniques and enzymatic structure probing (Van Gelder et al., 1994). The most highly 
conserved regions are boxed. 
Structure and characteristics 
The hY RNAs do not contain modified nucleosides (Hendrick et al., 1981; Kato et al., 
1982) and possess a triphosphate at their 5' end (Hendrick et al., 1981). Like all RNA 
polymerase III transcripts, hY RNAs are synthesized with an oligouridine stretch at their 
3' end, but unlike the other RNA polymerase III transcripts, the oligouridine stretch of 
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hY RNAs is not lost because of 3' end processing. In Xenopus laevis, however, the 
Y RNAs are processed and as a result the cytoplasmic Y RNAs in X. laevis cells do not 
contain the oligouridine stretch (O'Brien et al., 1993). In addition to sequence 
homologies, hY RNAs exhibit similarity at the secondary structure level. Proposed 
secondary structures show that all four hY RNAs can be folded into a structure containing 
a large pyrimidine-rich internal loop and a long stem in which the 5' and 3' ends of the 
molecules are base-paired (Wolin and Steitz, 1983; O'Brien and Harley, 1990). The 5' 
and 3' termini of the four different h Y RNAs are highly conserved at the level of both 
primary and secondary structure (Van Gelder et al., 1994). The secondary structures of 
human Yl and Y5 RNA have been determined using both chemical probing and 
enzymatic digestion using several ribonucleases. The results indicate that the secondary 
structure of the hY RNAs (Fig. 2) largely corresponds to the predicted secondary 
structure. The pyrimidine-rich region of hYl RNA is protected to chemical reagents 
under native conditions and is therefore probably involved in a tertiary interaction (Van 
Gelder et al., 1994). 
Table I Expression of Y RNAs in cells from various origin. 
SPECIES 
man 
monkey 
dog 
cat 
Pig 
cow 
rabbit 
mouse 
rat 
hamster 
rat 
guinea pig 
X. laevis 
iguana 
duck 
trout 
С elegans 
Yl 
+· 
+ 
+ 
+ 
+ 
+ 
+ 
+· 
+ 
+ 
+ 
# 
• с 
a 
+ 
η 
Y3 
+· 
+ 
+ 
+ 
+ 
+ 
+ 
+· 
+ 
+ 
+ 
# 
+· 
+· 
+ 
# 
+· 
Y4 
+* 
+ 
+ 
+ 
+ 
+ 
+ 
# 
+· 
+* 
Y5 
+· 
+ 
+ 
+ 
+ 
+ b 
# 
+' 
2 
Presence of Y RNAs in other species, demonstrated by anti-Ro/SS-A 
immunoprecipitation. Northern blot analysis and/or cloning and sequencing. 
+, presence of a Y RNA homologous to the indicated human Y RNA, 
based on immunoprecipitation data as well as hybridisation with the 
corresponding human Y RNA probe; tt, presence of a Y RNA solely 
demonstrated by immunoprecipitation. Y RNAs which have been cloned and 
sequenced are indicated by an asterisk. 
Presence of hY5 homologue has been reported by Pruijn et al. (1993), 
but could not be confirmed by F arris et al. (1995). 
Q 
χΥα has no apparent homologue in humans. 
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Evolutionary conservation 
In every species studied so far Y RNAs could be detected using anti-Ro antibodies which 
are able to immunoprecipitate Ro RNPs from cell extracts (Hendrick et al, 1981; Reddy 
et al, 1983; Mamula étal., 1989; Craft étal, 1990; Itoh étal, 1990; O'Brien étal, 
1993; Van Horn et al, 1995) or by Northern blot hybridization using human Y RNA 
probes (Pruijn et al, 1993; Farris et al, 1995). The number of distinct Y RNAs varies 
between species from one in Caenorhabditis ele gans (Van Horn et al, 1995) to four in 
human, monkey, dog, cat, pig, guinea pig and X. laevis (Itoh et al, 1990; Pruijn et al, 
1993; O'Brien et al, 1993) (see table I). Most of these Y RNAs show some similarity to 
the human Y RNAs, based upon length and hybridization with human Y probes. The most 
conserved Y RNA is Y3 (Pruijn et al, 1993; O'Brien et al, 1993; Farris étal, 1995) 
followed by Yl, Y4 and Y5, respectively. A similar conservation was seen for the 
Y RNA pseudogenes, for which it was shown that hY3-like genomic sequences are most 
widely spread across species, while hY4-like sequences are the least conserved (Farris 
et al, 1995). The four human Y RNAs, the four Y RNAs from X. laevis (χΥα, xY3, 
xY4 and xY5) (O'Brien et al, 1993), the two Y RNAs from iguana (iY3 and iY4) (Farris 
et al, 1995), the Y RNA from С. elegans (ceY3) (Van Horn et al, 1995) and the two 
mouse Y RNAs (Farris et al, 1996), have been cloned and sequenced. The sequenced 
Y RNAs show conservation of their primary structures and of their secondary structures 
(the pyrimidine-rich internal loop and the stem formed by the 5' and 3' termini). A 
sequence alignment for all sequenced Y3 RNAs is shown in Fig. 3. The homology 
between the vertebrate Y3 RNA sequences (human, mouse, X. laevis and iguana) is very 
high: 79% overall identity. The homology with the nematode sequence is less 
pronounced. The highest degree of sequence conservation is found in the stem structure, 
which was also conserved among the different human Y RNA sequences, and in the 
Y3-specific PyUUCUUUPu sequence (Van Horn et al, 1995), present in the internal 
pyrimidine-rich loop. 
The La protein 
The human La gene, which is 9.5 kbp from the transcription initiation site to the 
polyadenylation site, is split into 11 exons and located on chromosome 2 (Chambers 
et al, 1988) (Fig. 4A). The promoter region resembles that of "housekeeping" genes in 
that it contains a G/C rich region and does not contain a TATA-box (Chambers et al, 
1988). cDNAs encoding the human La protein have been cloned and sequenced 
(Chambers et al, 1988; Chan et al, 1989a; Pruijn et al, 1991). The cDNA encodes a 
408 amino acids long polypeptide which has a calculated molecular mass of 46.7 kDa 
(Fig. 4B). 
La binds the hY RNAs directly, independent of the presence of the Ro proteins (Pruijn 
et al, 1991). Consistent with the fact that the La protein binds all RNA polymerase ΙΠ 
transcripts at the 3' oligouridine stretch this element was also shown to be the primary 
binding site for the La protein on the hY RNAs (Stefano, 1984; Mathews and Francoeur, 
1984; Pruijn et al, 1991) (see Fig. 1). 
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20 40 60 
• τ τ 
hY3 GQCü-QCüCCQAQUGCAQÜQGUGUUUACAACUAAUUGAUCACAACCAGUUACAGAUUUCUU» 
mY3 QGÜÜ-GGüCCqAGAGÍIAGPGgUGUUUACAACUAAUUGAUCACAACCAGUUACAGAUUUCUU» 
xY3 GOCÜ - QOUCCQAAGGCAGUGGÜUGCCACCAUUAAUUGAUUACAGACAGUUACAGACUUCUU» 
ÍY3 GQCO-GqüCCGAUUGCAqUGQÜACUUAUAAUUAAUÜGAUCACAGUCAGUUACAGGÏJUUCÜU* 
++ + +++++++ + ++++++ + + ++++++++ +++ +++++++++ +++++ 
ceY GOOCUCgOUCCGAgOUüCAUGGÜCUCCAAUGUGUGUGUGÜGUGÜGU -- -UUUCUU* 
** * ******* **** * * * * ***** 
80 100 
τ τ 
hY3 •UGUUCCUUCUCCACUC --CCACUOCUUC-AC-OUGACÜAq- -CCUUU 
mY3 •UGUUCCUUCUCCGCUC CCACüaCUUC-AC-DÜGACCAG- -CCUÜU 
XY3 •UGUU-CUUCUCCCCUC CCACUGCDÜC-CC-UUGACUAQ- -CCU 
ÍY3 •UGUUCUUUCUCCACUC CCACÜGCUUC - AC - UUGACÜAG - - ÜCU 
++++ ++++++ +++ ++++++++++ + +++++ ++ ++ 
ceY •UA-GGAACCUCGGUUCCAACCUCAUCUUGACC-UÜGAAACUACUÜÜGACC-GCOCC 
* *** ** ** ** * * ***** * * 
Figure 3. Sequence alignment of Y3 RNAs. Nucleotides conserved among human (h), mouse (m), X. laevis 
(x) and iguana (i) are indicated by pluses, while nucleotides conserved among vertebrates and C. elegans 
(ce) are indicated by asterisks. Basepaired nucleotides in the conserved stem, formed by the S' and 3' ends 
of the molecule, are bold and underlined. Sequences were aligned using the program CLUSTAL W(1.4), 
which is part of the Wisconsin Package V 7.0., and adjusted manually, (h: Wolin and Steitz, 1983. m: 
Farris et al., 1996. χ: O'Brien et al., 1993. i: Farns et al., 1995. ce: Van Horn et al., 1995) 
Structure and characteristics 
In the primary sequence of the La protein several structural motifs can be discerned (Fig. 
4B). The La protein contains two RNP motifs (also named RNA binding domain or RNA 
recognition motif), which are often found in RNA binding proteins and are essential for 
RNA binding for a number of proteins (reviewed in: Mattaj, 1993). The first one spans 
the region from amino acid 112 to 187 (Chan et al., 1989b) and the second one the 
region from 230 to 300 (Birney et ai, 1993). The first RNP motif together with 
N-terminally flanking sequences was shown to be involved in binding to hY RNAs (Praijn 
et al., 1991). A putative ATP binding motif (with consensus sequence GXXXXGK) has 
been identified from amino acids 333 to 339 (Topfer et al., 1993). Three PEST regions 
(rich in the amino acids P, E, S, and T), which are susceptible to proteolytic cleavage 
(Chan et al., 1989b), are present in the La protein. These PEST regions may explain the 
relative instability of the La protein, often leading to proteolytic degradation products of 
approximately 23, 29 and 43 kDa (Habets et al, 1983; Chan et al., 1986). Two sequence 
elements homologous to the double-stranded RNA-dependent protein kinase PKR have 
been described in the C-terminal part of the protein (from amino acids 249 to 271 and 
338 to 363) (Clemens, 1993). Finally, a nuclear localization signal, resembling the 
consensus bipartite nuclear localization signal (Dingwall and Laskey, 1991), has been 
identified and mapped from amino acids 383 to 400 (Simons et al., 1996a). 
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A 
= = I I Н Д Д Д І M 3 1 = =: chr. 2 
1 2 3 4 5 8 7 8 9 10 11 
В 
PEST
 ρ κ η
 ATP PEST 
и — 1 Ί И 11 • 
1 RNP motif RNP motif PKR NLS 4 0 e 
Figure 4. Structure of the human La protein. (A) Schematic structure of the gene. The exons are numbered 
(1-11). (B) Schematic structure of the protein. RNP motif: also known as RNA Recognition Motif (RRM), 
PEST: PEST region, PKR: PKR-Iike sequence element, ATP: ATP-binding motif, NLS: nuclear 
localization signal. 
La is a highly phosphorylated protein with at least 8 isoelectric forms (with pi from 6 
to 7) as determined by two-dimensional gel electrophoresis (Pizer et al., 1983; Francoeur 
et al., 1985a; Pfeifle et al., 1987). Only serines and threonines are phosphorylated in the 
La protein (Pfeifle et al., 1987) and phosphorylated residues are only present in the 
C-terminal 23 kDa cleavage fragment of the protein (Chan et al., 1986) probably 
resulting from proteolytic cleavage in the central PEST region. 
Evolutionary Conservation 
The La protein is well conserved during evolution as shown by the fact that proteins 
immunoreactive with human (monospecific) anti-La antibodies and of similar size as the 
human La protein are present in cells of monkey, pig, cow, dog, cat, rabbit, rat, mouse 
and Plasmodium falciparum (Hoch and Billings, 1984; Francoeur et al., 1985b; Chan and 
Tan, 1987; Slobbe et al., 1991). Besides the human La clone, cDNAs encoding bovine, 
mouse, rat, Xenopus laevis, Drosophila melanogaster and Saccharomyces cerevisiae La 
have been isolated and characterized (Chan et al., 1989b; Topfer étal., 1993; Semsei 
et al., 1993; Scherly et ai, 1993; Yoo and Wolin, 1994; Bai et al., 1994; Lin Marq and 
Clarkson, 1995). In the case of X. laevis two almost identical La polypeptides have been 
described (Scherly et al., 1993). Mouse, rat and X. laevis La contain species-specific 
inserts in their C-terminal part as compared to human La. The homology with the human 
La amino acid sequence varies from 25% identity in the case of S. cerevisiae to 95% in 
the case of bovine La. All identified structural motifs seem to be conserved across species 
(Pruijn, 1994). 
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The R06O protein 
The gene for the R06O protein has been mapped on the short arm of chromosome 1 (Chan 
et ai, 1994; Frank and Mattei, 1994). Full length cDNA clones encoding the R06O 
protein have been reported by several groups (Deutscher et al, 1988; Ben Chetrít et al, 
1989; Pruijn étal, 1991). Two types of R06O are encoded by these clones: RooOa 
(Deutscher et al, 1988; Pruijn et al., 1991), which contains 538 amino acids and has a 
deduced molecular mass of 60.6 kDa and Ro6O0 (Ben Chetrit et al., 1989), which 
contains 525 amino acids and has a deduced molecular mass of 59.3 kDa (Fig. 5). These 
two proteins are generated via alternative splicing, which leads to the replacement of the 
C-terminal 24 amino acids of Ro60a by 11 distict amino acids in the case of Ro60/3 
(Chan and Buyon, 1994). RooOa is the predominant type expressed in all human cells 
tested (Chan and Buyon, 1994). Antigenically distinct variants of R06O have been found 
in some cell types. Erythrocytes, for example, contain a Ro protein of 60 kDa, which is 
different from but related to R06O (Rader et al., 1989), while platelets do not contain 
detectable amounts of the R06O protein (Itoh and Reichlin, 1991). 
In analogy to the La protein, R06O is able to bind to the h Y RN As directly, independent 
of La or Ro52 (Pruijn et al, 1991). Ro60 binds to the lower part of the conserved stem 
structure as shown by RNase protection experiments (Wolin and Steitz, 1984). A 
conserved bulged cytidine in this stem appears to be of major importance for efficient 
binding (Pruijn et al, 1991). 
Structure and characteristics 
Like many other RNA binding proteins, R06O contains a RNP motif in the primary amino 
acid sequence (amino acids 92-161) (Fig. 5). Although it is thought that the RNP domain 
is necessary for binding to hY RNAs, it has become clear that the correct conformation of 
R06O is extremely important for binding, since deletion of small regions at either the N-
R06O 
RNP motif Zn-flnger 
β 
538 
525 
Figure 5. Schematic representation of the structure of the RooOa and Ro60|3 proteins. RNP motif: also 
known as RNA Recognition Motif (RRM), Zn-flnger: zinc finger motif. 
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or C-terminus precludes binding to hY RNA (Pruijn et al., 1991). From amino acid 305 
to 323 a potential zinc finger motif is present. Zinc finger motifs often reside in DNA 
binding proteins, but have also been described in RNA binding proteins (Pieler and 
Bellefroid, 1994). In 1994 it has been shown that Ro60 (peptide 304-324) indeed is able 
to bind Zn2+ (Muller etat., 1994). As yet, no function has been assigned to the zinc 
finger motif in Ro60. 
Evolutionary conservation 
Homologues of Ro60 could be detected by Western blotting in extracts of cells from 
monkey, pig, cow, dog, cat, rabbit, rat, mouse and guinea pig (Itoh et ai, 1990; Slobbe 
étal., 1991) using monospecific anti-Ro antibodies. Complementary DNAs encoding the 
Ro60 protein from X. laevis and C. elegans have been cloned (O'Brien et al., 1993; Van 
Hom étal., 1995). X. laevis Ro60 is of equal length as the human Ro60a and shows 
78% identity. С elegans Ro60 (643 amino acids) is 105 amino acids longer than human 
Ro60a, including an extension of 47 amino acids at the N-terminus and displays 36% 
identity with the two vertebrate Ro60 proteins. The RNP motif is quite conserved, 
although the C. elegans Ro60 protein contains two insertions in this motif. The putative 
zinc finger in the human sequence is not conserved in the X. laevis and the C. elegans 
proteins. 
The Ro52 protein 
The Ro52 gene was mapped on chromosome 11 (Frank et al., 1993). The complete gene 
spans 10 kb of DNA and contains 7 exons (Chan et al., 1995a) (Fig. 6A). An alternative 
Ro52 cDNA (Ro52/3), missing the leucine zipper domain, turned out to be the product of 
an alternatively spliced mRNA, in which exon 4 was skipped (Chan et al., 1995a; our 
unpublished results). Two cDNA clones, encoding the Ro52 protein have been isolated 
and characterized (Chan et al., 1991; Itoh et al., 1991). They are identical in the coding 
region except for one nucleotide and encode a protein of 475 amino acids with a 
calculated molecular mass of 54.1 kDa. No homology with the Ro60 protein was found. 
Antigenically distinct counterparts of the Ro52 protein in both erythrocytes and platelets 
have been described (Rader et al., 1989; Itoh and Reichlin, 1991). 
In 1988 it was reported that Ro52 is a component of the Ro RNPs (Ben Chetrit et al., 
1988). The protein does not bind to the h Y RN As directly, but probably is associated 
with the particle via interaction with the Ro60 protein (Slobbe et al., 1992). Despite these 
observations the association of Ro52 with Ro RNPs is still controversial (Kelekar et al., 
1994; Peek et al., 1994; Boire et al., 1995) and evidence proving such an association is 
complicated by the fact that some anti-Ro52 antibodies have been reported to cross-react 
with Ro60 (Itoh et al, 1992). Nevertheless, the observation that anti-Ro52 and anti-Ro60 
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Figur« б. Schematic representation of the structure of the Ro52 protein. (A) Structure of the gene. The 
exons in the gene are numbered. (B) Structure of the proteins. RING: RING finger motif, B-box: B-box 
motif, α-helical: α-helical domain, Leu: leucine zipper motif, rfp: г/р-Ше domain. 
antibodies are frequently found simultaneously in patient sera (Slobbe et al., 1991), may 
indicate that Ro52 and Ro60 have some kind of interaction. The recent observation of 
Chan et al. (1995b) that overexpression of Ro52 can overcome the aberrant nucleolar 
localization of overexpressed Ro60 in cultured HEp-2 cells supports this idea. 
Structure and characteristics 
Three domains can be discerned in the primary structure of the Ro52 protein (Fig. 6B). 
The N-terminus contains a zinc finger-like domain, which is referred to as RING finger-B 
box domain (Reddy et al., 1992). The central part is predicted to form a long α-helical 
domain with the potential to form coiled-coils and carries a leucine zipper motif in the 
C-terminal part. Leucine zippers were originally described in DNA binding proteins but 
later these motifs were shown to be involved in protein-protein interaction and dimer 
formation as well (reviewed in: Alber, 1992). The C-terminal part of Ro52 (the rfp-like 
domain) shows a striking homology to the human transforming protein rfp and to the 
mouse rpt-1 protein. Ro52 thus is a member of this rfp protein family, of which all 
members contain the three described domains. Most φ proteins are DNA binding 
proteins that play a role in transcription regulation (Chan and Andrade, 1992; Bellini 
et al, 1993). The precise biological significance of the individual domains is not clear 
yet. 
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Evolutionary conservation 
In contrast to the La and the R06O protein, which are well conserved during evolution, 
the Ro52 protein appeared to be detectable only in human, monkey and guinea pig cells 
on Western blots using human anti-Ro/SS-A antibodies (Itoh et al., 1990; Slobbe et al., 
1991). In spite of the lack of immunological cross-reactivity a cDNA encoding Ro52 from 
mouse cells has been cloned (EMBL database: accession no. L27990). The derived amino 
acid sequence shows 70% identity to the human polypeptide. 
Possible functions 
Although most components of the Ro RNP complex are quite conserved during evolution 
and expressed in a large variety of organisms ranging from C. elegans to human, their 
functions are still not elucidated. In view of their conservation and exclusively 
cytoplasmic localization (O'Brien et al, 1993; Peek et al., 1993; Simons étal., 1994), 
Ro RNPs most likely support cytoplasmic functions in the cell. The fact that Y3 appears 
to be the most conserved Y RNA while the other Y RNAs vary in their distribution 
across species and different types of cells, suggests that the different Ro RNPs might be 
functionally interchangeable and that the Ro RNPs possibly perform very similar or 
overlapping functions. Despite the fact that to the complete Ro RNPs no function has 
been assigned yet, functional aspects of individual components have been reported. 
Consistent with the fact that La binds to all newly synthesized RNA polymerase III 
transcripts, the La protein was shown to be involved in transcription of these RNAs. The 
La protein is necessary for correct and efficient termination of RNA polymerase III 
transcription and for efficient reinitiation by RNA polymerase III on the template 
(Gottlieb and Steitz, 1989a; Gottlieb and Steitz, 1989b; Maraia et al., 1994a). Potentially 
related to this function, it has been shown that La is capable of unwinding DNA-RNA 
hybrids and double-stranded RNA in an ATP-dependent manner (Bachmann et al., 1990b; 
Xiao et al., 1994). Increasing evidence supports the idea that La may also play a role in 
the translation process. La was shown to be involved in internal initiation of translation of 
poliovirus RNA (Meerovitch et al., 1993; Svitkin etal., 1994a) and. in alleviation of 
translational repression of HIV-1 mRNA by binding to the TAR element present in the 
%' UTR of these transcripts (Svitkin et al., 1994b; Chang et al, 1994). Very recently La 
has been shown to bind a subset of 40S ribosomal particles and to be able to bind 18S 
rRNA directly (Peek et al., 1996). 
In X. laevis oocytes the R06O protein has been found in association with variant 5S rRNA 
precursors. These variant 5S rRNAs are processed inefficiently and eventually degraded. 
R06O thus has been proposed to function in a quality control or discard pathway for 5S 
rRNA biosynthesis (O'Brien and Wolin, 1994). Whether Y RNAs are also involved in 
this process is not known. 
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For Ro52 no function has been described yet, but the presence of zinc finger and leucine 
zipper motifs suggests that it might interact with nucleic acids. Recently it was shown that 
Ro52 indeed is capable of binding to DNA in vitro but the physiological significance of 
this observation is unknown (Frank et al., 1995). Based on its similarity with the rfp 
protein family it is plausible to assume that Ro52 has a function in regulation of gene 
expression at the transcriptional level. 
Localization and nucleocytoplasmic transport 
Nucleocytoplasmic transport of proteins and RNA occurs via nuclear pore complexes 
(NPC), macromolecular assemblies present in the nuclear envelop. While nuclear import 
of proteins has been studied extensively over the past few years and at present is 
understood reasonably well, our knowledge on the mechanisms of nuclear export of RNA 
and proteins is still very poor (reviewed in: Izaurralde and Mattaj, 1995; Gerace, 1995). 
In contrast to smaller proteins, which in principle can diffuse into the nucleus, import of 
larger proteins is an energy-dependent, saturable process involving specific signals on the 
transported proteins (reviewed in: Simos and Hurt, 1995). These signals are called 
nuclear localization signals (NLSs) and can be divided into two classes. Members of the 
first class consist of a short stretch of basic amino acids, similar to the prototype SV40 Τ 
antigen NLS (PKKKRKV) (Kalderon et al., 1984). The second class is characterized by 
two stretches of basic amino acids separated by a spacer of approximately 10 random 
amino acids and is called the bipartite NLS (Dingwall and Laskey, 1991). In the 
cytoplasm the NLS is bound by NLS receptors, which dock the NLS-containing protein to 
the NPC. Subsequently the protein-receptor complex is translocated through the NPC. 
This step requires energy and a GTPase (Ran/TC4 or homologues thereof) has been 
reported to be involved in this process (Newmeyer and Forbes, 1988; Melchior et al., 
1993; Moore and Blobel, 1993). The NLS-receptor and Ran/TC4 are recycled and thus 
are able to return to the cytoplasm. 
Nuclear export of proteins is a rather new field of research and our knowledge on this 
process and the components involved is therefore limited. Recently it has become clear 
that analogous to nuclear import, nuclear export of proteins is also mediated by positive 
signals (nuclear export signals (NES)) residing on these molecules (reviewed by: Gerace, 
1995). The NESs identified so far appear to be enriched in leucine and other hydrophobic 
residues and bear no obvious similarity to NLSs. Receptors for export, which are able to 
interact with NESs, have also been identified. Like NLS-receptors, NES-receptors may be 
shuttling carriers that operate in the nuclear-to-cytoplasmic direction. In addition to the 
rapid NES-mediated export of proteins, export with slower kinetics has been described as 
well. Nuclear export of these proteins is determined by the degree of their nuclear 
retention (Wagner and Hall, 1993). In this case proteins might leave the nucleus via 
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passive diffusion or via interactions with proteins bearing specific export signals. 
The study of the RNA export process, which is the main nucleocytoplasmic transport 
event of RNAs, is still at an early stage (Izaurralde and Mattaj, 1995). Like other 
transport processes, RNA export is energy-dependent and saturable, indicating that a 
carrier is involved in the export process (Jarmolowski et al., 1994). Several proteins have 
now been identified as being involved in the export of various RNAs through the NPC 
(Izaurralde and Mattaj, 1995). For one of these proteins (Rev), involved in the export of 
unspliced HIV mRNAs, it has been shown that it contains a functional NES (Fischer 
et al., 1995). Next to specific proteins, additional common factors seem to be necessary 
for export of different classes of RNAs. Also in the case of RNA export, the shuttling 
GTPase Ran/TC4 (or homologues thereof) appears to be necessary (Moore and Blobel, 
1994; Schlenstedt et al., 1995; Cheng et al, 1995). 
Y RNAs 
The intracellular localization of Ro RNPs has been addressed in many studies over the 
past 10 years, primarily by means of immunofluorescence using anti-Ro/SS-A antibodies. 
The results of these studies, however, vary dramatically. Cell enucleation and Xenopus 
laevis oocyte injection studies provided more reliable localization data. Using these 
techniques, it was shown that Y RNAs are exclusively located in the cytoplasm implying 
a cytoplasmic localization of the Ro RNPs (O'Brien et al., 1993; Peek et al., 1993; 
Simons et al., 1994). 
Export of Y RNAs turned out to be an energy-dependent, saturable process (Simons 
et al., 1994; Simons et al., 1996b). Binding of Ro60 to hYl RNA in the nucleus 
appeared to be absolutely necessary for the export of the Y RNAs, while binding of La 
resulted in nuclear retention of hYl RNA in X. laevis oocytes (Simons et al., 1994; 
Simons et al., 1996a). In addition to Ro60, nuclear export of Y RNAs requires another 
titratable factor, which is also involved in the export of tRNA. Recently, it has been 
shown by in situ hybridization experiments that a small amount of hYl, hY3, and hY5 is 
also present in discrete structures near the nucleolar rim, called perinucleolar 
compartments (PNCs) (Matera et al., 1995). In addition to the Y RNAs, other RNA 
polymerase III transcripts (MRP RNA (=Th RNA) and RNase Ρ RNA) could be detected 
in these PNCs, while Ro60, Ro52 and La were not present. The polypyrimidine tract 
binding protein (hnRNP I/PTB) appeared to be concentrated in PNCs as well. Because 
PNCs are not the sites of synthesis of the RNAs present in these compartments (Matera 
et al., 1995), PNCs may represent cellular compartments in which other aspects of RNP 
biogenesis (such as assembly) occur. 
The La protein 
Many previous studies have shown, that under normal conditions the La protein mainly 
resides in the nucleus, consistent with the role of the La protein in termination of RNA 
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polymerase Ш transcription. The nuclear localization is not restricted to the nucleoplasm, 
since La has been found in the nucleolus as well (Deng et al., 1981). Nevertheless a 
certain amount of La has been reported to reside in the cytoplasm as well (Habets et al., 
1983; Boire and Craft, 1990; Peek et al., 1993; Simons étal, 1994), in agreement with 
the stable association of La with the cytoplasmic Y RN As. Cytoplasmic accumulation of 
La has been reported to occur under certain stress conditions like viral infection 
(Baboonian et al, 1989; Bachmann étal, 1989a; Meerovitch étal, 1993), UV 
irradiation (Bachmann étal, 1990a; Furakawa étal, 1990; Golan étal, 1992) and 
inhibition of RNA synthesis (Bachmann et al, 1989b). Consistent with this re-distribution 
under stress conditions, it was shown that La is a shuttling protein (Chapter 4). Nuclear 
import of the La protein was shown to be energy-dependent and mediated by an NLS in 
the C-terminal part of the protein, which resembles the bipartite NLS (Simons et al, 
1996a). Like nuclear import, nuclear export of La appears to be energy-dependent as 
well, suggesting that La export is mediated by an NES. Furthermore, sequence elements 
in the central part of the molecule were shown to be involved in the nuclear retention of 
the La protein. The exact interplay between the NLS, retention domain and (putative) 
NES is not completely understood yet. 
The Ro proteins 
In immunofluorescence studies with anti-Ro/SS-A antibodies, the Ro52 and Ro60 protein 
have been demonstrated to reside either only in the nucleus, in both nucleus and 
cytoplasm or predominantly in the cytoplasm (reviewed in: Van Venrooij et al, 1993). 
Cell enucleation and microinjection experiments convincingly showed, that Ro52 and 
Ro60 are present in both nucleus and cytoplasm, although the distribution of the two 
proteins is not the same (O'Brien et al, 1993; Peek et al, 1993; Simons étal, 1994; 
Keech étal, 1995). Both proteins are transported to the nucleus in an energy-dependent 
manner, suggesting that for import of both proteins an NLS is required (Simons et al, 
1994). However, in the amino acid sequence of these proteins no canonical NLS can be 
discerned. 
Outline of this thesis 
Ro RNPs consist of one RNA polymerase III transcribed Y RNA and at least three 
proteins, namely La, Ro60 and Ro52. In spite of their ubiquitous expression and 
evolutionary conservation, their function is still unknown. 
The aim of the investigations reported here was to obtain more insight into the 
intracellular localization and transport of Ro RNP components. As a model-system 
X. laevis oocytes were used which can be easily manipulated by microinjection. Via 
nuclear injections of the Y RNAs and cytoplasmic injections of the La, Ro60 and Ro52 
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protein, the distribution of the components between nucleus and cytoplasm could be 
established (Chapter 2). 
The transport of the La protein was studied in more detail. The import of the La protein 
was found to be mediated by an NLS. By injecting a series of La mutants, the position of 
the NLS in the amino acid sequence could be determined (Chapter 3). Furthermore, 
sequence elements involved in nuclear retention of the La protein were mapped by nuclear 
injections of La mutants (Chapter 3). In spite of the strong nuclear accumulation and 
retention of La in X. laevis oocytes, it could be shown that the La protein is able to 
shuttle between nucleus and cytoplasm in human-mouse heterokaryons (Chapter 4). 
Nuclear export of hYl RNA was shown to be dependent on Ro60 binding, while binding 
of the La protein resulted in nuclear retention of hYl RNA (Chapter 5). Competition 
studies with other RNAs indicated that next to Ro60 another factor is involved in nuclear 
export of hYl RNA (Chapter 5). 
Finally, the data presented in this thesis are discussed in a more general manner in 
Chapter 6. 
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ABSTRACT 
Xenopus laevis oocytes have been employed to determine the intracellular localization of 
components of Ro ribonucleoprotein particles (Ro RNPs) and to study the assembly of 
these RNA-protein complexes. Microinjection of the protein components of human Ro 
RNPs, i.e. La, R06O and Ro52, in Xenopus laevis oocytes showed that all three proteins 
are able to enter the nucleus, albeit with different efficiencies. In contrast, the RNA 
components of human Ro RNPs (the Y RNAs) accumulate in the Xenopus laevis 
cytoplasm upon injection. Localization studies performed at low temperatures indicated 
that both nuclear import of Ro RNP proteins and nuclear export of Y RNAs are mediated 
by active transport mechanisms. 
Immunoprecipitation experiments using monospecific anti-La and anti-Ro60 antibodies 
showed that the Xenopus laevis La and R06O homologues were cross-reactive with the 
respective antibodies and that both Xenopus laevis proteins were able to interact with 
human Yl RNA. Further analyses indicated that (i) association of Xenopus laevis La and 
R06O with Y RNAs most likely takes place in the nucleus, (ii) once formed, Ro RNPs are 
rapidly exported out of the nucleus, and (iii) the association with La is lost during or 
shortly after nuclear export. 
INTRODUCTION 
The Ro/SS-A and La/SS-B antigens are common targets of autoimmune responses 
occurring in a number of rheumatic disorders, of which systemic lupus erythematosus and 
Sjogren's syndrome are the most prominent [reviewed in: Tan, 1989]. Antibodies against 
these antigens have been of great help in the characterization of these autoantigens and 
they also have some clinical interest in diagnosing different rheumatic diseases [reviewed 
in: Slobbe et ai, 1991a]. 
The Ro/SS-A antigen consists of a set of ribonucleoprotein particles, designated Ro 
RNPs. Ro RNPs consist of an RNA molecule, complexed with several proteins. The 
RNAs are transcribed by RNA polymerase III and, in humans, vary in length from 84 to 
112 nucleotides [Hendrick et al., 1981]. They are referred to as hYl, hY3, hY4 and hY5 
RNA (hY2 RNA is a truncated version of hYl RNA). Their sequences have been 
determined [Kato et al., 1982; Wolin and Steitz, 1983; O'Brien and Harley, 1990] and 
the predicted secondary structures are characterized by base-pairing of the highly 
conserved 5' and 3' termini [reviewed by van Venrooij et al., 1993]. The number of Y 
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RNAs differs among species, varying from two in duck and mouse to four in several 
other mammals [Hendrick et al, 1981; Mamula et al., 1989a; Praijn et al., 1993]. In 
human tissues also a difference in the distribution of the four Y RNAs has been detected: 
in red blood cells only hYl and hY4 RNA [Rader et al., 1989; O'Brien and Harley, 
1990] and in human platelets only hY3 and hY4 RNA [Itoh and Reichlin, 1991] could be 
detected, while other human cells contain all four Y RNAs. 
The protein part of a Ro RNP consists of at least 3 different proteins: the La protein (La) 
and the 52 kDa and 60 kDa Ro proteins (Ro52 and Ro60, respectively). One of the 
functions proposed for La is a role in the correct termination of transcription by RNA 
polymerase III [Gottlieb and Steitz, 1989a, 1989b]. La binds transiently to all RNA 
polymerase III transcripts, but is believed to bind to Y RNAs more stably, because Y 
RNAs don't loose their 3' U-tail which is the primary binding site for the La protein 
[Stefano, 1984; Mathews and Francoeur, 1984; Pruijn et al. 1991]. For the Ro proteins 
different variants have been found in different cell types. While most human cells contain 
Ro60 and Ro52, red blood cells contain Ro proteins of 60 kDa and 54 kDa which are 
antigenically different from, but related to Ro60 and Ro52, respectively [Rader et al., 
1989]. Moreover, in human platelets only a 52 kDa Ro protein can be detected that is 
also antigenically different from Ro52 [Itoh and Reichlin, 1991]. The binding site for 
Ro60 is the terminal part of the conserved stem-structure of the Y RNAs [Wolin and 
Steitz, 1984; Pruijn et al, 1991]. Ro52 does not seem to bind directly to Y RNA, but 
most likely associates with the particle via protein-protein interactions with Ro60 [Slobbe 
et al., 1992]. However, direct evidence for the association of Ro52 with Ro RNPs is still 
lacking and is complicated by the fact that some anti-Ro52 antibodies have been reported 
to cross-react with Ro60 [Itoh et al., 1992] 
Although a number of functions for Ro RNPs have been proposed [reviewed in: Pruijn et 
al., 1990], the actual function of these particles is still unknown. Also their intracellular 
localization is not clear yet. This subject has been addressed in several studies, but the 
results are controversial. By immunofluorescence Ro protein components were detected in 
only the nucleus [Harmon et al, 1984; Lopez-Robles et al, 1986; Xia et al, 1987; 
Mamula et al, 1989a], in both nucleus and cytoplasm [Ben-Chetrit et al, 1988; Slobbe et 
al, 1991b] or merely in the cytoplasm [Alspaugh and Maddison, 1979; Hendrick et al, 
1981; Bachmann et al, 1986]. We studied the intracellular localization and transport of 
Ro RNPs by microinjection of the different components into Xenopus laevis oocytes. This 
approach has proven to be very successful in studying transport of other RNPs, in 
particular Ul snRNP [reviewed in: Nigg et al, 1991]. 
In this study in vitro translated La, Ro52 and Ro60 were injected into the oocyte 
cytoplasm to elucidate their transport and localization. The Y RNAs, on the contrary, 
were injected into the nucleus of oocytes. The association of hYl RNA with Xenopus 
laevis La and Ro60 was examined by immunoprecipitation studies. Our results suggest a 
model in which the Ro and La proteins after their synthesis are transported to nucleus, 
where they associate with the newly synthesized Y RNAs. The assembled Ro RNP 
particles are then rapidly exported to the cytoplasm. 
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MATERIALS AND METHODS 
In vitro transcription / translation 
The transcription vectors for hY RNAs were derived from pHYl, pHY3, pHY4 and 
pHY5 [Praijn et al., 1991; Peek et al, 1993]. By PCR а Τ7 RNA polymerase promoter 
was inserted at a position that allowed wild-type 5'-end formation during transcription and 
a Dral site was created at a position corresponding to the З'-end of the respective h Y 
RNA. The PCR products were cloned into pUC18. The Ul snRNA clone in pUC19 has 
been described by Surowy et al. [1989]. After linearization with Dral (hYl) and Ddel 
(Ul) and transcription with T7 RNA polymerase, RNAs corresponding to the wild-type 
sequences were obtained. The Ul clone was transcribed in the presence of 
m7G(5')ppp(5')G cap. 0.5 /tg of linearized template DNA was transcribed in 10 μ\ 
buffer, containing 40 mM Tris-HCl (pH 7.9), 6 mM MgCl2, 2 mM spermidine, 10 mM 
NaCl, 10 mM dithiothreitol, 0.1 mg/ml BS A, 1 mM NTPs, 2 U RNasin, 1 mM 
m7G(5')ppp(5')G (in case of Ul RNA) and 20 /¿Ci o^P-UTP with 10 U of T7 RNA 
polymerase. Unincorporated nucleotides were removed by gel filtration and proteins were 
removed by phenol-chloroform (1:1) extraction. 
The cDNA clones for La and Ro60, used for in vitro transcription/translation, have been 
previously described by Pruijn et al. [1991]. The Ro52 cDNA clone used is identical to 
the Ro52 cDNA clone described by Itoh and co-workers [1991] and was isolated from a 
human placental cDNA library and subcloned into pGEM-3Zf(+) [Bozic et al., 1993]. In 
vitro transcription/translation was carried out as described by Scherly et al. [1989]. 
Oocyte injection 
Oocytes were released from the ovary by treatment with collagenase В (2.5 mg/ml) in 
Barth-medium without Ca2 +. For protein studies 40 nl of the in vitro translation mixture 
was injected into the cytoplasm of fully grown oocytes and subsequently incubated in 
Barth-medium supplemented with cycloheximide at a concentration of 100 ¿ig/ml. After 
18 hours the oocytes were manually dissected in J-buffer (20 mM Tris-HCl, pH 7.5, 70 
mM NH4C1, 7 mM MgCl2, 0.1 mM EDTA, 2.5 mM dithiothreitol, 10% glycerol). The 
nuclear fraction was precipitated immediately in ethanol, whereas the "total" and 
cytoplasmic fractions were first homogenized in TN150E (10 mM Tris-HCl (pH 8.0), 150 
mM NaCl, 1 mM EDTA). After removal of part of the yolk and insoluble components by 
centrifugation, proteins were precipitated by adding 5 volumes of acetone. Pellets were 
resuspended in SDS-sample buffer and portions of 4 oocyte equivalents were analyzed by 
10% SDS-PAGE. 
For RNA injections, oocytes were first centrifuged (600 g, 20 min., room temperature) to 
visualize the nucleus. 25 nl of the in vitro transcribed RNA was injected into the nucleus 
of oocytes. After incubation and dissection of the oocytes the fractions were homogenized 
in 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 1.5% SDS, 300 mM NaCl, 1.5 mg/ml 
proteinase К and incubated at 56°C for 30 min. Proteins were extracted once with 
phenol/chloroform (1:1) and RNA was precipitated by adding 4 vol of ethanol. RNA of 
one oocyte equivalent was analyzed on a 10% denaturing Polyacrylamide gel. For 
immunoprecipitation oocytes were homogenized in TN150E. 
The Xenopus laevis Ul RNA gene used for injection is described by Zeller et al. [1984]. 
The hY RNA genes are located on a genomic DNA fragment described by Wolin and 
Steitz [1983]. The hYl and hY3 genes were first subcloned by ligating the EcoRI-Sall 
33 
fragment (hYl) and EcoRI-BamHI fragment (hY3) into pGEM-3Zf(+). The DNA (1 
mg/ml) was mixed with an equal volume of [a-32P]-UTP (10 mCi/ml) and injected (25 nl) 
into the oocyte-nuclei. After 40 hours, RNA was extracted from the oocytes and analyzed 
on Polyacrylamide gels. Gel-purified RNA [Mattaj and Zeiler, 1983] was dissolved in 
water and re-injected into the oocyte nucleus and analyzed as described. 
Antisera 
The anti-La, anti-Ro60 and anti-Sm sera were from autoimmune patients. The anti-La and 
anti-Ro60 antibodies were affinity-purified using bacterially expressed La and Ro60 
[Slobbe et al., 1992]. Their monospecificity was confirmed by Western blotting and by 
immunoprecipitation of in vitro translated proteins. The specificity of the anti-Sm serum 
was determined by Western blotting, counter-immunoelectrophoresis and RNA 
precipitation. 
Immunoprecipitation 
Antisera were coupled to protein Α-agarose by head over head rotation at room 
temperature for 1 h in IPPS00 (10 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.1% NP-40). 
For each precipitation 50 μΐ of affinity-purified anti-La or anti-Ro60 or 2 μΐ of anti-Sm or 
normal human serum were used. Immunoprecipitations were carried out in IPP150 (10 mM 
Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% NP^O) for 2 h at 4°C. Immunoprecipitation 
with oocyte extracts was performed with 3 oocyte equivalents. The RNA was extracted 
and analyzed as described in the oocyte injection section. 
For immunoprecipitation of endogenous proteins, oocytes were labelled in Barth-medium 
with 0.5 mCi 35S-methionine. After 40 hours the oocytes were homogenized in 
SlOO-buffer (25 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 0.25 mM dithiothreitol, 0.5 mM 
phenylmethylsulfonyl fluoride, 0.1 M KCl, 0.01% NP-40, 20% glycerol), centrifuged to 
remove insoluble components and yolk and used for immunoprecipitation. The 
precipitated proteins were resuspended in SDS-sample buffer and analyzed by 10% 
SDS-PAGE. 
RESULTS 
Nuclear import of human La, Ro52 and Ro60 in Xenopus laevis oocytes 
Because immunofluorescence led to controversial localization data, especially in the case 
of the Ro proteins, the intracellular localization of the Ro RNP proteins was studied by an 
alternative approach. In vitro translated La, Ro60 and Ro52 proteins were injected into 
the cytoplasm of Xenopus laevis oocytes. After an overnight incubation the intracellular 
distribution was determined by dissection of the oocytes and analysis of the cytoplasmic 
and nuclear fractions. 
Injected 35S-labelled recombinant proteins, obtained by translation in a wheat germ 
extract, became distributed among nucleus and cytoplasm after an overnight incubation. 
The La protein showed a strong nuclear accumulation leaving only a minor part in the 
cytoplasm (Fig. 1A, lanes 3-5). Also a substantial amount of Ro60 had entered the 
nucleus (Fig. IB, lanes 3-5), although the efficiency of nuclear entry appeared to be 
somewhat lower than that for La. In case of Ro52 most of the protein remained in the 
cytoplasm, although detectable amounts were reproducibly imported into the nucleus 
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Figure 1. Nuclear impon of La, Ro60 and Ro52 polypeptides. In vitro translated La (A), Ro60 (B) and 
Ro52 (C) were injected into the cytoplasm of Xenopus laevis oocytes. After incubation at room temperature 
(RT) (lanes 3-5) or 0°C (lanes 6-8) for 18 hours, oocytes (T) were dissected into cytoplasmic (C) and 
nuclear (N) fractions which were analyzed by 10% SDS-PAGE. Lanes 1: Protein molecular weight 
markers. Lanes 2: In vitro translation products used for injection (i). The positions of the full length La, 
Ro60 and Ro52 polypeptides in the gel are indicated. The apparent difference in migration between nuclear 
and cytoplasmic La protein is due to the presence of some remaining yolk protein in the cytoplasmic 
fraction. When nuclear La is analyzed in combination with cytoplasmic La (Lane T), i.e. in the presence of 
cytoplasmic material, it also migrates like cytoplasmic La. Note that migration of La in the nuclear fraction 
is identical to that of the in vitro translation product, which was used for injection. 
(Fig. 1С, lanes 3-5). When La, Ro52 and Ro60 were injected into the nucleus of oocytes 
instead of into the cytoplasm the same distribution between cytoplasm and nucleus after 
an overnight incubation was obtained (data not shown), suggesting that the observed 
distributions reflect equilibrium situations. 
In the La translation mixture (Fig. 1A, lane 2) the full length protein is accompanied by a 
prominent smaller polypeptide. This represents a characteristic degradation product of the 
La protein [Habets et al, 1983; Chan and Tan, 1987], caused by the presence of a 
so-called PEST-region in the middle of the protein [Chan et al, 1989a], which is known 
to be very susceptible to proteolytic degradation. This degradation product represents the 
N-terminal half of the La protein, because only this part contains methionines and thus is 
the part of the protein that will be radioactively labelled during in vitro translation by 
35S-methionine. The observation that this truncated variant of La completely remained in 
the cytoplasm (Fig. 1A, lanes 3-5) strongly suggests that transport of the full-length La 
protein to the nucleus is not caused by diffusion. 
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To investigate the mechanism of nuclear import of all three proteins the oocytes were, 
after injection, incubated at 0°C instead of at room temperature (RT). This approach 
allows us to distinguish between diffusion and active transport because incubation at 0°C 
severely reduces the rate of energy-dependent transport while diffusion is hardly influen­
ced [Newmeyer et al, 1986; Breeuwer et al, 1990]. As shown in Figures 1A, IB and 
1С transport to the nucleus of La, R06O, as well as Ro52 was drastically reduced when 
oocytes were incubated at 0°C (lanes 6-8) in comparison with incubations at room 
temperature (lanes 3-5). Furthermore, this effect appeared to be reversible: oocytes, that 
were first incubated at 0°C for 18h and subsequently at room temperature for 24h, 
displayed protein distributions similar to oocytes that had been incubated at room 
temperature only (data not shown). 
As a control, the U1A protein which previously has been shown to be actively transported 
to the nucleus [Kambach et al, 1992], was included in these types of experiments. 
Nuclear import of the U1A protein was also severely inhibited at 0°C and restored when 
oocytes were subsequently incubated at room temperature (data not shown). From these 
results we conclude that the La, Ro52 and R06O proteins are transported to the nucleus 
via an active process. 
Nuclear export of Y RNA in Xenopus laevis oocytes 
Having observed active nuclear import of the three different Ro RNP proteins, the 
localization of the RNA components of Ro RNPs in Xenopus laevis oocytes was studied. 
For this purpose, in vitro transcribed hYl, hY3, hY4 and hY5 RNA were injected into 
the nucleus of oocytes, i.e. in the cellular compartment where they are synthesized, and 
the distribution of the RNAs after 4 and 18 hours after injection was studied. In vitro 
transcribed Ul snRNA was co-injected as a control. Figure 2A shows that, upon injection 
into the nucleus, hYl, hY3 and hY4 RNA gradually moved to the cytoplasm. The 
distribution of hY5 RNA was not clear since it was not stable upon injection into the 
oocyte. After approximately 8 hours nuclear export of hYl RNA was completed (data not 
shown). The control RNA, Ul snRNA, was, as expected, first transported to the 
cytoplasm before returning to the nucleus (Fig. 2A) [see: Nigg et al, 1991]. 
In vitro produced hY RNAs are structurally identical to hY RNAs isolated from human 
cells, except for the 3' uridine stretch which is 4 nucleotides long rather than 2 or 3. 
Apparently, these in vitro produced molecules are quite stable in oocytes. However, the 
possibility that the behaviour of an injected in vitro produced hY RNA is different from 
that of an endogenously transcribed equivalent can not be excluded. Therefore, hY RNA 
genes (encoding hYl and hY3 RNA) were injected in the oocyte nucleus together with 
[a-32P]-UTP. A Xenopus laevis Ul RNA gene was injected as a control. Both hY3 RNA 
and Ul RNA were transcribed efficiently in oocytes, in contrast to hYl RNA which was 
transcribed very poorly (data not shown). Therefore, the endogenously transcribed hY3 
and Ul RNAs were isolated and re-injected. Figure 2B shows that the distribution of 
these RNAs was similar to that of the in vitro transcribed RNAs (compare Fig. 2A with 
Fig. 2B). Also in this case the hY RNA was predominantly located in the cytoplasm 
while Ul RNA localized primarily in the nucleus 24 hours after injection. The 
distribution of in vivo transcribed hY3 RNA was also studied directly after injection of 
the hY3 gene (and the Ul gene as a control) into the oocyte nucleus along with 
radioactive label and analysis of the cytoplasmic and nuclear localization of transcribed 
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RN As after a relatively long period of time (40 h). Since both Y RN As and U RNAs are 
rather stable in Xenopus laevis oocytes, one would expect a distribution that strongly 
resembles the real distribution of in vivo transcripts. Indeed, also in this experiment hY3 
RNA was found to be primarily cytoplasmic in contrast to Ul RNA, which was, as 
expected, mainly nuclear (data not shown). We conclude that the intracellular transport of 
the in vitro transcribed RNAs is indistinguishable from that of the in vivo transcribed 
RNAs. 
To investigate whether transport of hY RNA to the cytoplasm was an energy-dependent 
process, injected oocytes were incubated at 0°C. Virtually no export to the cytoplasm of 
hYl RNA nor of Ul RNA could be observed (Fig. 2C, compare lanes 2-4 with lanes 
5-7), strongly suggesting that nuclear export of hYl RNA to the cytoplasm is an active 
process. We conclude that h Y RNA, after synthesis in the nucleus, is actively transported 
to and accumulates in the cytoplasm. 
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Figure 2. Nuclear export of hY RNAs. (A) In vitro transcribed hYl, hY3, hY4, hY5 and Ul RNA were 
co-injected into oocyte nuclei. RNA was extracted from total oocytes (T), cytoplasmic (C) and nuclear (N) 
fractions immediately (lanes 1-3), 4 hours (lanes 4-6), 18 hours (lanes 7-9) and 42 hours (lanes 10-12) after 
injection and analyzed on a denaturing Polyacrylamide gel. (B) In vivo transcribed hY3 RNA and Ul RNA 
were gel-purified and re-injected into the oocyte nucleus. Immediately (lane 1), 4 hours (lanes 2-4) and 24 
hours (lanes 5-7) after injection, oocytes were dissected and the extracted RNAs analyzed on a denaturing 
Polyacrylamide gel. (c) In vitro transcribed hYl RNA and Ul RNA were co-injected into the oocyte nucleus 
and subsequently incubated at room temperature (RT) (lanes 2-4) or 0°C (lanes 5-7) for 18 hours. 
Thereafter RNA was extracted from the fractions and analyzed. Lane 1: RNA extracted from oocytes 
immediately after injection. 
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Formation of Ro RNPs in Xenopus laevis oocytes 
The observations that the Y RNAs accumulate in the oocyte cytoplasm and that the Ro 
proteins at least in part move to the nucleus, prompted us to investigate whether the 
injected hYl RNA associates with Xenopus laevis proteins leading to the formation of a 
ribonucleoprotein particle. We hypothesized that such proteins would be homologous to 
the human Ro and La proteins. Recently, the presence of two variants of the La protein 
as well as a R06O homologue in Xenopus laevis have been reported and cDNAs encoding 
these proteins have been cloned [Scherly et al., 1993; O'Brien et al., 1993]. To 
investigate the association of hYl RNA with Xenopus laevis R06O and La proteins, 
affinity- purified monospecific human anti-Ro60 and anti-La antibodies were used. One of 
the prerequisites for the use of these antibodies is cross-reactivity of the antibodies with 
their Xenopus laevis homologues. To study this, immunoprecipitations with a 
radio-labelled Xenopus laevis oocyte extract were performed. Precipitation with 
monospecific anti-La antibodies showed, that these antibodies recognized at least one of 
the two Xenopus laevis La variants, which are not separated by SDS-PAGE (Fig. ЗА, 
lane 3). Precipitations with monospecific anti-Ro60 antibodies revealed that these 
antibodies were reactive with the Xenopus laevis R06O homologue (Fig. ЗА, lane 4). 
When monospecific anti-Ro52 antibodies were used for similar immunoprecipitations no 
specific precipitation of a Xenopus laevis polypeptide was observed (data not shown). This 
is in agreement with previous results indicating that immunoreactive Ro52 could only be 
detected in primate cells [Slobbe et al., 1991]. As a control for the immunoprecipitations 
normal human serum and a polyclonal serum containing antibodies to the Sm-proteins, 
which are associated with U snRNPs and are present in Xenopus laevis oocytes [Zeller et 
al., 1983], were used (Fig. ЗА, lanes 6 and 5, respectively). 
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Figure 3. hYl RNA association with Xenopus laevis proteins. (A) Proteins from an 35S-labelled Xenopus 
laevis oocyte extract were immunoprecipitated using antibodies with various specificities and analyzed by 
SDS-PAGE. Lane 1: Protein molecular weight markers. Lane 2: Mixture of in vitro translated recombinant 
human La and R06O (rRo/La). Lane 3: Anti-La precipitation (α-La). Lane 4: Anti-Ro60 precipitation 
(a-Ro60). Lane 5: anti-Sm precipitation (a-Sm). Lane 6: Normal human serum (NHS) precipitation. (B) In 
vitro transcribed hYl RNA and Ul RNA were co-injected into oocyte nuclei and after 18 hours RNA from 
total oocytes (T), cytoplasmic (C) and nuclear (N) fractions were extracted and analyzed by Polyacrylamide 
gel electrophoresis (lanes 1-3). Cytoplasmic and nuclear fractions were used to perform 
immunoprecipitations with anti-La (lanes 4 and 5), anti-Ro60 (lanes 6 and 7), anti-Sm (lanes 8 and 9) and 
normal human serum (lanes 10 and 11). С and N correspond to the cytoplasmic and nuclear fraction, 
respectively. 
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Using the monospecific affinity-purified anti-La and anti-Ro60 antibody preparations the 
association of Xenopus laevis La and R06O with hYl RNA was investigated. When hYl 
RNA and Ul RNA were co-injected into the nucleus of oocytes the expected distribution 
after an overnight incubation was obtained (Fig. 3B, lanes 1-3). Cytoplasmic as well as 
nuclear extracts of these oocytes were used for immunoprecipitations. Anti-Ro60 
antibodies efficiently precipitated labelled hYl RNA from the cytoplasmic extract, while 
anti-La antibodies resulted in signals that were not or hardly above background (Fig. 3B, 
lanes 4-7). Control antibodies from the anti-Sm or from a normal human serum did not 
precipitate hYl RNA (Fig. 3B, lanes 8-11). Ul RNA was, as expected, specifically 
precipitated by the anti-Sm antibodies, especially from the nuclear extract, in accordance 
with the nuclear accumulation (Fig. 3B, lanes 8 and 9). The specificity of the 
immunoprecipitation was further confirmed by the lack of precipitation by normal human 
serum. From these results we conclude that in vitro transcribed hYl RNA, which 
accumulates in the cytoplasm, is associated with the Xenopus laevis R06O protein but 
apparently not or hardly with the Xenopus laevis La protein. 
The weak precipitation of hYl RNA with anti-La antibodies as compared with anti-Ro60 
antibodies was rather unexpected, since several studies performed in mammalian cells 
indicate that in such cells most, if not all hY RNA molecules are associated with La 
[Boire and Craft, 1990; Peek et ai, 1993]. A possible explanation for this phenomenon is 
that this affinity-purified anti-La antibody is poorly recognizing and precipitating the 
Xenopus laevis La protein when associated with hYl RNA. Differences in efficiency of 
precipitation of Xenopus laevis La RNPs by various antibodies raised against human La 
have been reported before [Terns et al., 1992]. Therefore, several monospecific anti-La 
sera were compared in immunoprecipitating capacity of Xenopus laevis La from a 
35S-methionine labelled oocyte extract. The monospecific anti-La serum used in the 
experiments described above precipitated both human and Xenopus laevis La with a high 
efficiency (data not shown). Furthermore, this antibody precipitated 32P labelled hYl 
RNA incubated in an oocyte extract at least as efficiently as antibodies from other sera. In 
fact, hYl RNA precipitation with the monospecific anti-Ro60 serum used in the 
experiment depicted in Figure 3B was less efficient than precipitation with the 
monospecific anti-La serum (data not shown). In conclusion, the weak precipitation of 
hYl RNA from the oocyte cytoplasm by anti-La antibodies does not seem to be caused by 
the quality or specificity of the antibody used. 
To shed more light on this aspect and to investigate whether the association of the 
Xenopus laevis La and R06O proteins with hYl RNA takes place in the cytoplasm or the 
nucleus, the following experiment was performed. hYl RNA and Ul RNA were 
co-injected into the nucleus of oocytes and, after 4 and 18 hours of incubation, nuclear 
and cytoplasmic fractions were prepared. In parallel, extracts were prepared from 
similarly injected oocytes that were incubated for 18 hours at 0°C. At the latter 
temperature, hYl RNA and Ul RNA are not transported to the cytoplasm (Fig. 4A, lanes 
8-10). As observed before, after 4h incubation at room temperature part of the hYl and 
Ul RNAs had been transported to the cytoplasm (Fig. 4A, lanes 2-4). 18 hours after 
injection most of the hYl RNA was present in the cytoplasm while most of the Ul RNA 
had returned to the nucleus (Fig. 4A, lanes 5-7). Immunoprecipitations with various 
antibodies were performed on the different cytoplasmic and nuclear fractions. The 
precipitations with anti-La antibodies clearly indicate, that in the nucleus La efficiently 
associates with hYl RNA and that the La-hYl RNA complex was found almost 
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exclusively in the nucleus (Fig. 4B, lane 2). This is especially evident after an incubation 
for 18h at 0°C (Fig. 4B, lane 6). In the cytoplasmic fractions no or hardly any La-hYl 
RNA complex could be observed (Fig. 4B, lanes 1, 3, 5). These results suggest that in 
Xenopus laevis oocytes the association with La is lost during transport of hYl RNA to the 
cytoplasm. The latter observations are in agreement with the weak immunoprecipitation 
signals observed before (Fig. 3B). Similar precipitations with anti-Ro60 antibodies 
showed that hYl RNA in the cytoplasm is associated with Ro60 while Ro60-hYl RNA 
complexes in the nucleus are not detectable after incubations at room temperature (Fig. 
4B, lanes 7-10). In contrast, hYl RNA in the nucleus is precipitable with anti-Ro60 
antibodies when the oocytes are incubated at 0°C (Fig. 4B, lane 12), suggesting that the 
binding of Xenopus laevis Ro60 to hYl RNA takes place in the nucleus, followed by 
rapid export to the cytoplasm. Control precipitations were performed with anti-Sm 
antibodies and normal human serum. It appears that only Ul RNA molecules, that have 
passed through or are in the cytoplasm, are immunoprecipitable with anti-Sm antibodies 
(Fig. 4B, lanes 13-17). Ul RNA that did not leave the nucleus during the 0°C incubation 
and for that reason is not complexed with Sm-proteins [Nigg et al., 1991] could not be 
precipitated by anti-Sm antibodies , as expected (Fig. 4B, lane 18). 
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Figure 4. Assembly and nuclear export of hYl RNP in Xenopus laevis oocytes. 
(A) In vitro transcribed hYl RNA and Ul RNA were co-injected into the oocyte nucleus and incubated at 
room temperature (lanes 2-7) or 0°C (lanes 8-10). After 4 hours (lanes 2-4) and 18 hours (lanes 5-10) RNA 
from total oocytes (T), cytoplasmic (C) and nuclear (N) fractions were extracted and analyzed on gel. Lane 
1: RNA extracted from oocytes immediately after injection (t=0). The RNA in each lane corresponds to the 
contents of 0.5 oocyte or oocyte compartment.(B) Injected RNAs as in (A) were immunoprecipitated from 
the cytoplasmic (C) and nuclear (N) fractions with anti-La (lanes 1-6), anti-Ro60 (lanes 7-12), anti-Sm 
(lanes 13-18) and normal human serum (lanes 19-24) and analyzed by Polyacrylamide gel electrophoresis. 
Material from three oocytes (or oocyte compartments) was used for each immunoprecipitation. Subscripts 
indicate the incubation times and superscripts refer to the incubation temperature before preparation of the 
extracts (No superscript corresponds to incubation at room temperature). 
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DISCUSSION 
The intracellular localization of Ro RNPs has been studied by several groups primarily 
using the immunofluorescence technique. The results of these studies were not very 
conclusive. In a recent study [Peek et al., 1993] it became clear that the localization as 
determined by immunofluorescence critically depends on the cell fixation method. The 
contradicting results obtained witfi the immunofluorescence technique might be explained 
in part by leakage of intracellular components during fixation or by masking of epitopes 
due to fixation. Recently, cell enucleation studies have shed more light on the intracellular 
localization of Ro RNPs [O'Brien et al, 1993; Peek et al, 1993]. In order to verify and 
extend these data a second approach was chosen: injection of Ro RNP components into 
Xenopus laevis oocytes. This approach has also successfully been employed to elucidate 
the intracellular distribution and transport of different U snRNPs and their proteins 
[reviewed in: Nigg et al, 1991]. While this work was in progress Ro RNPs were 
identified and characterized in Xenopus laevis [O'Brien et al, 1993], which allowed us to 
use the oocytes as a bona fide system to study the intracellular distribution and transport 
of Ro RNP components. Four Y RNAs, corresponding to Y3, Y4, Y5 and an RNA not 
related to one of the human Y RNAs, designated xYa RNA, as well as a 60 kDa Ro 
protein were characterized in Xenopus laevis. 
Ro RNP proteins are actively transported to the nucleus 
When injected into the cytoplasm, the recombinant human La protein accumulates in the 
oocyte nucleus. The primarily nuclear localization is in agreement with the results 
obtained with immunofluorescence [Hendrick et al, 1981], cell fractionation [Habets et 
al, 1983] and immunoelectron microscopy [Carmo-Fonseca et al, 1989]. The 
observation that Ro60 and Ro52 are also actively transported to the nucleus, although less 
efficiently, is in agreement with data obtained by cell enucleation of Jurkat and 3T3 cells 
[Peek et al, 1993]. After cell enucleation La, Ro52 and Ro60 were found in both 
cytoplasm and nucleus. Minor quantitative differences obtained by different techniques as 
oocyte injection and cell enucleation might be explained by the different cell types that 
were used in these studies and/or by differences in the total amount of Ro or La protein 
per cell. Furthermore, one should realize that the binding to endogenous components, like 
Y RNAs, may influence the intracellular distribution of the injected molecules. 
All three proteins are transported to the nucleus via an active transport mechanism. This 
probably implies that a nuclear localization signal (NLS) is involved. An NLS is a 
structural element that both is necessary and sufficient for transport of a protein to the 
nucleus. A nuclear protein will either possess its own NLS or enter the nucleus by 
cotransport while associated with another protein containing an NLS [Silver, 1991; 
Garcia-Bustos et al, 1991]. A sequence element matching the bipartite NLS [Dingwall et 
al, 1991], which is found in the majority of nuclear proteins, is present in La but not in 
Ro60 or Ro52. At present, studies are being performed to determine which sequences in 
La, Ro60 and Ro52 are involved in nuclear import of these proteins. 
Y RNAs are located in the cytoplasm 
In contrast to the Ro RNP specific proteins, hY RNAs were found to be located 
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exclusively in the cytoplasm after an overnight incubation of injected oocytes. Upon 
injection h Y RN As are actively exported out of the nucleus into the cytoplasm. These 
results are in agreement with the data obtained with cell enucleation studies [O'Brien et 
al, 1993; Peek et al, 1993] in which human and murine cells were used. In vivo 
transcribed hY3 RNA also accumulated in the cytoplasm, thereby justifying the use of in 
vitro transcribed RNAs. In accordance with our results, the endogenous Xenopus laevis 
xY RNAs were recently also shown to be exclusively localized in the oocyte cytoplasm 
[O'Brien et al, 1993]. It therefore seems unlikely that the use of a heterologous RNA 
might have influenced the results. 
The hYl gene was transcribed very poorly in Xenopus laevis oocytes and produced 
several transcripts of approximately hYl RNA size. A possible explanation for the 
inefficient transcription of the hYl gene is that the upstream sequence present in this 
genomic clone was relatively small (approximately 100 bp, instead of approximately 400 
bp in the case of the hY3 gene). Probably some essential transcription regulatory 
sequence elements in the hYl gene are lacking. 
Interaction of Xenopus laevis La and Ro60 with hYl RNA 
La is evolutionarily reasonably well conserved, as has been shown by Western blotting 
data [Hoch et al., 1984; Slobbe et al., 1991b] and cDNA sequence comparisons [Chan et 
al, 1989b; Scherly et al, 1993; Topfer et al, 1993; Semsei et al, 1993]. Two Xenopus 
laevis La cDNA variants have been described. Both encode polypeptides that are about 20 
amino acids longer (427 and 428 amino acids, respectively) than their human counterpart 
[Scherly et al, 1993]. Monospecific anti-La antibodies immunoprecipitated at least one of 
these Xenopus laevis La proteins which indeed had an apparent molecular weight 
somewhat higher than that of the human La protein. Like human La, Xenopus laevis La 
was able to associate with hYl RNA. The evolutionary conservation of Ro60 is also 
evident: 60 kDa proteins from various species react on Western blots with antibodies 
raised against human Ro60 [Mamuia et al, 1989a; Slobbe et al, 1991b]. By 
immunofluorescence the existence of the Ro/SS-A antigen in frogs has been demonstrated 
[Xia et al, 1987]. A cDNA encoding a 60-kDa Ro protein sharing 78% amino acid 
sequence identity with human Ro60 has recently been isolated from a Xenopus laevis 
cDNA library [O'Brien et al, 1993]. Our immunoprecipitation experiments showed that 
Xenopus laevis indeed contains a 60 kDa protein which is reactive with anti-Ro60 
antibodies and is able to interact with hYl RNA (Fig. ЗА, lane 4 and Fig. 3B, lane 6). 
Analyses of the association of Xenopus laevis La with hYl RNA strongly suggest that 
during or shortly after export from the nucleus La dissociates from hYl RNA in oocytes. 
A similar phenomenon has been observed with the transport of 5S rRNA from nucleus to 
cytoplasm in Xenopus laevis oocytes [Guddat et al, 1990]. The loss of association with 
La might be related to the fact that pre-5S rRNA loses its 3' U-stretch upon processing. 
At the moment it is not clear whether the human Y RNAs in Xenopus laevis oocytes are 
also subject to processing events at their З'-end. The apparent dissociation of La from 
hYl RNA in Xenopus laevis oocytes is, however, in contradiction to the results obtained 
by enucleation [Peek et al., 1993] and fractionation [Boire and Craft, 1990] of human 
cells because Y RNAs were found to be stably associated with the La protein in these 
cells. Future studies will show whether dissociation of La from Y RNAs is dependent on 
the type of cell studied. 
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In addition to La, Xenopus laevis R06O was found to associate with hYl RNA. The low 
level of association of R06O with nuclear hYl RNA as detected at 4 h after injection 
suggests that the association with R06O might be the rate limiting step in nuclear export of 
hYl RNA. An alternative explanation would be that the Ro60-hYl RNA association in 
the nucleus is very inefficient and mostly takes place after export of hYl RNA to the 
cytoplasm. Indeed, the Ro60-hYl RNA association in the nucleus at 0 °C incubation 
appears to be rather inefficient (Figure 4B, lane 12), which may, however, also be related 
to the smaller amount of R06O in the oocyte nucleus in comparison with the amount of 
La. Alternatively, the association of R06O with hYl RNA in the nucleus might be 
temperature dependent. Preliminary results of experiments, in which we injected a hYl 
RNA mutant that was unable to associate with R06O, however, strongly suggest that R06O 
binding in the nucleus is required for efficient export of hYl RNA to the cytoplasm 
(unpublished observations). 
The results presented in Figure 4 might suggest that the binding of endogenous R06O and 
La to hYl RNA injected into oocytes is mutually exclusive. Although we can not 
completely exclude this possibility for the Xenopus laevis proteins, several data obtained 
with the human and mouse proteins, however, indicate that both proteins can 
simultaneously bind to one hY RNA molecule [Mamula et al., 1989b; Boire et al., 1990; 
Peek et al., 1993]. 
The combination of the present results and the results obtained by enucleation of human 
and murine cells [Peek et al., 1993] leads to the following model for Ro RNP synthesis 
and assembly. R06O and La, after translation in the cytoplasm, are actively transported to 
the nucleus. In the nuclear compartment they associate with Y RN As shortly after or even 
during transcription. Once such complexes have been formed, they are rapidly and 
actively exported out of the nucleus to the cytoplasm where they will fulfil their 
function(s). It should be noted that our results do not exclude the posibility that other, yet 
unidentified factors are also involved in the transport process. 
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ABSTRACT 
The La (SS-B) autoantigen is a 47 kDa protein which binds to the 3' termini of nascent 
RNA polymerase III transcripts and to a number of viral leader RNAs. The La protein 
plays a direct role in the termination of RNA polymerase III transcription and recent 
findings have suggested an additional role in several aspects of translation of (viral) 
mRNAs. In this study we have addressed the intracellular trafficking of the La protein 
and characterized ci'j-acting elements involved in nuclear import and retention in Xenopus 
laevis oocytes by microinjecting in vitro translated La protein. The steady-state 
distribution of recombinant human La protein was, like the endogenous Xenopus La 
protein, mainly nuclear. Nuclear import of La appeared to be energy-dependent and is 
governed by a nuclear localization signal (NLS) located in the extreme C-terminal part of 
the protein, resembling the consensus bipartite NLS. Another sequence element in La, 
which completely corresponds to the bipartite NLS consensus, appeared to be 
non-functional in nuclear import of the La protein. Nuclear accumulation of La was found 
to be mediated by retention in the nuclear compartment. The N-terminal RNA binding 
domain of La is not involved in this retention, but sequence elements in the central region 
of the polypeptide (amino acids 165 to amino acids 337) appear to be required. Amino 
acids 266-269 as well as 313-337 were found to be of major importance for retention in 
the nucleus. 
INTRODUCTION 
Sera from patients with rheumatic diseases like Sjogren's syndrome and systemic lupus 
erythematosus frequently contain antibodies directed to cellular proteins. One class of 
autoantibodies is directed to a 47 kDa protein, called La or SS-B [1,2]. In cells the La 
protein associates with various small RNA molecules to form La ribonucleoprotein 
particles (La RNPs) [3]. 
The RNA component of a La RNP mostly is a newly synthesized RNA polymerase III 
transcript, such as (the precursor of) 7S RNA, 5S rRNA, tRNA, U6 RNA or Y RNA. In 
addition some virally encoded RNAs may be bound by La, such as adenovirus VAj and 
VA„ RNA, Epstein-Ban· virus EBER1 and EBER2 RNA and leader RNAs of vesicular 
stomatitis virus and rabies virus [2]. The primary binding site for the La protein is the 
З'-oligouridine stretch, common to all RNA polymerase III transcripts [4-6]. La associates 
with most RNAs only transiently, because the 3' oligouridine stretch is removed during 
maturation of these RNAs. However, the Y RNAs and the virally encoded VA and EBER 
RNAs retain the La binding site and La therefore binds these RNAs in a more stable 
49 
fashion. 
In agreement with the binding of La to all newly synthesized RNA polymerase III 
transcripts, it has been shown that La is necessary for efficient and correct termination of 
RNA polymerase III transcription [7-9]. Potentially related to this activity, purified La has 
been shown to contain ATP-dependent unwinding activity, able to melt DNA-RNA 
hybrids and double-stranded RNA (dsRNA) [10,11]. Recently, the results of in vitro 
studies showed, that La may also be involved in internal initiation of translation of 
poliovirus RNA [12,13] or in alleviation of translation repression by the leader sequence 
ofHIV-1 mRNA [14,15]. 
Consistent with the role of La in transcription termination the majority of anti-La 
antibodies in immunofluorescence studies appear to decorate the nucleus. However, an 
intracellular re-distribution (cytoplasmic accumulation) of La has been reported under 
certain stress conditions such as viral infection [12,16-18], UV irradiation [19-21] and 
inhibition of RNA synthesis [22]. Based on these observations La was proposed to shuttle 
between nucleus and cytoplasm and to be involved in the nucleo-cytoplasmic transport of 
RNA polymerase III transcripts [22]. However, La did not seem to be involved in the 
nuclear export of 5S rRNA in Xenopus laevis oocytes [23]. 
Several groups have independently isolated complementary DNA clones encoding the 
complete human La protein [24-26]. The La protein is composed of 408 amino acids, 
with a predicted molecular weight of 46.7 kDa. In its primary sequence several structural 
motifs can be discerned like two RNP motifs, three PEST-regions and a potential 
ATP-binding site [1,27,28]. Also, cDNAs encoding bovine, mouse, rat, Xenopus laevis, 
Drosophila melanogaster and Saccharomyces cerevisiae La have been isolated and 
characterized [25,28-31]. 
Nuclear import of proteins is mediated by nuclear pore complexes present in the nuclear 
envelope. Transport occurs either by diffusion (for small proteins) or is mediated by 
nuclear localization signals (NLSs) present in proteins [32]. Although some variation 
among defined NLSs has been noted, they were all found to contain a high percentage of 
basic amino acids. The prototype and best studied NLS is present in the SV40 large Τ 
antigen: Pro-Lys-Lys-Lys-Arg-Lys-Val. In spite of the existing diversity between NLSs a 
consensus NLS has been proposed [33], consisting of a bipartite structure with two basic 
amino acids at the N-terminus, a spacer of ten random amino acids and a second stretch 
of basic amino acids (at least three out of five) at the C-terminal end. A sequence 
corresponding to the bipartite NLS was found in 56% of proteins known to reside in the 
nucleus, one of which is the La protein [33]. 
Recently, Schmidt-Zachmann and co-workers [34] tried to identify sequence elements 
which are required for export of nuclear proteins. Their results indicated that export is 
not mediated by specific export signals, but instead is limited because of the presence of 
specific domains in the protein which are involved in nuclear retention. Others however, 
claim that nuclear export of proteins, like nuclear import, is mediated by specific signals 
[35-37]. 
In this study we investigated the nuclear import and retention of the human La protein by 
microinjection of Xenopus laevis oocytes. We determined which structural elements of the 
protein are involved in nuclear uptake and nuclear retention. The C-terminal part of La 
was found to contain both an NLS resembling the bipartite NLS and sequence elements, 
distinct from the NLS, which are involved in nuclear retention. 
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MATERIALS AND METHODS 
cDNA constructs 
A cDNA clone encoding human La, which has been described previously by Pruijn et al. 
[5], was inserted into pGEM-3Zf(+) lacking the unique ВатШ site [38]. Point mutants, 
in which the codons for one, two or three amino acids were changed, were made using 
either the Sculptor in vitro mutagenesis system (Amersham) or the U-DNA Mutagenesis 
Kit (Boehringer Mannheim). Each mutation introduced a unique ВатШ site (La313/4, 
La316/7, La 334/5, La355/6, La381 and La383/4), a unique Clal site (La 151/2, 
La266/9, La338/40, La344/6, La362/3 and La388/9) or a unique Nari site (La366/7). 
The mutation was checked by digestion with the respective restriction enzyme in 
combination with £coRI and by DNA sequencing. The numbers in the substitution 
mutants indicate which amino acids of the human La sequence were mutated (Lal51/2: 
amino acids 151-152 Lys-Gly are changed to He-Asp; La266/9: amino acids 266-269 
Arg-Gly-Ala-Lys to Ile-Asp-Ala-Glu; La313/4: amino acids 313-314 Glu-Ala to Gly-Ser; 
La316/7: amino acids 316-317 Lys-Lys to Gly-Ser; La334/5: amino acids 334-335 
Arg-Arg to Gly-Ser; La338/40: amino acids 338-340 Gly-Lys-Gly to Val-Ile-Asp; 
La344/6: amino acids 344-346 Lys-Ala-Ala to Ile-Asp-Asp; La355/6: amino acids 
355-356 Val-Gln to Gly-Ser; La362/3: amino acids 362-363 Thr-Lys to lie-Asp; La366/7: 
amino acids 366-367 Ser-Asp to Gly-Ala; La381: amino acids 381 Pro is mutated in Ser; 
La383/4: amino acids 383-384 Lys-Arg to Gly-Ser; La388/9: amino acids 388-389 
Glu-Thr to lie-Asp). Mutant LaA312-336 was made by ligating the smallest 
ВатШ-НіпаШ fragment of La334/5 into the largest Hindlll-BamUl fragment of La313/4. 
LaAN165 and LaA137-306 were constructed as described by Pruijn et al. [39]. The 
mouse dihydrofolate reductase clone (mDHFR) in pBluescribe(-) has been described 
before [40]. DHFR-La382-408 and DHFR-La385-408 were made by ligating the smallest 
BamUl-Hindlll fragment of La381 and La383/4, respectively, into the largest 
Bgill-Hindlll fragment of mDHFR-pBluescribe(-). DHFR-Lal65-408 was made by 
ligating the smallest Ddel-Hindlll fragment (with filled up Ddel site) of La 
wt-pGEM3Zf(+) into the largest Bglll-Hindlll fragment (with filled up BgRl site) of 
mDHFR-pBluescribe(-). 
In vitro transcription/translation 
In vitro transcription/translation was carried out as described previously [38]. Wild type 
La and all LaAC380 proteins were produced after linearization with Hindlll and Avail, 
respectively. Mutants LaAC265, LaAC337, LaAC343 and LaAC361 were made by 
linearizing La266/9, La338/40, La344/6 and La362/3, respectively, with Clal and 
LaAC312 was made by digestion of La313/4 with ВатШ. DHFR-La385-408 was made 
by digestion with Hindlll. DHFR-La382-397 and DHFR-La382-408 and were made by 
digestion of DHFR-La382-408 with ÄspMl and Hindlll, respectively. DHFR-Lal65-380 
was made by digestion of DHFR-Lal65-408 with Avail. 
Oocyte injection 
Oocytes were released from the ovary, injected in either cytoplasm or nucleus with the in 
vitro translated protein(s), manually dissected and analyzed by SDS-PAGE [41]. To 
control nuclear injection, samples were mixed with dextran blue (Serva Biochemica) (10 
mg/ml) and 20 nl was injected into the nucleus. After dissection only oocytes with blue 
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nuclei were used for analysis. 
Anti-La antibodies 
The anti-La antibodies, used for immunoprecipitation, were affinity-purified from an 
autoimmune patient serum using bacterially expressed La [42]. Their monospecificity was 
confirmed by Western blotting and by immunoprecipitation of in vitro translated proteins. 
Immunoprecipitation 
Antibodies were coupled to protein Α-agarose by head over head rotation at 20°C for 1 h 
in IPP500 (10 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.1% NP-40). For each precipitation 
50 μΐ of affinity-purified anti-La or normal human serum were used. 
Immunoprecipitations were carried out in IPPi50 (10 mM Tris-HCl, pH 8.0, 150 mM 
NaCl, 0.1% NP-40) for 2 h at 4°C. Oocytes were labelled in Barth-medium with 0.5 mCi 
35S-methionine. After 40 hours the oocytes were dissected and the different fractions were 
homogenized in SlOO-buffer (25 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 0.25 mM 
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 0.1 M KCl, 0.01% NP-40, 20% 
glycerol). The total oocyte extract and cytoplasmic fraction were centrifuged to remove 
insoluble components and yolk. Four oocyte equivalents of each fraction were used in 
every immunoprecipitation. The precipitated proteins were solubilized in SDS-sample 
buffer and analyzed by 10% SDS-PAGE. 
RESULTS 
Nuclear import of the La protein in Xenopus Iaevis oocytes 
In agreement with most immunofluorescence data on the subcellular localization, the La 
protein was recently shown to accumulate in the nucleus of Xenopus Iaevis oocytes [41]. 
A human La cDNA clone was transcribed and translated in vitro in the presence of 
35S-labelled methionine. The radio-labelled La protein was injected into the cytoplasm of 
oocytes and, after an incubation period, the intracellular distribution of the La protein was 
monitored by dissecting oocytes into cytoplasmic and nuclear fractions followed by 
SDS-PAGE analysis. To learn more about the kinetics of nuclear import we determined 
the distribution at various time points after microinjection. Fig. 1A shows that upon 
injection into the cytoplasm, La gradually enters the nucleus. The first signal in the 
nucleus is seen after 4 hours of incubation (Fig. 1A, lane 17), eventually resulting in an 
almost complete nuclear accumulation after 24 hours (Fig. 1A, lanes 21-23). The situation 
after 24 hours reflects an equilibrium situation, because a prolonged incubation resulted in 
a similar distribution (data not shown). Although most of the La protein is located in the 
nucleus at equilibrium, it is evident that also a substantial amount is present in the 
cytoplasm. As noted before [41] the specificity of nuclear import is substantiated by the 
lack of nuclear import of the 28 kDa degradation product of La. This degradation product 
results from cleavage of the La protein in or near the central PEST region [25]. Only the 
N-terminal degradation product will be labelled and therefore detectable, because the 23 
kDa C-terminal part does not contain methionines. 
In order to rule out the possibility that the in vitro translated recombinant human La 
protein behaves aberrantly in oocytes, the distribution of the endogenous La protein was 
investigated as well. In Xenopus Iaevis two La variants have been described [29]. The two 
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Figure 1. Nuclear import of the La protein. (A) Radiolabeled in „ 
vitro translated La (rLa, lane 2) was injected into the cytoplasm to· m» τ с Ν ,u τ с Ν 
of Xenopus laevis oocytes. At time points 0 (lanes 3-5), 'Λ 
(lanes 6-8), 1 (lanes 9-11), 2 (lanes 12-14), 4 (lanes 15-17), 8 es 
Ganes 18-20) and 24 (lanes 21-23) hours after injection oocytes <· 
(T) were dissected into cytoplasmic (C) and nuclear (N) *> 
fractions, which were analyzed by 10% SDS-PAGE. Lane 1: « к 
Protein molecular weight markers. The positions of the wild
 ч
 Я В 
type La protein (La wt) and the 28 kDa degradation product — 
(arrow) are indicated. The apparent difference in migration ι ι ΐ 4 « · 7 · ι ι ο ι ι 
between nuclear and cytoplasmic La protein is due to the 
presence of some remaining yolk protein in the cytoplasmic fraction. When nuclear La is analyzed in 
combination with cytoplasmic La (Lane T), i.e. in the presence of cytoplasmic material, it also migrates like 
cytoplasmic La. Note that migration of La in the nuclear fraction is identical to that of the in vitro 
translation product, which was used for injection. (B) Proteins from "S-labelled Xenopus laevis oocyte total 
(T), cytoplasmic (C) and nuclear (N) extracts were immunoprecipitated using affinity-purified anti-La 
antibodies Ganes 6-8) and normal human serum (NHS) (lanes 9-11) and analyzed by SDS-PAGE. The 
position of Xenopus laevis La protein is marked by an open circle. Lane 1: Protein molecular weight 
markers. Lanes 2-4: 1% of the T, С and N extracts, respectively, used in immunoprecipitation. Lane 5: In 
vitro translated recombinant human La (rLa). 
Xenopus La variants are homologous to human La (approximately 70% amino acid 
sequence identity) and are either 19 or 20 amino acids longer than human La because of 
an insertion in the C-terminal part of the protein. To examine the distribution of 
endogenous La, oocytes were labelled with 35S-methionine and dissected. The Xenopus 
laevis La proteins in the cytoplasmic and nuclear fractions were immunoprecipitated with 
monospecific anti-La antibodies isolated from a patient serum. It is clear that at least one 
of the two Xenopus laevis La variants was recognized by the anti-La antibodies (Fig. IB, 
lanes 6-8). Note that probably due to the insertion the Xenopus laevis protein(s) migrate(s) 
somewhat more slowly than the recombinant human La protein (compare lane 5 with lane 
6). More importantly, the endogenous La protein distribution is in agreement with the 
recombinant La distribution: the majority of the endogenous La appears to be present in 
the nucleus (Fig. IB, lanes 6-8). The difference in precipitation efficiency between the 
total fraction and the nuclear fraction is probably due to the different conditions during 
immunoprecipitation. In the nuclear fraction no yolk proteins are present, in contrast to 
the total and the cytoplasmic fractions which contain, in spite of the removal of most of 
the yolk by centrifugation, a relatively high amount of yolk proteins, resulting in a 
decreased precipitation efficiency of the La protein in these fractions. However, 
immunoprecipitations from nuclear and cytoplasmic fractions under identical conditions, 
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achieved by mixing labelled nuclear fraction with an equivalent amount of unlabelled 
cytoplasmic fraction and vice versa, confirmed that the majority of endogenous La is 
present in the nucleus (data not shown). The specificity of the immunoprecipitations was 
confirmed by the lack of precipitation by antibodies from normal human serum (Fig. IB, 
lanes 9-11). In conclusion, microinjected recombinant human La as well as endogenous 
Xenopus laevis La are primarily but not exclusively localized in the nucleus of Xenopus 
laevis oocytes. 
To prove that the intracellular distribution of microinjected La after 24 hours reflects the 
steady-state situation, La was injected into the nucleus rather than into the cytoplasm. The 
results in Fig. 2 demonstrate that after a 24 hours incubation at 20°C hardly any 
difference can be observed between the distribution obtained after injection into the 
nucleus or into the cytoplasm (compare lanes 2-4 with 5-7). Note that most of the 28 kDa 
degradation product at this time point has already left the nucleus (after injection into the 
latter compartment) (Fig. 2, lanes 5-7). In parallel, La was injected in either nucleus or 
cytoplasm of oocytes, which were then subsequently incubated at 0eC. At this 
temperature energy-dependent transport is severely hampered, in contrast to passive 
diffusion [43,44]. La injected into the cytoplasm hardly enters the nucleus at 0°C, 
consistent with an energy-dependent nuclear import mechanism (Fig. 2, lanes 9-11). 
When injected into the nucleus, on the other hand, La largely remains in the nucleus (Fig. 
2, lanes 12-14), in spite of the fact that re-import would not be feasible under these 
conditions (Fig. 2, lanes 9-11) suggesting that La does either not leave the nucleus or 
requires energy to be exported to the cytoplasm. Note that the 28 kDa degradation 
product did leave the nucleus at 0°C, which is most likely due to passive diffusion. 
RT <£C 
с a? £ m 
ю» M W T C N T C N I T C N T C N 
1 2 3 4 5 6 7 β 9 10 11 12 13 14 
Figure 2. Steady-state distribution of micro-injected recombinant human La in Xenopus laevis oocytes. 
Radiolabeled in vitro translated human La protein (i, lane 8) was injected into oocyte cytoplasm (Ç) (lanes 
2-4 and 9-11) or oocyte nucleus (N) (lanes 5-7 and 12-14) and incubated for 18 hours at room temperature 
(RT) (lanes 2-7) or 0°C (lanes 9-14). After incubation, oocytes (T) were manually dissected into 
cytoplasmic (C) and nuclear (N) fractions and analyzed by SDS-PAGE. Lane 1: Protein molecular weight 
markers. The positions of the wild type La protein (La wt) and the 28 kDa degradation product (arrow) are 
indicated. 
Determination of the nuclear localization signal of the La protein 
In order to determine the sequence elements of the La protein involved in nuclear uptake, 
nuclear import of several mutants was studied upon injection into the cytoplasm. Both a 
La mutant lacking the N-terminal 164 amino acids (LaAN165) and a mutant with an 
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internal deletion spanning the region from amino acids 138 to 305 (LaA137-306) showed 
nuclear accumulation comparable to wild-type protein (Fig. ЗА, compare lanes 8-13 with 
lanes 2-4). In contrast, the 28 kDa degradation product, representing the N-terminal half 
of the protein, did not enter the nucleus, as observed before. Also, a mutant lacking only 
the C-terminal 62 amino acids (LaAC346), was not imported into the nucleus (Fig. ЗА, 
lanes 5-7). Two other C-terminal deletion mutants (LaAC304 and LaAC380) showed no 
nuclear import either (data not shown). These results strongly suggested that the element 
involved in nuclear import is located in the C-terminus of the La protein. 
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Figure 3. Nuclear import of various La mutants. In vitro 
translated La protein and mutants thereof (indicated in the 
figure with an open circle) were injected into the cytoplasm of 
Xenopus laevis oocytes and after incubation for 18 hours at 
room temperature, oocytes (T) were dissected into cytoplasmic 
(C) and nuclear (N) fractions and analyzed by 10% 
»«««• т^ашт SDS-PAGE. Lanes 1: Protein molecular weight markers. (A) 
La wt and deletion mutants LaAC346, LaAN165 and 
14 ^ LaA137-306. (B) La wt and substitution mutants La313/4, 
1 2 3 4 6 6 7 La316/7, La355/6, La381 and La383/4. (C) La wt and internal 
deletion mutant LaA312-336. 
In the primary sequence of the human La protein three sequence elements homologous to 
the bipartite NLS [33] can be discerned. Two of these elements are located in the 
C-terminal part of the protein. The first one spans the region from amino acids 316 to 
332 and perfectly corresponds to the bipartite NLS consensus [33], having two basic 
amino acids at the N-terminal side of the element, a spacer region of 10 amino acids and 
three basic amino acids out of five at the C-terminal side. The second element, from 
amino acids 383 to 400, resembles a bipartite NLS, having two N-terminal basic amino 
acids, a spacer region of 12 amino acids and two basic amino acids out of four at the 
C-terminal end. The former element will be referred to as box A and the latter as box В 
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(see also Fig. 5). To analyze whether (one of) these elements were involved in nuclear 
import of La, single, double or triple amino acid substitution mutants were made in the 
C-terminal region of La. The distribution of five of such mutants obtained after injection 
into the cytoplasm and subsequent incubation of the oocytes is depicted in Figure 3B. 
Only the mutant in which the first two basic amino acids of box В (at positions 383 and 
384) had been altered (La383/4) was not imported into the nucleus (Fig. 3B, lanes 17-19), 
in contrast to the other substitution mutants (La313/4, La316/7, La355/6 and La381), 
which efficiently entered the nucleus, comparable to the wild-type La protein (Fig. 3B, 
lanes 2-16). In one of these mutants (La316/7) the first two basic amino acids of box A 
were changed into glycine-serine. Several other point mutants tested (see Fig. 5) also 
showed strong nuclear accumulation (data not shown). In summary, C-terminal deletion 
mutants lacking box В but containing box A (e.g. LaAC346) lost the capacity to enter the 
nucleus. In agreement with this a mutation of the first two amino acids of box A still 
allowed nuclear uptake in contrast to a similar mutation of box B. The finding that box A 
was not required for nuclear import was substantiated by the fact that a mutant in which 
the entire box A was deleted (LM312-336) still showed nuclear accumulation (Fig. 3C, 
lanes 5-7). Taken together these data, which are summarized in Fig. 5, indicate that box 
A, although perfectly matching the consensus bipartite NLS, does not function as an NLS 
in La and that nuclear accumulation of the La protein is completely dependent on box B. 
The NLS of La is able to direct a cytoplasmic protein to the nucleus 
To investigate whether box В of La was not only necessary but also sufficient for nuclear 
accumulation, the C-terminal end of La (amino acids 382-408) was fused to the 
cytoplasmic protein dihydrofolate reductase (DHFR). After in vitro translation this fusion 
protein (DHFR-La382-408) was injected into the cytoplasm of Xenopus laevis oocytes. 
Figure 4. Nuclear import of DHFR-La 
fusion proteins. In vitro translated proteins 
(positions indicated in the figure with an 
open circle) were injected into the 
cytoplasm of Xenopus laevis oocytes and 
after incubation for 18 hours at room 
temperature, oocytes (T) were dissected 
into cytoplasmic (C) and nuclear (N) 
fractions and analyzed by 10% SDS-PAGE. 
(A) Lanes 2-4: wild type La. Lanes 5-7: 
wild type DHFR. Lanes 8-10: DHFR fused 
to amino acids 382 to 408 of the La 
protein. Lanes 11-13: DHFR fused to 
amino acids 385 to 408 of the La protein. 
(B) Lanes 2-4: wild-type DHFR. Lanes 
5-7: DHFR fused to amino acids 382 to 
397 of the La protein together with DHFR 
fused to amino acids 382 to 408 of the La 
protein. Lanes 1: Protein molecular weight 
markers. 
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Fig. 4A shows that DHFR by itself was not transported to the nucleus (lanes 5-7). 
However, when the C-terminal part of La was fused to DHFR this fusion protein entered 
the nucleus as efficiently as wild-type La (Fig. 4A, lanes 8-10). The specificity of the 
nuclear accumulation of this fusion protein was substantiated by the lack of nuclear 
import of a similar construct (DHFR-La385-408) (Fig. 4A, lanes 11-13), which is 
identical to DHFR-La3 82-408 except for the first two basic amino acids of box В and one 
amino acid (382) flanking box В at the N-terminus. These results confirm the importance 
of the basic amino acids 383-384 for nuclear import. To investigate the requirement of 
the C-terminal amino acids of box B, a C-terminal deletion mutant was prepared which 
lacks the last lysine of box В (DHFR-La382-397). Upon injection into the cytoplasm the 
efficiency of nuclear import of this mutant was severely reduced in comparison with 
DHFR-La382-408 (Fig. 4B, lanes 5-7). This result indicates that the most C-terminal 
amino acids of La are involved in NLS formation and suggests that also the lysine residue 
at position 400, the only basic amino acid in this region, might be important. Taken 
together, the data (summarized in Fig. 5) indicate that box В at the C-terminus of the La 
protein is both necessary and sufficient for nuclear import of La. Therefore we conclude 
that the C-terminal region of La contains a functional, genuine NLS. 
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Figure 5. Summary of the nuclear 
localization signal mapping data. 
Schematic representation of the 
structure of La and of the various 
La mutants analyzed. RNP motif 
= RNA Recognition Motif 
(RRM), PEST: PEST region, 
PKR: PKR-like sequence element, 
ATP: ATP-binding motif, A and 
B: NLS-like sequence boxes A and 
B. Circles in the representation of 
mutants indicate the relative 
p o s i t i o n of amino acid 
substitutions. The ability of the 
mutants to enter the nucleus is 
listed on the right. 
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Nuclear retention of the La protein 
In the next series of experiments the ability of the La protein to leave the nucleus was 
analyzed by injection of different mutants into the nucleus of Xenopus laevis oocytes. 
Upon injection of the wild-type La protein into the nucleus the same distribution was 
obtained as after injection into the cytoplasm, i.e. the majority being present in the 
nuclear compartment and only a small amount in the cytoplasm (Fig. 2 and 6, lanes 2-7). 
Such a steady-state distribution might reflect efficient re-import of La after leaving the 
nucleus. To investigate this possibility, the La mutant with an inactive NLS (La383/4), 
was injected into the nucleus. As shown in Fig. 6 this mutant displayed wild-type 
distribution, indicating that La did not or only very inefficiently leave the oocyte nucleus 
(lanes 8-13). This observation implies, that La in these cells is efficiently retained in the 
nucleus. An obvious candidate for a nuclear retention signal of La is the most N-terminal 
RNP motif (amino acids 112-187), because this motif is necessary for the (transient) 
association of La with RNA polymerase III transcripts [34], which primarily occurs in the 
nucleus. However, this RNP motif appeared not to be involved in retention, since the 28 
kDa degradation product of La, which contains the complete RNA binding domain and is 
able to interact with RNA polymerase III RNAs in vitro [5], was not retained in the 
nucleus (Fig. 6). This conclusion is substantiated by the observations that a mutant 
lacking almost the complete N-terminal RNP motif as well as the NLS (LaAN165AC380) 
was not exported from the nucleus (Fig. 7A, lanes 14, 15) and that a point mutant 
Lal51/2AC380, carrying amino acids substitutions in the conserved RNP1 octamer of this 
RNP motif, did also not leave the nucleus (data not shown). These data strongly suggest 
that the retention signal resides in the C-terminal part of the La protein. 
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Figure 6. Nuclear retention of the La protein. In vitro translated wild type La (lanes 2-7) and La383/4 
(lanes 8-13) were injected into nuclei of Xenopus laevis oocytes and immediately (lanes 2-4 and 8-10) or 
after an incubation of 18 hours at room temperature dissected into cytoplasmic (C) and nuclear (N) fractions 
and analyzed by SDS-PAGE. The positions of both proteins are indicated by open circles and the position of 
the 28 kDa degradation product with arrows. Lane 1: Protein molecular weight markers. 
To investigate where in the C-terminal part of La the retention signal was located several 
C-terminal deletion mutants were constructed and assayed for their ability to leave the 
nucleus. LaAC337, LaAC343, LaAC361 and LaAC380 were efficiently retained in the 
nucleus upon injection therein (Fig. 7A, lanes 6-13). In contrast to this, the removal of 
more amino acids (mutants LaAC265 and LaAC312) is not tolerated because these 
mutants are exported. Since box A is still present in all C-terminal deletion mutants which 
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are retained in the nucleus, box A in this context might have become a functional NLS 
and thus retention of these mutants might reflect efficient re-import. This possibility was 
ruled out by the observation that LaAC337 was not imported into the nucleus upon 
injection into the cytoplasm (data not shown), indicating that box A is not functional as a 
NLS in these mutants. In conclusion, the retention signal of the La protein appears to 
reside in the region between amino acids 165 and 337. 
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Figure 7. Nuclear retention of La mutants. In vitro translated La protein and mutants thereof (positions 
indicated in the figure with an open circle) were injected into the nucleus of Xenopus laevis oocytes and 
after incubation for 18 hours at room temperature, oocytes were dissected into cytoplasmic (C) and nuclear 
(N) fractions and analyzed by 10% SDS-PAGE. Lanes 1: Protein molecular weight markers. (A) La 
deletion mutants LaAC265, LaAC312, LaAC337, LaAC343, LaAC361, LaAC380, LaAN165AC380 and 
LaA137-306AC380. (B) LaAC380 (as a control) and amino acid substitution mutants La266/9úC380, 
La338/40AC380, La344/6AC380, La362/3AC380. (C) Wild-type DHFR and DHFR-La fusion protein 
DHFR-Lal56-380 were injected in nucleus (lanes 1-3) or cytoplasm (lanes 4-6). Total oocytes (T) were 
analyzed immediately after injection or incubated for 18 hours at room temperature and subsequently 
dissected into cytoplasmic (C) and nuclear (N) fractions and analyzed. (D) La266/9AC380 together with 
LaAC312 (lanes 2-5) and LaAC337 (lanes 6, 7) injected in the nucleus and incubated at 20°C (lanes 2, 3 
and 6, 7) or 0°C (lanes 4, 5). 
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In the region harbouring a putative nuclear retention signal the second RNP motif (amino 
acids 230-300) for which no function has been described yet, and one of the two sequence 
elements homologous to the dsRNA-activated protein kinase PKR (amino acids 249-271) 
are located [27,45]. Several amino acid substitution mutants were analyzed in the 
retention assay: La266/9 in which amino acids 266, 267 and 269 were changed, La338/40 
in which amino acids 338, 339 and 340 were changed, La344/6 in which amino acids 
344, 345 and 346 were changed and La362/3 in which amino acids 362 and 363 were 
changed. To prevent re-import all mutants were produced with a C-terminal truncation 
(ДС380) that is, they lack a functional NLS. After injection into the nucleus of Xenopus 
laevis oocytes, all point mutants, except for La266/9AC380, were efficiently retained in 
the nucleus (Fig. 7B, lanes 4-11) A number of additional substitution mutants 
(Lal51/2AC380, La313/4AC380, La 316/7ДС380, La 366/7ДС380 and La355/6AC380) 
also were strongly retained in the nucleus (data not shown). In summary, only point 
mutant La266/9AC380, in which both the RNP1 sequence of the C-terminal RNP motif 
and the sequence of the most N-terminal PKR-like element were changed, was able to 
leave the nucleus to some extent (Fig. 7B, lanes 4, 5). Consistent with these results, 
amino acid substitutions in the C-terminal PKR-like element (amino acids 338-363) did 
not affect retention of La. Another mutant LaA137-306AC380, which contains the 
complete C-terminal PKR-like element but lacks the central region of the La protein is 
exported from the nucleus (Fig. 7A, lanes 16, 17). These data, summarized in Fig. 8, 
indicate that the nuclear retention signal of La resides in the region of amino acids 165 to 
337, in which amino acids 266 to 269 seem to be very important. 
To test whether this element is not only required but also sufficient for nuclear retention, 
the central region of La containing the putative retention signal (amino acids 165-380) 
was fused to DHFR. This fusion protein (DHFR-Lal65-380) was injected into the nuclei 
of Xenopus laevis oocytes. In Figure 7C it is shown, that DHFR on itself was exported to 
the cytoplasm (lanes 2, 3), while DHFR-Lal65-380 was efficiently retained in the nucleus 
(lanes 3, 4). The ability of DHFR-Lal 65-380 to be retained in the nucleus does not 
reflect efficient re-import, because DHFR-Lal65-380 is not imported into the nucleus 
upon injection into the cytoplasm (Fig. 7C, lanes 6, 7). The observed retention of 
DHFR-Lal65-380 can also not be explained by rapid nuclear export followed by a fast 
degradation in the cytoplasm, since the fusion protein is stable in both cytoplasm and 
nucleus (Fig. 7C, compare lane 1 and 4 with lanes 2, 3 and 5, 6, respectively). In 
conclusion, the central part of the La protein contains a nuclear retention signal, which is 
functional in other proteins as well. 
The energy requirement of the export process was also investigated. For this purpose 
La266/9AC380 and LaAC312 were injected into the nucleus and the oocytes were then 
incubated at 0°C or 20°C. The export of both mutants is severely inhibited at 0°C (Fig. 
7D, compare lanes 2, 3 with 4, 5). Note, that the export of the 28 kDa degradation 
product of La is not inhibited upon incubation at 0°C. Also the export of DHFR is not 
influenced (data not shown). These results strongly suggests that the export of the La 
protein is an energy-dependent process. 
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Figure 8. Summary of the nuclear 
retention signal mapping data. 
Schematic representation of the 
structure of La and of the various 
La mutants analyzed. For an 
explanation of structural motifs, 
see legend to Fig. 5. NLS: nuclear 
localization signal. Circles in the 
representations of mutants indicate 
the relative positions of amino 
acids substitutions. OHFR: 
dihydrofolate reductase. The 
ability of the mutants to be 
retained in the nucleus is listed. 
DISCUSSION 
La is localized in both nucleus and cytoplasm 
Many previous studies have shown, that under normal conditions the La protein mainly 
resides in the nucleus, consistent with the role of the La protein in termination of RNA 
polymerase III transcription. The nuclear localization is not restricted to the nucleoplasm, 
since La has been found in the nucleolus as well [46]. Nevertheless a certain amount of 
La has been reported to reside in the cytoplasm [41,47-49], in agreement with the stable 
association of La with the human Y RN As, which have been shown to be exclusively 
cytoplasmic [41,49,50]. Cytoplasmic accumulation of La has been reported to occur under 
certain stress conditions like viral infections [12,16-18], UV irradiation [19-21] and 
inhibition of RNA synthesis [22]. Taken together, these studies suggest that La may have 
both a nuclear and a cytoplasmic localization. 
The advantages of microinjection of Xenopus laevis oocytes in comparison with other 
localization techniques such as immunofluorescence have been discussed before [41]. 
Using this technique we recently showed that injected human La accumulates in the 
nucleus [41]. In the present study we extend these analyses and provide data showing that 
the intracellular distribution appears to be independent of the cellular compartment into 
which human La was injected. Even so, the observed distribution for injected human La 
protein and endogenous Xenopus laevis La protein was shown to be very similar (Fig. 1). 
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We further provide evidence that the La protein contains a functional nuclear localization 
and retention signal, both located in the C-terminal part of the protein. Furthermore, the 
presence of a nuclear export signal was suggested by the finding that La mutants which 
were not retained in the nucleus showed energy-dependent export. 
Nuclear import of La is temperature-dependent and is mediated by a nuclear 
localization signal located in the C-terminal part of the protein. 
La is imported into the nucleus via an energy-dependent transport mechanism. This 
suggests the involvement of a nuclear localization signal, because it is known that energy 
is required for the import of NLS-containing proteins through nuclear pore complexes 
[51]. Deletion mutant analyses identified a NLS in the C-terminal part of the protein. In 
this region of La two bipartite NLS-like sequences are present: box A, which perfectly 
matches the bipartite NLS consensus sequence [33] and box-B, which resembles it. 
Bipartite NLSs have been identified in a number of proteins [33]. Mutation of the basic 
amino acids at the N-terminal side of the bipartite NLS has been reported to abolish 
nuclear import of several proteins [52-56]. Some nuclear proteins have more than one 
NLS, which are, in most cases, all necessary for an efficient nuclear uptake of the protein 
[32]. Our results, however, showed that box A is not involved in nuclear import of La 
and that only box В is both necessary and sufficient for nuclear uptake. In view of the 
inability of box A to cause nuclear accumulation we conclude that the presence of a 
sequence element perfectly matching the bipartite NLS consensus in the primary sequence 
of a nuclear protein does not necessarily imply that this is the element directing nuclear 
import. 
Comparison of the NLS of the La protein with the bipartite NLS consensus reveals that in 
the human La NLS the spacer region is 12 amino acids long rather than the 10 amino 
acids in the NLS consensus. However, in two independent studies the spacer length of an 
NLS could be reduced or increased without any effect on the activity of the NLS, 
showing that the requirement for a fixed number of amino acids in the spacer is not very 
strict [55,56]. Furthermore, the C-terminal part of the La NLS contains only two instead 
of three out of five basic amino acids in the consensus. 
The La NLS is evolutionarily well conserved, as shown by an alignment of all known La 
sequences (Fig. 9). Although a putative NLS is clearly discernable in the C-terminal part 
of the yeast protein, this sequence is not included in the alignment since the yeast La 
protein apparently lacks the complete C-terminal part present in vertebrate and insect La 
[31] and the putative NLS does not seem to be related to the NLSs found in other species. 
All species aligned contain a spacer region of 12 amino acids, except for bovine and 
Drosophila La, in which the spacer region is one amino acid shorter. The basic amino 
acids at both ends of the NLS are fully conserved. In mouse, rat and Drosophila La 
additional basic amino acids are present in the C-terminal part of the NLS, which means 
that in these species, like in the bipartite NLS consensus, three {Drosophila) or four 
(mouse, rat) out of five amino acids are basic in this region. In addition to the basic 
amino acids, also the acidic nature of the spacer appears to be well conserved (except for 
Drosophila La). Other amino acids in the C-terminal part of La are also highly conserved 
during evolution, like for instance the prolines at positions 381 and 394 and the glutamic 
acid and the aspartic acid at position 402 and 407, respectively. Proline 381, however, 
was found not to be required for a functional NLS, since mutant La381 in which this 
proline was replaced by a serine was readily imported into the nucleus (Fig. 3B, lane 16). 
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Figure 9. Evolutionary conservation of the La NLS. The С-terminal amino acid sequences of La from 
several species derived from cDNA sequences are aligned (hLa: human; bLa: bovine; rLa: Tat; mLa: 
mouse; rabLa: rabbit; xLaA: Xenopus laevis, variant A; xLaB: Xenopus laevis, variant B; dLa: Drosophila 
melanogaster). The consensus amino acid sequence for this element of La is listed at the bottom. Underlined 
are the two basic regions corresponding to the bipartite NLS. Genbank/EMBL data base accession numbers 
of the cDNAs are h: J04205, X13697 [24,25]; b: X13698 [25]; г: X67859 [30]; m: L00993 [28]; rab: 
L08230; xA: X68817 [29]; xB: X68818 [29]; d: L32988 [31]. 
Nuclear retention of La 
It is not clear yet how nuclear export of proteins is mediated. It has been suggested that 
this process is controlled by nuclear retention [34,57], but recent data claim the 
involvement of specific c/s-acting sequence elements in the protein [35-37]. 
La 383/4, a mutant which is unable to enter the nucleus, also does not leave the nucleus 
after being injected into this compartment (Fig. 6, lanes 8-13). This indicates, that in 
oocytes La is either efficiently retained in the nucleus or that a functional signal is 
required for nuclear export. This signal could be the NLS sequence as was suggested 
recently [35]. However, analysis of additional mutants of La (i.e. LaAC265, LaAC312 
and La266/9AC380), which lacked a functional NLS but still were able to leave the 
nucleus, excluded this latter possibility. The failure of La383/4 to leave the nucleus can 
be best explained by efficient nuclear retention of this protein. A logical candidate for a 
nuclear retention signal of La is the N-terminal RNP motif (amino acids 112-187), 
because this region is involved in the binding of La to RNA polymerase III transcripts 
[5]. However, analysis of several mutants indicated that this RNP motif is not involved in 
nuclear retention of La. Instead, a region encompassing amino acids 165 to 337 seems to 
be involved in retention. In this region amino acids 266-269 and amino acids 312-337 
appear to be of major importance. Export studies with DHFR-rusion proteins (Fig. 7C) 
convincingly showed that this region of La is sufficient for nuclear retention. 
Besides the N-terminal RNP motif, a second RNP motif has recently been identified in 
the La protein [27]. The latter (amino acids 230 to 300) contains the conserved RNP-1 
sequence in the region from amino acids 268 to 275 [27]. In La266/9, which is not 
efficiently retained in the nucleus, the amino acid substitutions are located precisely in 
this putative RNP motif: amino acids Arg266, Gly267 and Lys269 being changed into He266, 
Asp267 and Glu269, respectively. These changes (especially residue 269, which was 
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changed from a positively charged into a negatively charged amino acid) might negatively 
influence the function of the RNP motif. Because RNP motifs in general are involved in 
the binding of RNA, it is possible that binding to a nuclear RNA (partially) governs 
nuclear retention. Residues 266 to 269 are also part of one of two sequence elements 
homologous to a region of the dsRNA-dependent protein kinase PKR (amino acids 
249-271 and 338-363) [45]. Like PKR, La was also shown to interact with dsRNA and 
inhibit PKR activation by unwinding dsRNA [11]. Although the precise binding site for 
dsRNA on La has not been determined yet, an interaction with dsRNA in the nucleus 
might thus mediate nuclear retention of La. Paradoxically the second PKR-like element in 
La (amino acids 338-363), not involved in nuclear retention of La, corresponds to the 
dsRNA-binding site of PKR, containing a sequence element that is also found in other 
dsRNA-binding proteins [58,59]. Further experiments are needed to further substantiate 
whether the PKR-like element 249-271 in La indeed is involved in binding to dsRNA. 
Our combined data indicate that there are at least two mechanisms for nuclear export of 
proteins. One of these appeared to proceed both at 20°C and 0°C, suggesting that this 
mechanism is energy-independent. Export of both the N-terminal, 28 kDa degradation 
product of La and DHFR (22 kDa) proceeds via this pathway. Similarly, 
energy-independent nuclear export has been reported for the much larger (106 kDa) 
progesterone receptor [60]. The second nuclear export pathway, which was observed for 
LaAC312 and La266/9AC380, appeared to be blocked at 0°C. The most likely 
explanation would be that energy is required for this pathway to be active. 
Energy-dependent nuclear export has been reported before for pyruvate kinase and the 
HIV-1 Rev protein [34,36]. Analogous to nuclear import, nuclear export of two La 
mutants predicts the involvement of a nuclear export signal which, in the case of La, most 
likely will be located somewhere between amino acid 200 (based on estimation of the 
cleavage site that generates the 28 kDa degradation product) and amino acid 312. An 
alternative explanation for the observed inhibition of export at 0°C that can not be ruled 
out yet is that (de)phosphorylation (in the region 200-312) is a prerequisite for the La 
mutants to leave the nucleus. 
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ABSTRACT 
The human autoantigen La (SS-B) is a phosphoprotein of 47 kDa, which is involved in 
the termination of RNA polymerase III transcription. Consistent with this function La has 
been shown to reside predominantly in the nucleus, but it is reported to be transported to 
the cytoplasm under stress conditions, like viral infection and UV irradiation. In the 
present study paper we analyzed the effect of a heat shock on La localization and 
observed a reversible nucleolar accumulation after a 105 min incubation of HEp-2 cells at 
44°C. Inhibition of either RNA synthesis by administering a-amanitin or actinomycin D 
to HEp-2 cells for one hour, or protein phosphorylation or dephosphorylation by an one 
hour incubation of HEp-2 cells with staurosporin or akadaic acid, respectively, appeared 
to have no detectable influence on the intracellular localization of the La protein. 
By using human-mouse heterokaryons we were able to show that La, consistent with the 
redistributions studies, is a nucleocytoplasmic shuttling protein. The possible implications 
of this finding are discussed. 
INTRODUCTION 
The human La protein is a predominantly nuclear protein of 47 kDa that was originally 
identified as an autoantigen recognized by antibodies in sera from patients with rheumatic 
diseases like Sjogren's syndrome and systemic lupus erythematosus. Various small RNA 
molecules have been reported to associate with the La protein in cells to form La 
ribonucleoprotein particles (La RNPs) [1]. 
Newly synthesized RNA polymerase III (Pol III) transcripts, such as (precursors of) 7S 
RNAs, 5S rRNA, tRNA, U6 snRNA and Y RNAs are, in most cases transiently, 
associated with the La protein. In addition to these RNAs some virally encoded RNAs, 
such as adenovirus VA, and VA„ RNA, Epstein-Barr virus EBER1 and EBER2 RNAs and 
leader RNAs of vesicular stomatitis virus and rabies virus (reviewed in [2] and [3]), may 
be bound by La. These various RNAs contain a short tract of uridylate residues at their 3' 
termini, which was shown to be the primary binding site for the La protein [4-6]. In 
contrast to other Pol HI transcripts, the 3' oligouridine stretch of the Y RNAs and the 
virally encoded VA and EBER RNAs is not removed during maturation and these RNAs 
are bound by La in a stable manner. 
Consistent with the binding of La to all newly synthesized RNA polymerase III 
transcripts, it has been shown that La has a function in correct termination and 3' end 
formation during transcription by Pol III [7,8] and facilitates re-initiation of Pol III 
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transcription [9]. Other results suggest a role for the La protein in translation processes. 
La has been shown to be involved in internal initiation of translation of poliovirus RNA 
[10,11] and in alleviation of translation repression by the leader sequence of HIV-1 
mRNA [12,13] in in vitro translation systems. 
La is a highly phosphorylated protein with at least 8 distinct isoelectric forms (with pi 
ranging from 6 to 7) [14-16]. The phosphorylated residues, which were shown to be 
meanly serine(s) and to a lesser extent threonine(s) [16], are only present in the 
C-terminal half of the protein, as revealed by the phosphorylation state of the most stable 
degradation products of the protein [17]. These products probably results from proteolytic 
cleavage at or near the central PEST region, a region which is known to be susceptible to 
proteolytic cleavage. 
Most immunofluorescence studies using anti-La antibodies show a predominantly nuclear 
staining which is consistent with the role of La in Pol III transcription. Other techniques 
also indicate that the majority of La indeed is present in the nucleus [18-21]. In agreement 
with the nuclear localization La has been shown to contain a nuclear localization signal 
(NLS) at the extreme C-terminus of the molecule [22]. The nuclear localization is not 
restricted to the nucleoplasm, since La has been found in the nucleolus as well [23]. In 
contrast to the nuclear localization a cytoplasmic accumulation of La has been reported to 
occur under certain stress conditions, such as viral infection [10,24-26], UV irradiation 
[27-29] and inhibition of mRNA synthesis [30]. Based on these observations La was 
proposed to shuttle between nucleus and cytoplasm and to be involved in 
nucleocytoplasmic transport of RNA polymerase III transcripts [30]. However, La was 
shown not to be involved in the nuclear export of 5S rRNA and hYl RNA in Xenopus 
laevis oocytes [21,31,32]. 
To shed more light on the proposed shuttling of the La protein we analyzed in the present 
study the localization of the La protein under stress conditions like heat-shock, inhibition 
of RNA synthesis and inhibition of protein kinases or phosphatases. Furthermore, the 
ability of La to shuttle was tested in human-mouse heterokaryons. 
MATERIALS AND METHODS 
Cell culture 
Human HEp-2 and mouse 3T3 cells were cultured in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal calf serum. Cells were grown on glass 
coverslips to about 80% confluency before use. When indicated cells were subsequently 
incubated for one hour in the presence of either 1 /¿g/ml or 200 ¿tg/ml α-amanitin 
(Boehringer Mannheim) or 0.05 /xg/ml or 5 μg/ml actinomycin D to inhibit RNA 
synthesis, 1 μΜ staurosporine (Boehringer Mannheim) to inhibit protein kinases or 1 μΜ 
okadaic acid (Sigma) to inhibit protein phosphatases. For heat-shock treatment cells were 
incubated at 44°C for 105 min. 
Immunofluorescence 
Cells were fixed in methanol (-20CC) for 5 min, followed by rinsing with acetone. After 
washing in PBS, fixed cells were incubated with either the anti-La monoclonal antibody 
SW5 [33], the anti-UlA/U2B" monoclonal antibody 9A9 [34] or the anti-Ro60 
monoclonal antibody 2G10 [33] for 30 min, washed with PBS and incubated with 
FITC-labelled rabbit anti-mouse IgG (Dakopatts) for 30 min. Finally, cells were washed 
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and photographed under UV illumination. 
Heterokaryon formation 
For the preparation of heterokaryons 2 χ IO7 human HEp-2 cells and 2 χ IO7 mouse 3T3 
cells were mixed in Dulbecco's modified Eagle's medium (DMEM) supplemented with 
10% fetal calf serum. Cells were then centrifuged (5 min; 800 g) and washed two times 
with DMEM without fetal calf serum. Fusion was carried out in a glass tube, by adding 1 
ml 50% PEG 1500 (Boehringer Mannheim) to the cell pellet. Cells were incubated by 
gentle agitation for 30 s at room temperature and subsequently for 1 min at 37°C. Eight 
ml of DMEM with 10% fetal calf serum was added and cells were collected by 
centrifugation and grown overnight on glass coverslips in the presence of 20μg/ml 
cycloheximide. The coverslips were subsequently used for immunofluorescence. To 
distinguish human from mouse nuclei fixed cells were stained by Hoechst 33258 before 
the final wash step. 
RESULTS 
Intracellular localization of La under stress conditions 
Many immunofluorescence studies with anti-La antibodies have shown that under normal 
conditions the La protein mainly resides in the nucleus [2], consistent with the role of the 
La protein in transcription termination. However, a cytoplasmic accumulation of La has 
been reported to occur under a variety of stress conditions like viral infection [10,24,25], 
UV irradiation [27-29] and inhibition of RNA polymerase II transcription [30]. Our 
previous results revealed the presence of an NLS, an element involved in nuclear 
retention as well as a putative nuclear export signal (NES) in the La protein [22]. The 
relative activity of these elements, which may be modulated by e.g. (de)phosphorylation, 
most likely determines the nucleocytoplasmic distribution of La in a cell. 
A В 
Figure 1. Intracellular localization of La after Pol III inhibition. HEp-2 cells were incubated without (A) or 
in the presence of 200 pg/ml α-amanitin (B) for one hour, fixed and used in immunofluorescence using 
anti-La antibodies. 
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Because the La protein is specifically involved in RNA synthesis by RNA polymerase III 
[7-9], we analyzed the intracellular localization of La after inhibition of RNA polymerase 
III. Human HEp-2 cells were cultured for one hour in the presence of 200 μ£/πι1 
α-amanitin, a concentration which leads to inhibition of both RNA polymerase II and III 
activity. Untreated cells show the expected fine-speckled staining of the nucleoplasm in 
indirect immunofluorescence with anti-La antibody SW5 (Fig. 1A). After treatment with 
α-amanitin no change in the intracellular distribution of the La protein was observed 
(compare Fig. 1A with Fig. IB). Incubation of HEp-2 cells in the presence of 1 μg/ml 
α-amanitin (a concentration which leads to inhibition of merely RNA polymerase II), 
0.05 ^g/ml actinomycin D (inhibition of only RNA polymerase I) or 5 μg/ml 
actinomycin D (inhibition of both RNA polymerase I and II) also showed no change in 
immunofluorescence pattern of La in comparison with untreated cells (data not shown). 
To check the effectivity of the drugs used control incubations were carried out using 
monoclonal antibody 9A9 (anti-UIA and anti-U2B"). The results showed a markedly 
changed nuclear staining pattern after treatment of the cells with inhibitor concentrations 
(of both α-amanitin and actinomycin D) that effected RNA polymerase II activity (data 
not shown). From these results we concluded that the intracellular localization of the La 
protein does not seem to be dependent on active transcription processes. 
Since culturing at increasing temperatures is known to have a more dramatic effect on 
metabolic processes, in the next experiment the influence of a heat shock on the 
localization of the La protein was investigated. HEp-2 cells were cultured for 105 min at 
a temperature of 44°C. Immediately after the heat shock a clear difference in 
immunofluorescence pattern of La was observed. Untreated cells showed a homogeneous 
fine-speckled staining of the nucleoplasm and a weak staining of the nucleoli while in heat 
shocked cells next to the fine-speckling of the nucleoplasm an increase in nucleolar 
staining was obtained (compare Fig. 2A with Fig. 2B). A cytoplasmic accumulation of the 
La protein, which has been reported to occur under certain other stress situations 
[10,24,25,27-30], was not observed. The nucleolar accumulation appeared to be 
reversible, because the intensity of nucleolar fluorescence decreased to the level of 
untreated cells when heat shocked cells were subsequently incubated at 37°C for 18 hours 
(Fig. 2C). 
A B C 
Figure 2. Intracellular localization of La after heat-shock. HEp-2 cells were incubated at 37°C (A) or 44°C 
(B) for 104 min or incubated at 44°C for 105 min, followed by an incubation at 37°C for 18 hours (C). 
Cells were than fixed and used in immunofluorescence using anti-La antibodies. 
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Because La is a highly phosphorylated protein [14-16], the influence of phosphorylation 
and dephosphorylation on the localization of La was studied. HEp-2 cells were incubated 
with either staurosporine, which is a potent inhibitor of protein kinases [35], or okadaic 
acid, an inhibitor of protein phosphatases [36]. No redistribution of the La protein could 
be observed upon incubation of the cells for one hour with 1 μΜ of either toxin (data not 
shown), indicating the intracellular localization of the La protein apparently is not 
dependent on the inhibited kinases and phosphatases within the time course of the 
experiment. 
Nucleocytoplasmic shuttling of the La protein 
In spite of the lack of effect on La localization of inhibition of RNA synthesis and kinases 
and phosphatases, both the nucleolar accumulation during heat shock and the changes in 
La localization previously reported to occur under stress conditions [10,24-29], suggest 
Hoechst anti-La 
Figure 3. Shuttling of La in human-mouse heterokaryons. HEp-2 cells were fused to 3T3 cells and 18 hours 
later the resulting heterokaryons were fixed and stained with Hoechst 33258 (A, C) to identify mouse nuclei 
(indicated by arrows) and with monoclonal antibodies specifically directed to human La (B, D). Mouse 
nuclei, which are part of heterokaryons are indicated by a large arrow, while the nuclei of non-fused mouse 
cells are indicated by a small arrow. Note that nuclei of non-fused mouse cells are not stained by the La 
monoclonal antibody used (B, D). 
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that La is able to migrate through the nuclear pore complex in both directions and thus 
may be a shuttling protein. To study this aspect in more detail we used the heterokaryon 
assay, a system which has been used previously to demonstrate the shuttling ability of 
other proteins [37-39]. Human HEp-2 and mouse 3T3 cells were fused and the cells were 
cultured for 18 hours in the presence of cycloheximide, to prevent de novo protein 
synthesis. Subsequently the cells were fixed and analyzed by Hoechst 33258 staining and 
anti-La immunofluorescence. In Figure ЗА and С it can be seen that mouse nuclei 
(indicated by arrows) can be readily distinguished from human nuclei by staining the cells 
with Hoechst 33258. Only mouse nuclei within a heterokaryon cell (Figure ЗА, С: 
indicated by large arrows) can be stained with the monoclonal anti-La antibody SW5, 
which specifically reacts with human La (Figure 3B, D: indicated by arrows), whereas 
mouse nuclei in non-fused cells (Figure ЗА, С: indicated by small arrows) are not 
reactive with this anti-La antibody (Figure 3B, D). These results strongly suggest that in 
heterokaryon cells human La is able to leave the human nucleus and to enter the mouse 
nucleus and thus that La shuttles between nucleus and cytoplasm. 
DISCUSSION 
In accordance with its proposed function(s), such as a role in transcription termination by 
RNA polymerase III, role in the regulation of protein synthesis [10,13,40] and a potential 
role in the nucleocytoplasmic transport of RNA polymerase III transcripts, La has been 
proposed to be a shuttling protein [30]. The observed equilibrium distribution of the La 
protein reflects the equilibrium situation for established shuttling proteins, which are 
mainly found in the nucleus by immunofluorescence [39]. Using a heterokaryon system in 
combination with a human La specific antibody it could be shown for the first time that 
La is able to shuttle from a human nucleus via the cytoplasm to a mouse nucleus (Fig. 3). 
However, we can not completely exclude the possibility that only La molecules present in 
the cytoplasm of the human cells prior to heterokaryon formation entered the mouse 
nucleus, although only a relatively small amount of La is present in the cytoplasm as has 
been shown by three different techniques [19-21] and it seems rather unlikely that this 
amount is sufficient for the efficient anti-La staining of the mouse nucleus in 
heterokaryons. 
La was shown to be involved in the translation of poliovirus and HIV-1 mRNAs [10-13]. 
Furthermore, the La protein inhibits the activation of the double-stranded RNA activated 
protein kinase PKR, which when activated inhibits translation [40] and very recently it 
has been demonstrated that La binds a subclass of the 40S ribosomal subunits in the 
cytoplasm probably via a direct interaction with 18S rRNA [41]. Because of the apparent 
function(s) in both cytoplasm and nucleus it would be economical for La to be able to 
shuttle, adapting its localization to its requirement in either nucleus or cytoplasm. 
The shuttling ability of La seems to be in contradiction with the recent observation that 
La with a non-functional NLS in oocytes is not exported from the nucleus in Xenopus 
laevis oocytes [22]. However, it might be possible that the efficient nuclear retention 
observed in oocytes, which are highly specialised cells, is less extreme in other cells. 
Moreover, the observation that nuclear export of a mutant of La, in which both the NLS 
and the putative nuclear retention element were inactivated, was temperature dependent 
suggested that La might also contain a nuclear export signal (NES) [22]. Furthermore, it 
is feasible that the activities of the NLS, the retention element and the NES in La are 
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œing regulated, leading to modulation of nucleocytoplasmic shuttling. Because La is a 
lighly phosphorylated protein [14-16], phosphorylation/dephosphorylation is the most 
jbvious mechanism involved in such a modulation. Moreover, phosphorylation and 
^phosphorylation have been shown to influence the nuclear import and export of several 
)roteins [42], probably by altering the activity of the NLS or NES or by increasing or 
lecreasing nuclear or cytoplasmic retention. Phosphorylation of La has been shown to be 
estricted to the C-terminal part of the protein [17], i.e. the region where both the nuclear 
etention element and the nuclear localization signal are located [22]. A possible extreme 
phosphorylation state of the human La protein in X. laevis oocytes could account for the 
îfficient nuclear retention. 
Paradoxically, we did not observe a change in intracellular localization of La after 
itaurosporine or okadaic acid treatment of cells. However, this does not imply that 
^phosphorylation of the La protein does not influence its subcellular distribution. Both 
itaurosporine and okadaic acid are potent inhibitors of protein kinases and phosphatases, 
•espectively, but their action on these enzymes is not general. Staurosporine inhibits only 
protein kinases that share structural homology with protein kinase С in the essential 
region in the catalytic domain [35] and okadaic acid inhibits protein phosphatases 1 and 
IA while other protein phosphatases are not or only weakly inhibited [36]. Often the 
distribution of proteins is influenced by only one phosphorylation site [42], meaning that 
эпіу one or a limited number of kinases and phosphatases is responsible for the 
localization changes. The kinase(s) or phosphatase(s) that are able to modify La may not 
be sensitive to staurosporine or okadaic acid. A detailed analysis of La phosphorylation 
ind the effect of different toxins on the phosphorylation state and intracellular localization 
is required to shed more light on this issue. 
The cytoplasmic accumulation of the La protein in CV-1 cells reported to occur after 
inhibition of RNA Pol Π activity [30] could not be reproduced by us using either 
ictinomycin D or α-amanitin. Even high concentrations of a-amanitin, reported to result 
in RNA Pol III inhibition, did not interfere with the intracellular localization of La. Thus, 
ilthough La under these conditions is not required any more for termination of RNA 
Pol III transcription this apparently does not lead to a change in localization of the 
protein. At present, we don't have an explanation for the contradictory results after 
α-amanitin treatment that are described in this paper and in the previous publication [30]. 
In part, the discrepancy might be related to use of another anti-La monoclonal antibody. 
Recently, we have demonstrated that the epitope recognized by SW5, the monoclonal 
antibody used in the present study, is accessible on the free La protein as well as on the 
La protein assembled in cellular complexes [33]. Differences in the accessibility of the yet 
unknown epitope recognized by the monoclonal antibody used in the other study may in 
part explain the effects observed. 
A distinct redistribution of the La protein to the nucleolus was observed when cells were 
heat-shocked. This was an unexpected finding since a number of other stress conditions 
have been reported to result only in a cytoplasmic accumulation of La. A nucleolar 
localization of the La protein, which appeared to be cell cycle dependent (it only occurred 
during the G, phase) has been reported before [23]. During the G[ phase the nucleoli, 
which are disassembled during mitosis, re-associate again. It is therefore tempting to 
speculate that La may have a function in the assembly and maintenance of nucleoli. 
During heat-shock the nucleolus becomes destabilized as indicated by the translocation of 
heat-shock proteins to the nucleoli [43-46]. It is possible that La protein is recruited to the 
nucleolus in order to stabilize them. Alternatively, a heat shock may change the nucleolar 
structure in such a way that antibodies have a better access to the La protein in this 
compartment. In conclusion, besides the intracellular shuttling of La between nucleus and 
cytoplasm, La might also be able to shuttle within the nucleus, i.e. between nucleoplasm 
and nucleoli. 
In summary, we have shown that La is a nucleocytoplasmic shuttling protein, which is in 
accordance with its ability to relocate in the cell upon stress, with the reported nuclear 
import and export of the protein [22] and with its (putative) functions in nucleus and 
cytoplasm. Further investigations are necessary to see in which way the activity of the 
different signals present on La, i.e. NLS, retention element and NES, is modulated. 
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ABSTRACT 
Ro RNPs are evolutionarily conserved ribonucleoprotein particles, which consist of a 
small RNA known as Y RNA associated with several proteins, like La, R06O and Ro52. 
The Y RNAs (Y1-Y5), which are transcribed by RNA polymerase III, have been shown 
to reside almost exclusively in the cytoplasm as Ro RNPs. To obtain more insight into the 
nuclear export pathway of Y RNAs, hYl RNA export was studied in Xenopus laevis 
oocytes. Injection of various hYl RNA mutants showed that an intact R06O binding site is 
a prerequisite for nuclear export, while the presence of an intact La binding site resulted 
in strong nuclear retention of hYl RNA. Competition studies with various classes of 
RNAs indicated that in addition to R06O another titratable factor was necessary for 
nuclear export of hYl RNA. This factor appears also to be involved in nuclear export of 
tRNA. Because export of hYl RNA could not be blocked by a synthetic peptide 
containing the recently identified nuclear export signal of the HIV-1 Rev protein, nuclear 
export of hYl RNA does not seem to be dependent on a Rev-like nuclear export signal. 
INTRODUCTION 
Ro RNPs are ribonucleoprotein particles which consist of a Y RNA molecule and several 
proteins (reviewed in: Van Venrooij et al, 1993). Four different RNA polymerase III 
transcribed Y RNAs have been characterized in human cells. They vary in length from 84 
to 112 nucleotides and are referred to as: hYl, hY3, hY4 and hY5 RNA (Hendrick et al, 
1981). The secondary structure of these homologous Y RNAs is characterized by 
base-pairing of the conserved 3'- and 5'-ends of the RNA molecules (Wolin & Steitz, 
1983; Van Gelder et al, 1994). Two common proteins have been shown to bind directly 
to the Y RNAs: R06O, which binds to the terminal part of the conserved stem structure 
(stem 1, see Fig. 1) (Wolin & Steitz, 1984; Pruijn et al, 1991) and La, which binds to 
the 3' oligo-uridylate stretch of the RNA molecules (Mathews & Francoeur, 1984; 
Stefano, 1984; Pruijn et al., 1991). Ro52, another putative Ro RNP protein, does not 
bind directly to the Y RNAs, but probably associates with the particle via protein-protein 
interaction (Slobbe et al, 1992). 
The Y RNAs (Hendrick et al, 1981; Pruijn et al, 1993; O'Brien et al, 1993; Farris et 
al, 1995; Van Horn et al, 1995), the R06O protein (Chan & Buyon, 1994 and references 
therein; Van Hom et al, 1995) and the La protein (Pruijn, 1994 and references therein) 
of the Ro RNPs are well conserved during evolution. Using a variety of techniques, such 
as enucleation of tissue culture cells (O'Brien et al, 1993; Peek et al, 1993) and 
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injection of X. laevis oocytes (O'Brien et al, 1993; Simons et al, 1994) it has been 
shown that Ro RNPs are located in the cytoplasm. As a consequence, newly RNA 
polymerase III transcribed Y RNAs have to be exported to the cytoplasm. 
Very little is known about the mechanism of nuclear export of RNA (reviewed in: Simos 
& Hurt, 1995; Izaurralde & Mattaj, 1995). Analogous to the mechanism of nuclear 
import it is to be expected that export involves binding of specific proteins to RNAs that 
have to be exported. Consistent with this prediction, nuclear export of several RNAs has 
been shown to be a saturable, energy requiring, carrier-mediated process. (Zasloff, 1983; 
Hamm & Mattaj, 1990; Jarmolowski et al., 1994). 
Much of the information available on RNA export concerns RNA polymerase II 
transcripts like mRNA and Ul snRNA. In the nucleus mRNA is associated with the very 
abundant heterogeneous nuclear RNP (hnRNP) proteins. Several of these proteins shuttle 
between nucleus and cytoplasm and for hnRNP Al it has been shown that it was 
associated with poly(A)+ RNA in both compartments, suggesting that hnRNP Al mediates 
this export (Pinol-Roma & Dreyfuss, 1991, 1992, 1993). Processing steps leading to the 
formation of the З'-end of mRNA, in some way appeared to be coupled to export of 
mRNA (Eckner et al., 1991). The mono-methyl guanosine cap structure, present at the 
5'-end of all RNA polymerase II transcripts, has been shown to be important for the 
export of both U snRNAs and mRNAs (Hamm & Mattaj, 1990; Jarmolowski et al., 
1994). A nuclear cap binding protein (СВР) has been identified and has been shown to be 
involved in export of these RNAs (Izaurralde et al., 1994). 
For the RNA polymerase III product 5S rRNA it has been shown that mutants which 
could not bind to L5 or TFIIIA, were not exported (Guddat et al., 1990), suggesting a 
role for these proteins in the export process. Via a similar method a role for SRP9/SRP14 
in the export of SRP RNA (He et al., 1994) was established. 
In the study reported here we investigated the export mechanism of Y RNAs. Previously 
we showed that hY RNAs after injection into the nucleus of X. laevis oocytes are 
exported to the cytoplasm in an energy-dependent way (Simons et al., 1994). Now we 
extend these studies and show that the Ro60 protein is involved in hYl RNA export, in 
contrast to the La protein which binding leads to an opposite effect, that is nuclear 
retention of Y RNAs. Furthermore, we present evidence that the export of Ro RNPs is a 
saturable process and that in addition to Ro60 another trans-acting factor is involved. This 
factor is also involved in the export of tRNA. 
MATERIALS AND METHODS 
cDNA constructs 
The transcription vector for hYlwt RNA has been described by Simons et al. (1994). The 
mutant hYl RNA constructs were made from this hYlwt RNA construct by PCR 
techniques. The PCR products were cloned into pUC18. Xenopus UlASm RNA and 
5S rRNA constructs and human tRNAT" and U6Ass RNA constructs with promoters for 
transcription by T7 RNA polymerase have been described previously (Hamm et al., 1987; 
Hamm & Mattaj, 1989; Chow et al., 1992; Jarmolowski et al., 1994). For transcription 
the clones were linearized with Dral (hYlwt, hYlAC, hYlASlLl, U6Ass and 5S), Xbal 
(hYlXba and hYlXbaAC), BamHI (UlASm) or Bfal (tRNAT")· 
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In vitro transcription 
For 32P-labelled RNAs 0.5 μg of linearized template DNA was transcribed in 10 μ\ 
buffer, containing 40 mM Tris-HCl (pH 7.9), 6 mM MgCl2, 2 mM spermidine, 10 mM 
NaCl, 10 mM dithiothreitol, 0.1 mg/ml BSA, 1 mM NTPs, 2 U RNasin, 1 mM 
m7G(5')ppp(5')G (in case of UlASm RNA) and 20 /xCi o^P-UTP with 10 U of T7 RNA 
polymerase. Unincorporated nucleotides were removed by gel filtration and proteins were 
removed by phenol-chloroform (1:1) extraction. Non-radioactive competitor RNAs were 
prepared as described by Jarmolowski et al. (1994). 
Oocyte injection 
The RNA was microinjected into the nucleus of Xenopus laevis oocytes (Simons et al., 
1994). To control nuclear injection, samples were mixed with dextran blue (Serva 
Biochemicals) (10 mg/ml) and a total volume of 25 nl was injected per nucleus. After 
manual dissection only oocytes with blue nuclei were used for analyses. After incubation 
and dissection the fractions were homogenized in 50 mM Tris-HCl (pH 7.5), 5 mM 
EDTA, 1.5% SDS, 300 mM NaCl, 1.5 mg/ml proteinase К and incubated at 56°C for 30 
min. Proteins were extracted with phenol/chloroform (1:1) and RNA was precipitated by 
adding 4 vol of ethanol and analyzed on a 10% denaturing Polyacrylamide gel. BSA-R 
and BSA-M have been described by Fischer et al. (1995) and 250 ng of each is 
co-injected per oocyte. 
Immunoprecipitation 
Antisera were coupled to protein Α-agarose by head over head rotation at room tempera­
ture for 1 h in IPPsoo (10 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.1% NP-40). For each 
precipitation 50 μΐ of monoclonal anti-La (SW5) (Pruijn et al, 1995) or anti-Ro60 (2G10) 
(Veldhoven et al., 1995) or 1 μ\ normal human serum were used. 10 μ\ of HeLa S100 
extract (108 cells/ml) was mixed with 32P-labelled RNAs and incubated for 30 min at 0°C. 
Immunoprecipitations were carried out in IPP150 (10 mM Tris-HCl, pH 8.0, 150 mM 
NaCl, ImM MgCl2, 0.1% NP-40) by head over head rotation for 2 h at 4°C. The 
precipitate was washed three times with IPP150 and the RNA was extracted and analyzed 
as described in the oocyte injection section. 
RESULTS 
Role of Ro60 and La in the export of hYl RNA 
Previous experiments have shown that in vitro transcribed hY RNAs accumulate in the 
cytoplasm of X. laevis oocytes in an energy-dependent way (O'Brien et al, 1993; Simons 
et al, 1994). As has been shown for nuclear export of other RNAs (Simos & Hurt, 1995; 
Izaurralde & Mattaj, 1995), it seems likely that export of h Y RNAs is also mediated by 
specific nuclear proteins. For two proteins, i.e. Ro60 and La, it has been shown, that 
they bind in the nucleus to hY RNAs (Simons et al., 1994). To investigate whether Ro60 
and La are involved in nuclear export of hYl RNA, mutant hYl RNAs were constructed, 
in which the binding sites for these proteins were either changed or deleted. 
The different hYl RNA mutants, used for export studies, are depicted in Figure 1. To 
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interfere with the binding of R06O to hYl RNA the terminal part of the conserved stem 
(stem 1), which is the binding site for R06O (Wohn & Steitz, 1984, Praijn et al , 1991), 
had to be changed In hYlAC RNA the bulged С at position 9 in stem 1 is deleted An 
equivalent deletion in hY5 RNA resulted in reduced binding of human R06O in vitro 
(Pruyn et al , 1991) Also in the case of hYlAC RNA the deletion resulted in a lower 
affinity m vitro for R06O as compared to wild type hYl RNA (Fig 2, compare lane 12 
with lane 11) In a second mutant (hYlASlLl) the complete terminal part and the internal 
loop of the conserved stem structure (stem 1 and loop 1) are deleted This mutant is 
therefore unable to associate with R06O (Fig 2, lane 15) Because both mutants still do 
contain the 3' ohgo uridine stretch, which is the primary binding site for the La protein 
(Stefano, 1984, Mathews & Francoeur, 1984, Pruyn et al , 1991), both are able to bind 
the La protein (Fig 2, lanes 7, 10) 
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Figure 1. Secondary structure models for hYlwt RNA and mutants The structure of hYlwt RNA was 
proposed by Van Gelder et al (1994), while the structures of the mutants were based upon this hYlwt RNA 
structure Arrows indicate the positions of the mutations 
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Figure 2. Ability of mutant hYl RNAs to bind La and R06O proteins. In vitro transcribed hYl RNA, 
UlASm snRNA and tRNA™" were incubated in HeLa S100 extract and subsequently precipitated with 
monoclonal anti-La antibodies (lanes 6-10), monoclonal anti-Ro60 antibodies (lanes 11-15) or normal human 
serum (NHS) (lanes 16-20). RNA was isolated from the precipitates (lanes 6-20) or from 1% of the input 
RNA mixture (lanes 1-5) and analyzed by denaturing gel electrophoresis. hYlwt, hYlAC, hYlXba and 
hYlXbaAC migrate at approximately the same position in the gel, indicated by hYl. The relatively efficient 
precipitation of hYlwt RNA with NHS (lane 16) in this particular experiment appeared to be irreproducible. 
Note that due to a more efficient precipitation, the anti-La samples (lanes 6-10) are autoradiographed much 
shorter than the other samples. 
After in vitro transcription of hYlwt, hYlAC and hYlASlLl DNA, the resulting 
32P-labelled RNAs were injected into the nucleus of oocytes. At various time points after 
injection the oocytes were dissected and the distribution between nucleus and cytoplasm 
was examined. In vitro transcribed Ul snRNA with a mutated Sm binding site (UlASm), 
which is known to leave the nucleus and to remain in the cytoplasm (Hamm & Mattaj, 
1990), was co-injected as an internal control. In Figure ЗА it can be seen, that 
hYlwt RNA was gradually exported to the cytoplasm, as was observed before (Simons et 
α/., 1994). Complete export, however, takes more than 8 hours. Also hYlAC RNA was 
exported to the cytoplasm, but with a much lower efficiency (Fig. 3B). Eight hours after 
injection only a minor part of hYlAC RNA is present in the cytoplasm (Fig. 3B, lanes 8, 
9), while at that time point already half of the amount of hYlwt RNA has been exported 
to the cytoplasm (Fig. ЗА, lanes 8, 9). The lower rate of export of hYlAC RNA is most 
probably caused by the decreased affinity of hYlAC RNA for R06O in comparison with 
hYlwt RNA. A more drastically reduced export rate is observed for hYlASlLl RNA. In 
this case absolutely no export could be detected (Fig. 3C). After prolonged exposure of 
the autoradiograph it became evident that even after 24 hours no export of 
hYlASlLl RNA could be observed. In contrast to this, mutants hYlAS2Ll (in which 
stem 2 and loop 1 are deleted), hYlAS3L3 (in which stem 3 and loop 3 are deleted) and 
hYlAS4L4 (in which stem 4 and loop 4 are deleted) were exported to the cytoplasm with 
efficiencies similar to hYlwt (data not shown). In view of the fact that hYlASlLl RNA 
does not detectably associate with R06O, these results strongly suggest that R06O binding 
is necessary for the export of hYl RNA. Note that both hYlAC and hYlASlLl seem to 
be somewhat less stable than wild type hYl RNA (Fig. 3, compare panel A with panel B, 
C). This suggests that binding of R06O might stabilize the hYlwt RNA. Control injections 
of these RNAs into the cytoplasm revealed that they are 
stable in the cytoplasmic compartment during the coarse of the experiment implying that 
degradation indeed occurs in the nucleus (data not shown). 
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To analyze the influence of La binding on the export of hYl RNA, two hYl RNA 
mutants were made (hYlXba and hYlXbaAC), in which the binding site of La on 
hYl RNA was destroyed by mutating the 3' terminal UUU sequence into UAG (Fig. 1). 
In vitro binding experiments showed that both RNAs indeed unable to bind the La protein 
(Fig. 2, lanes 8, 9). In addition to the mutation at the 3' end of both molecules, one of 
these mutants (hYlXbaAC) also lacks the bulged С at position 9 as in hYlAC RNA. This 
means that hYlXbaAC RNA not only is unable to interact with La but that it has a 
decreased binding affinity for R06O as well (Fig. 2, compare lane 13 with 14). 
Figure 4 shows the results of injection of these radiolabelled RNAs into the nucleus of 
X. laevis oocytes. Mutant hYlXba RNA (Fig. 4B) was, like hYlwt RNA (Fig. 4A), 
transported to the cytoplasm, indicating that La-binding is not necessary for export of 
hYl RNA out of the nucleus. On the contrary, the inability of hYlXba RNA to interact 
with La appeared to increase the export efficiency dramatically. One hour after injection 
the majority of hYlwt RNA is still in the nucleus (Fig. 4A, lanes 4, 5), while 
hYlXba RNA has almost completely been transported to the cytoplasm (Fig. 4B, lanes 4, 
5). The most likely explanation for this result is that binding of hYl RNA to the La 
protein retains the hYl RNA in the nucleus of X. laevis oocytes. This is further 
substantiated by the fact that nuclear hYlwt RNA still contains the La binding site, while 
the cytoplasmic hYl RNA in the oocyte is shortened at the 3' end by 2 to 3 nucleotides, 
which disrupts the La binding site (data not shown). 
To investigate, whether an intact R06O binding site is also necessary for the export of the 
hYlXba RNA, hYlXbaAC RNA was tested for its ability to leave the nucleus. Indeed, 
mutant hYlXbaAC RNA was able to leave the nucleus (Fig. 4C), albeit with a lower 
efficiency than observed for hYlXba RNA. While hYlXba RNA is almost completely 
exported to the cytoplasm within 1 hour (Fig. 4B, lanes 4, 5), the hYlXbaAC RNA 
reached a similar distribution in about 5 hours (Fig. 4C, lanes 8, 9). Thus as observed for 
export of hYlwt RNA, efficient export of hYlXba RNA also seems to be dependent on 
the binding of R06O. 
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Figure 4. Nuclear export of hYI RNA 
mutants defective in La binding. In vitro 
transenbed UlASm RNA was co-injected with 
either hYlwt RNA (A), hYlXba RNA (В) or 
hYlXbaAC RNA (С) into X. laevis oocyte 
nuclei. RNA was extracted from total oocytes 
(T), cytoplasmic (C) or nuclear (N) fractions 
immediately (lane 1), 'A hour (lanes 2, 3), 1 
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hours (lanes 8, 9) and 24 hours (lanes 10, 11) 
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Saturation of hYI RNA export 
Previously it was shown that in competition experiments with tRNA, Ul snRNA and 
mRNA, increasing amounts of any of these RNAs specifically saturated their own export, 
while cross-competition with other RNAs had little or no effect (Jarmolowski et al., 
1994). At least one step in the export of these RNAs seems therefore to be mediated by 
(a) specific factor(s). To test the saturability of hYI RNA export, mutant hYlXba RNA 
was used instead of hYlwt RNA, because export of hYlXba RNA is not delayed by 
nuclear retention as shown above. 
In vitro transcribed radioactively labelled hYlXba RNA (0.05 pmol) was injected into the 
nucleus of X. laevis oocytes together with increasing amounts of in vitro transcribed 
unlabelled hYlXba RNA. As a control for specificity UlASm RNA was used, and 
U6 snRNA with a mutated single stranded region (U6Ass) was co-injected to ensure 
injection accuracy. Mutant U6Ass RNA remains in the nucleus after injection therein and 
will not enter the nucleus after injection into the cytoplasm (Hamm & Mattaj, 1989; 
Boelens et al., 1995). After one hour of incubation in the absence of any competitor, 
hYlXba RNA was, as expected, exported to the cytoplasm (Fig. 5, lanes 2, 3). 
Co-injection of increasing amounts of unlabelled competitor hYlXba RNA (0.21 to 2.5 
pmol per oocyte) resulted in progressive inhibition of export, confirming that the export 
process was saturable (Fig. 5). With 2.5 pmol of competitor export of labelled 
hYlXba RNA was completely blocked (Fig. 5, lanes 10, 11). The competition with 
hYlXba RNA appears to be specific, since the export of UlASm RNA was not 
influenced. U6Ass RNA was, as expected, not transported at all. When hYlXba RNA as 
competitor was replaced by hYlwt RNA, the latter RNA appeared to compete as good as 
the hYlXba RNA mutant (data not shown). 
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Figure 5. Saturability of hYl RNA export. A mixture of in vitro transcribed, ^P-labelled hYlXba RNA 
(0.05 pmol), UlASm RNA and U6Ass RNA was co-injected into X. laevis oocyte nuclei without (lanes 1-3) 
or together with 0.21 pmol (lanes 4, 5), 0.63 pmol (lanes 6, 7), 1.3 pmol (lanes 8, 9) or 2.5 pmol (lanes 
10, 11) nonlabelled hYlXba RNA. RNA was extracted from total oocytes (T; 2 oocyte equivalents), 
cytoplasmic (C; 4 oocyte equivalents) or nuclear (N; 4 oocyte equivalents) fractions immediately (lane 1) 
and one hour (lanes 2-11) after injection and analyzed on a denaturing Polyacrylamide gel. The band 
migrating at the position marked with an asterisk is a U6Âss RNA related product. 
Competition for a common hYl RNA export factor 
The saturation experiments indicate that nuclear export of hYlXba RNA is mediated by 
(a) limiting nuclear factor(s). The question remains whether this factor is specific for 
hYl RNA export (e.g. Ro60) or whether it mediates export of other RNAs as well. To 
shed more light on this a mixture of in vitro transcribed 32P-labelled UlASm RNA, 
5S rRNA, hYlXba RNA, U6Ass RNA and tRNAf was injected into the nucleus of 
oocytes in combination with a single, unlabelled competitor RNA at a concentration of 
2.5 pmol per oocyte. 5S rRNA and tRNA are included in this experiment since both of 
these RNAs are, like Y RNAs, RNA polymerase III transcripts which are known to be 
exported from the nucleus of X. leavis oocytes (Tobian et al., 1985; Guddat et al., 1990) 
The intracellular distribution of the different RNAs was determined three hours after 
injection, by dissection of the oocytes. Consistent with earlier findings (Zasloff, 1983; 
Tobian et al., 1985; Jarmolowski et ai, 1994), tRNA1?*, hYlXba and the majority of 
hYlASm were exported to the cytoplasm when no competitor RNA was co-injected 
(Fig. 6A, lanes 2, 3). In contrast, both 5S rRNA and U6Ass RNA were not detectably 
exported within three hours after injection (Fig. 6A, lanes 2, 3). 
When 2.5 pmol of competitor hYlXba RNA was co-injected with the mixture, only the 
export of hYlXba RNA was blocked, while the export of UlASm RNA and tRNAf was 
not influenced (Fig. 6A, lanes 4, 5), suggesting that the limiting nuclear export factor of 
hYlXba RNA is specific for this type of RNA. Similarly, export of neither hYlXba RNA 
nor tRNAT1 was hindered by competition with UlASm RNA, whereas the export of 
UlASm RNA was almost completely inhibited under these circumstances (Fig. 6A, lanes 
8, 9). Thus, the export pathway of hYl RNA is distinct from that followed by 
Ul snRNA. Surprisingly, 2.5 pmol of tRNA1-"* not only competed for tRNAT* export as 
expected but also severely interfered with the export of hYlXba RNA to the cytoplasm 
(Fig. 6A, lanes 6, 7). This inhibition of hYlXba RNA export by an excess of tRNAT" 
seems to be in contradiction with the result that export of tRNA'ΐle, could not be blocked 
by co-injection of 2.5 pmol of hYlXba RNA. However, co-injections of larger amounts 
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of competitor hYlXba RNA (up to 5 pmol) did result in significant inhibition of tRNAT" 
export when analyzed one hour after injection (Fig. 6B, compare lanes 2, 3 with 4, 5), 
strongly suggesting that export of hYlXba RNA and tRNAT" is dependent on a common 
factor. 
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Figure 6. Competition for hYl RNA export by other RNAs. (A) A mixture of in vitro transcribed, 
32P-labelled UlASm RNA, 5S rRNA, hYlXba RNA, U6Ass RNA and tRNAT" was co-injected into 
X. laevis oocyte nuclei without (lanes 2, 3) or together with 2.5 pmol hYlXba RNA (lanes 1, 4, 5), 
tRNA™ (lanes 6, 7), UlASm RNA (lanes 8, 9), 5S rRNA (lanes 10, 11) or U6Ass RNA (lanes 12, 13). 
RNA was extracted from total oocytes (T; 2 oocyte equivalents), cytoplasmic (C; 4 oocyte equivalents) or 
nuclear (N; 4 oocyte equivalents) fractions immediately (lane 1) and three hours (lanes 2-13) after injection 
and analyzed on a denaturing Polyacrylamide gel. (B) A mixture of in vitro transcribed, 32P-labelled UlASm 
RNA, hYlXba RNA and tRNA™' was co-injected into X. laevis oocyte nuclei without (lanes 2, 3) or 
together with 5 pmol hYlXba RNA (lanes 1, 4, 5). RNA was extracted from total oocytes (T; 2 oocyte 
equivalents), cytoplasmic (C; 4 oocyte equivalents) or nuclear (N; 4 oocyte equivalents) fractions 
immediately (lane 1) and one hour (lanes 2-5) after injection and analyzed on a denaturing Polyacrylamide 
gel. (C) A mixture of in vitro transcribed, 32P-labelled UUSm RNA, hYlXba RNA, U6Ass RNA and 
tRNAT" was co-injected into X. laevis oocyte nuclei without (lanes 2, 3) or together with 2.5 pmol 
hYlXbaRNA (lanes 4, 5) or hYl ASILI (lanes 1, 6, 7). RNA was extracted from total oocytes (T; 4 
oocyte equivalents), cytoplasmic (C; 4 oocyte equivalents) or nuclear (N; 4 oocyte equivalents) fractions 
immediately (lane 1) and one hour (lanes 2-7) after injection and analyzed on a denaturing Polyacrylamide 
gel. The band migrating at the position marked with an asterisk is a U6Ass RNA related product. 
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The binding of the latter factor to hYl RNA could either be Ro60-dependent, meaning 
that it requires the R06O protein for association with the hYl RNA, or Ro60-independent. 
To investigate this the competition experiment was performed with hYl AS ILI RNA as 
competitor, i.e. the mutant which is unable to interact with R06O. As can be seen in 
Figure 6C, hYlASlLl RNA equally well competed for export of hYlXba RNA (lanes 6, 
7) as hYlXba itself (lanes 4, 5). In combination with the observation that 
hYlASlLl RNA also competed for tRNA?" export (Fig. 6C, lanes 6, 7) these results 
strongly suggest that the common export factor acts independent of R06O. 
The question remains, whether other RNA polymerase III products, like 5S rRNA and 
U6 snRNA, are also able to compete for the export of hYlXba RNA. Previously it has 
been shown that both 5S rRNA and U6 snRNA are able to leave the nucleus of X. laevis 
oocytes (Guddat et al., 1990; Boelens et al., 1995). Therefore, the competition 
experiments were performed with either an excess of 5S rRNA (Fig. 6A, lanes 10, 11) or 
U6Ass RNA (Fig. 6A, lanes 12, 13). In both cases, no interference with hYl RNA (or 
tRNA1-*1 or Ul snRNA) export could be observed. 
In conclusion, export of hYl RNA is mediated by a nuclear factor, which is also 
necessary for the export of tRNA1-**. This factor is probably not shared by other RNA 
polymerase III transcripts such as 5S rRNA and U6 snRNA and is not involved in the 
export process of Ul snRNA. 
Competition of hYl RNA export with the Rev-NES 
The best studied protein involved in RNA export is Rev, a human immunodeficiency 
virus protein, which binds to the Rev response element (RRE) present in unspliced viral 
RNAs, resulting in nuclear export of these unspliced viral RNAs (Fischer et al., 1994). 
Recently it has been shown that the activation domain of Rev represents a nuclear export 
signal (NES) which interacts with a cellular factor that is limiting for Rev-mediated RNA 
export (Fischer et al., 1995). 
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Figure 7. Competition for hYl RNA export with BSA-Rev NES conjugates. A mixture of in vitro 
transcribed, 32P-labelled UlASm RNA, hYlXba RNA, U6Ass RNA and tRNA™ was co-injected into 
X. laevis oocyte nuclei together with 0.25 ^g BSA-R (BSA conjugated with Rev-NES peptides) (lanes 5, 6 
and 11, 12), 0.25 μ% BSA-M (BSA conjugated with mutant Rev-NES peptides) (lanes 3, 4 and 9, 10) or 
without competitor protein (lanes 1, 2 and 7, 8). One hour (lanes 1-6) and three hours (lanes 7-12) after 
injection RNA was extracted from cytoplasmic (C) and nuclear (N) fractions and analyzed on a denaturing 
Polyacrylamide gel. The band migrating at the position marked with an asterisk is a U6Ass RNA related 
product. 
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We wanted to investigate, whether hYl RNA also uses the Rev-mediated RNA export 
pathway. If so, transport of hYl RNA should be saturable with an excess of the Rev 
nuclear export signal peptide. To test this, BSA conjugated with Rev- NES peptides 
(BSA-R), used previously by Fischer et al. (1995), were co-injected. 250 ng of BSA-R 
was co-injected with a RNA mixture (containing UlASm RNA, hYlXba RNA, 
U6Ass RNA and tRNAI**) into the nucleus of X. laevis oocytes. As a negative control 
BSA-M (BSA conjugated with the M10-NES peptide) was co-injected. MIO is a Rev 
mutant with a double amino acid substitution in the Rev-NES, which is therefore unable 
to leave the nucleus and promote Rev-mediated RNA nuclear export (Fischer et al, 
1995). When the RNA mixture was injected into the nucleus without any BSA conjugate, 
hYlXba RNA and tRNAf" were exported within 1 hour (Fig. 7, lanes 1,2), while the 
majority of UlASm RNA was exported within 3 hours (Fig. 7, lanes 7, 8), similar to 
what was observed before. U6Ass RNA was, as expected, not exported at all. When the 
same RNA mixture was co-injected with BSA-R, UlASm RNA was not exported to the 
cytoplasm any more (Fig. 7, compare lanes 5, 6 and 11, 12 with lanes 1, 2 and 7, 8, 
respectively). Inhibition of UlASm RNA export with BSA-R has been observed before 
(Fischer et al., 1995). In contrast, co-injection of BSA-R with the RNA mixture had no 
noticeable effect on the export of tRNA^*, consistent with previous findings (Fischer et 
al., 1995), but also not on the export of hYlXba RNA (Fig. 7, compare lanes 5, 6 and 
11, 12 with lanes 1, 2 and 7, 8, respectively). The effect of BSA-R was specific, since 
co-injection of BSA-M did not influence the distribution of the injected RNAs, in 
particular UlASm (Fig. 7, compare lanes 1, 2 and 7, 8 with lanes 3, 4 and 9, 10, 
respectively). We conclude that the Rev-mediated RNA export pathway is not used by 
hYl RNA. 
DISCUSSION 
Using X. laevis oocyte injection and cell enucleation it has been shown that Y RNAs are 
primarily located in the cytoplasm of cells (O'Brien et ai, 1993; Peek et al., 1993; 
Simons et al., 1994). This implies that, like most other RNAs, Y RNAs have to be 
transported from the nucleus to the cytoplasm. Up to now nothing is known about the 
export pathway of Y RNAs. To elucidate the identity of any iranj-acting factor(s) 
involved in Y RNA export we started our investigations by testing whether the two 
proteins which are known to be associated with Y RNAs in the nucleus, i.e. La and 
Ro60, are involved in the export of the Y RNAs. 
Nuclear export of hYl RNA is dependent on Ro60 binding 
All mutations in the hYl RNA that changed the Ro60 binding site severely reduced the 
nuclear export rate. Mutant hYlASlLl, in which the complete Ro60 binding site was 
deleted, was not detectably exported to the cytoplasm. Because of the relative instability 
of this mutant RNA an alternative explanation would be that hYlASlLl RNA is exported 
slowly to the cytoplasm where it is degraded rapidly. This possibility, however, was ruled 
out by the observation that hYlASlLl RNA is stable in the cytoplasm. The nuclear 
instability of mutant RNAs in X. laevis oocytes was also observed with SRP RNA when 
the binding site for the SRP9 and 14 protein on the SRP RNA was mutated (He et al., 
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1994). Therefore it is likely that protein binding stabilizes these RNAs. Nevertheless, the 
decreased export rate of hYlAC RNA and the lack of export of hYlASlLl RNA are 
most likely explained by assuming that R06O binding is necessary for export of 
hYl RNA. This conclusion is in good agreement with our previous results which 
suggested that R06O associates with hYl RNA in the nucleus and that after this 
association the RNP is rapidly exported to the cytoplasm (Simons et al., 1994). 
Furthermore it has been shown that R06O is both present in the cytoplasm and in the 
nuclei of X. laevis oocytes (Simons et al., 1994), human (Peek et al., 1993) and mouse 
cells (O'Brien et al., 1993). Further studies are needed to find possible factor(s) to which 
the R06O protein binds in order to activate nuclear export and which part of R06O is 
involved in such an interaction. The finding that R06O is able to leave the nucleus 
associated with the Y RNAs and the fact that R06O is actively transported to the nucleus 
upon injection into the cytoplasm (Simons et al., 1994), strongly suggest that R06O is a 
shuttling protein. 
La binding is not necessary for nuclear export of hYl RNA, but mediates nuclear 
retention of hYl RNA in X. laevis oocytes 
Mutant hYlXba RNA, which is unable to interact with the La protein is rapidly exported 
to the cytoplasm. This result proves that La is not necessary for export of hYl RNA in 
X. laevis oocytes. This conclusion is further underlined by the fact that in X. laevis 
oocytes the nuclear hYl RNA indeed is associated with the La protein, while after or 
during export to the cytoplasm this association is lost (Simons et al., 1994). The same 
phenomenon of La dissociation during nuclear export was previously observed in the case 
of 5S rRNA (Guddat et al., 1990) and SRP RNA (He et al, 1994) and is probably 
caused by З'-end processing events leading to deletion of the La binding site. 
Interestingly, characterization of the Ro60-associated Y RNAs from X. laevis showed that 
these lack a functional La binding site (O'Brien et al., 1993). In this respect the X. laevis 
Y RNAs differ from the human Y RNAs for which it has been demonstrated that they are 
stably associated with the La protein in the cytoplasm as well (Boire & Craft, 1990; Peek 
et al., 1993). This implies that in human cells the Y RNAs either re-associate with 
cytoplasmic La protein after transport or that in these cells the Y RNAs are transported in 
a complex containing the La protein. 
As a consequence of the inability to associate with the La protein, hYlXba RNA is 
exported at a much higher rate than hYlwt RNA. This can be explained by assuming that 
association of La to hYlwt RNA leads to retention of the RNA in the nucleus, while the 
hYlXba RNA missing the La binding site is not retained and immediately exported. An 
alternative explanation could be that due to the mutation the structure of hYlXba RNA is 
changed in such a way that a binding site for a tRNA-specific export factor is created, 
resulting in fast nuclear export. However, this possibility seems unlikely because (i) only 
two terminal nucleotides at the 3' end, which are known not to be involved in secondary 
structural elements (Van Gelder et al., 1994), were changed in the hYlXba RNA, and (ii) 
hYlwt RNA appeared to compete for hYlXba RNA export equally well as the 
hYlXba RNA mutant (data not shown). In good agreement with the fast nuclear export of 
RNA mutants lacking the La binding site, we could show that La itself is very efficiently 
retained in X. laevis nuclei (Simons et al., submitted). Furthermore, it has been shown 
that La is one of the factors which is involved in the nuclear retention of U6 snRNA 
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(Boelens et al., 1995). 
It has been shown that hYlwt RNA associates with the La protein after injection into the 
nucleus (Simons et al., 1994), which probably leads to its nuclear retention. 
Subsequently, the З'-end of the hYlwt RNA molecule is gradually shortened, a process 
which might be dependent on the dissociation of the La protein allowing rapid export of 
the RNA to the cytoplasm. Thus the nuclear export rate of hYlwt RNA in oocytes is in 
fact dominated by two counteracting processes: retention of the RNA mediated by La 
binding and active export requiring the association with R06O. 
Mutant hYlXba RNA is exported at a very high rate: within 1 hour it is completely 
exported to the cytoplasm. So far the only RNA which was observed to be exported as 
fast as hYlXba RNA is tRNAT* (Zasloff et al., 1983; Jarmolowski et al., 1994), which 
is also a RNA polymerase Ш product. Similar to hYlXba RNA, the tRNA molecule 
analyzed in these studies also lacked a functional La binding site. The relatively low 
export rates reported for SRP RNA (He et al., 1994) and 5S rRNA (Guddat et al., 1990; 
Jarmolowski et al, 1994), two other RNA polymerase III products, might also be 
explained by retention in the nucleus via binding to La followed by export after release of 
the La protein. These results imply that La is not required for nuclear export of RNA 
polymerase III products and that in X. laevis oocytes the export rate of RNA polymerase 
III transcripts is strongly influenced by dissociation from the La protein and/or 3'-end 
trimming to disrupt the La binding site. 
hYl RNA export is saturable and requires a factor which is also needed for tRNA 
export 
As discussed before, R06O binding seems to be a prerequisite for Y RNA to leave the 
nucleus. As a consequence Y RNA export is expected to be a saturable process and 
indeed co-injection of increasing amounts of unlabelled Y RNA interfered with export of 
radiolabelled Y RNA. This effect is not necessarily due to a potentially limiting amount 
of R06O but may involve other, possibly more general export factors. Therefore, 
co-injections with other types of RNA were performed as well. 
Cross-competition experiments in which large amounts of either tRNA"!"*, UlASm RNA, 
5S rRNA or U6Ass RNA were co-injected with hYlXba RNA, showed that hYl RNA 
export could only be blocked with high concentrations of tRNAI**· This indicates that at 
least one iranj-acting factor involved in the export of hYl RNA is also involved in the 
export of tRNAT". This factor is most likely different from R06O, because R06O does not 
interact with tRNAs (Hendrick et al., 1981). 
Although two other RNA polymerase III transcripts, 5S rRNA and U6 snRNA, did not 
interfere with the export of either hYl RNA or iRNA1^*, the present results do not 
exclude the possibility that this factor is involved in export of other RNA polymerase III 
products as well. Both 5S rRNA and U6Ass RNA were not detectably exported in the 
time period of the experiment and their inefficiency/inability to enter the export pathway 
may explain their inert behaviour towards Y RNA or tRNA export. Further studies are 
required to investigate whether this factor is also involved in the export of other RNAs. It 
is likely that this factor has a higher affinity for human tRNAT" as compared to human 
YlXba RNA, because a larger amount of hYlXba RNA is necessary to saturate tRNAT* 
export than the amount of tRNAT" required to saturate the hYlXba RNA export. It will 
be interesting to identify and characterize this export-mediating factor. 
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bYl RNA export is not dependent on a Rev-like NES 
The recent identification of nuclear export signals, small sequence elements rich in 
leucine and other hydrophobic amino acids (Gerace, 1995), prompted us to investigate 
whether export of hYl RNA was also mediated by such a signal. Co-injection studies 
with a Rev peptide containing a nuclear export signal which is also involved in export of 
Ul snRNA showed that, although export of UlASm RNA was specifically blocked, the 
export of both tRNA1·"* and hYlXba RNA was not influenced. This strongly suggests that 
R06O and the yet unidentified trans-acting factor(s) involved in the export process of 
hYl RNA, do not contain a Rev-like nuclear export signal. The question remains whether 
R06O and/or the other factor(s) contain a different type of export signal or that their mode 
of action in the export process of hYl RNA is different. 
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Chapter 6 
GENERAL DISCUSSION 

GENERAL DISCUSSION 
Assembly of Ro RNP particles 
The results of the experiments described in chapter 2 show that each individual 
component of the Ro RNP particle is transported through the nuclear pore complex in an 
energy-dependent way. Upon injection, the La, R06O and Ro52 proteins are actively 
imported into the nucleus, while the hYl, hY3, hY4 and hY5 RNAs are actively exported 
from the nucleus. Furthermore, La and R06O appear to bind to hYl RNA in the nucleus. 
After transport to the cytoplasm the hYl RNA in Xenopus laevis oocytes is associated 
with R06O but not with the La protein. This is in contrast with the finding that the La 
protein remains associated with the Y RNAs in several types of cultured cells (Boire and 
Craft, 1990; Peek et al., 1993). 
R06O appears to be essential for the export of hYl RNA to the cytoplasm together with 
another protein, which is also involved in the nuclear export of tRNA (Chapter 5). As 
was already suggested by immunoprecipitations with anti-La antibodies (Chapter 2), the 
analysis of hYl RNA mutants convincingly showed that La is not involved in the export 
process of hYl RNA. Because of the high export rate and molecular mass of the 
Ro RNP, a nuclear export signal (NES) present on the Ro RNP complex most probably is 
involved in the export process. We showed that this presumptive nuclear export signal is 
distinct from the NES characterized on the HIV-1 Rev protein (Chapter 5). 
From the combined data, a pathway for hYl RNP assembly can be deduced (Fig. 1). 
Proteins La, R06O and Ro52 are synthesized in the cytoplasm and subsequently 
transported to the nucleus. Because all three protein are imported in an energy-dependent 
manner (Chapter 2), most probably nuclear localization signals (NLSs) are involved in 
some way. For the La protein a bipartite NLS has been mapped on the C-terminus of the 
protein. The putative NLSs for R06O and Ro52 have not been identified, yet. By scanning 
the primary structures of both proteins for NLSs of the SV40- or bipartite-type, only in 
R06O a possible NLS could be discerned (amino acids 132-150). This element seems 
bipartite in that it contains two lysines at the N-terminal side, a spacer of twelve amino 
acids and three out of five basic amino acids at the C-terminus. In the sequence of Ro52 
no obvious NLS can be detected, but based on the putative interaction with R06O in the 
Ro RNP particle (Slobbe et al., 1992) one could speculate that Ro52 is imported into the 
nucleus in association with R06O ("piggy-back" mechanism). 
The hYl RNA is transcribed by RNA polymerase III in the nucleus and released from the 
transcription complex in association with the La protein, as a consequence of the 
involvement of the La protein in the transcription termination process (Gottlieb and Steitz, 
1989a; Gottlieb and Steitz, 1989b; Maraia et al, 1994). Because of the association with 
the La protein, hYl RNA is temporarily retained in the nucleus (Chapter 3). During this 
period or possibly already during the transcription process, R06O and at least one export 
factor will bind to the Y RNA. The association of the Ro52 protein with Ro RNPs does 
not necessarily have to occur in the nucleus, but could also occur in the cytoplasm after 
nuclear export. 
To alleviate the nuclear retention of hYl RNA by La two mechanisms can be envisioned: 
(1) switching off nuclear retention of the La protein which might be achieved by 
phosphorylation or dephosphorylation or (2) dissociation of the La protein which may be 
followed by disruption of the La binding site. The first possibility is probably true for 
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Figure 1. Assembly of bYl RNP. 
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somatic cells for which it has been shown that Ro RNPs are stably associated with the La 
protein, while the second possibility most likely reflects the situation in X. laevis, where 
La is not associated with cytoplasmic Ro RNPs. 
After alleviation of retention the Ro RNP is transported to the nuclear pore complex and 
in an energy requiring translocation step the RNP is subsequently exported to the 
cytoplasm. This export step might need GTP hydrolysis because the GTPase Ran/TC4 
was shown to be involved in similar export processes (Izaurralde and Mattaj, 1995). 
Despite the fact that La does not seem to contribute to nuclear export of hYl RNA in X. 
laevis oocytes, it most likely is exported in association with Ro RNPs to the cytoplasm in 
mammalian cells. This can be concluded from the finding that all Ro RNPs in mammalian 
cells can be immunoprecipitated by anti-La antibodies (Peek et al, 1993). An alternative 
possibility is that La is released from the hY RNAs in the nucleus and that after hY RNA 
export cytoplasmic La will bind to these RNAs leading to La containing Ro RNPs. 
Analogous to NLS-receptors (Simos and Hurt, 1995), the export factor may also be a 
shuttling carrier, i.e. its release from the Ro RNP may occur in the cytoplasm followed 
by re-entry into the nucleus. 
Nucleocytoplasmic shuttling of the La protein 
Although immunofluorescence experiments show that La is predominantly localized in the 
nucleus, it became clear, by using other techniques, that a small but significant amount of 
the La protein resides in the cytoplasm (Chapter 2; Pruijn, 1994). Consistent with the 
nuclear and cytoplasmic localization, the La protein has been shown to be involved in 
both nuclear and cytoplasmic processes. Firstly, La is involved in transcription 
termination and transcript release and transcription reinitiation during RNA synthesis by 
RNA polymerase III (Gottlieb and Steitz, 1989a; Gottlieb and Steitz, 1989b; Maraia et 
al., 1994). Secondly, La has been shown to be involved in translation of some viral 
RNAs (Meerovitch et al., 1993; Chang et al., 1994; Svitkin et al., 1994a; Svitkin et al., 
1994b) and is in part associated with the 40S ribosomal subunit (Peek et al., 1996). 
The energy-dependent nuclear import of La is mediated by a bipartite nuclear localization 
signal present in the C-terminal part of the protein (Chapter 3). Based on the different 
functions of La in the two major subcellular compartments and the fact that La 
accumulates in the cytoplasm under certain stress conditions (reviewed in: Pruijn, 1994), 
one could speculate that La is a nucleocytoplasmic shuttling protein. Shuttling indeed 
seems to occur in human-mouse heterokaryons, in which human La appeared to be able to 
leave the human nucleus and enter the mouse nucleus (Chapter 4). Presently, it is not 
known whether nuclear export of La is mediated by positively acting signals like the 
nuclear export signals, recently identified in HIV-1 Rev and PKI (reviewed in: Gerace, 
1995), or that La is exported via a so-called "piggy-back" mechanism together with, for 
example, Y RNAs or other RNA polymerase III transcripts. Passive diffusion of La to the 
cytoplasm seems not very likely, since nuclear export of an import defective mutant was 
shown to be energy-dependent (Chapter 3). 
The regulation of the intracellular localization of La becomes even more complex when 
the nuclear retention of La is taken into consideration (Chapter 3). Nuclear retention of 
proteins most probably is the result of polymerization of the proteins in the nucleus or 
binding of the proteins to nuclear components (Schmidt-Zachmann et al., 1993). Similarly 
cytoplasmic retention might play a role. The stable binding to hY RNAs might be 
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considered as a mechanism of La retention in the cytoplasm. The intracellular distribution 
of La probably reflects a sort of equilibrium situation which is determined by the relative 
strength of the various signals. The strength of these signals may be modulated by protein 
modification. Interestingly, the region of La containing most of these signals is known to 
be highly phosphorylated in somatic cells. Phosphorylation of La leads to the occurrence 
of at least 8 isoelectric forms (Pizer et al, 1983; Francoeur et al, 1985; Pfeifle et al, 
1987). Moreover, phosphorylation is known to affect the intracellular localization of many 
proteins in different ways. Studies in which phosphorylation sites were mutated showed 
that nuclear import was either inhibited, as is the case for the SV-40 large Τ antigen (Rihs 
et al, 1991; Jans and Jans, 1994) and for human lamin A (Haas and Jost, 1993), or 
enhanced as is the case for the yeast SW15 (Moll et al, 1991), the X. laevis xnf7 protein 
(Li et al, 1994) and the viral Jun protein (Tagawa et al, 1995). Mutation of a threonine 
into a negatively charged amino acid (D or E) in the SV-40 Τ antigen (Jans et al., 1991) 
and the X. laevis xnf7 protein (Li et al, 1994) resulted in inhibition of nuclear import, 
which was shown to be caused by an increased nuclear retention in the case of xnf7 (Li et 
al, 1994). In addition, phosphorylation of the (shuttling) influenza virus matrix protein 
Ml was shown to cause inhibition of nuclear export which was, in this case, mediated by 
an increased nuclear retention (Whittaker et al, 1995). A decrease in the overall 
phosphorylation level of proteins by either inhibition of kinase activity or phosphatase 
treatment resulted in increased nuclear export of the influenza viral shuttling protein Ml 
(Whittaker et al, 1995), increased nuclear import of the viral Jun protein (Tagawa et al, 
1995) and inhibition of nuclear import of the human MyoD protein (Vandromme et al, 
1994), X. laevis nucleoplasmin (Vancurova et al, 1995), signal peptide-albumin 
conjugates (Mishra and Parnaik, 1995) and the human serum response factor 
(Gauthier-Rouviere et al, 1995). The opposite changes in the phosphorylation level, 
which can be achieved by kinase treatment or phosphatase inhibition, resulted in 
inhibition of nuclear import of the human glucocorticoid receptor (DeFranco et al, 
1991), yeast SW15 (Moll et al, 1991), chicken lamin B2 (Hennekes et al, 1993) and 
viral Jun (Tagawa et al, 1995) and to an increased nuclear import of Drosophila 
morfogen dorsal (Norris and Manley, 1992) and the HIV-1 matrix protein (Gallay et al, 
1995). The effect on the yeast SW15 protein appeared to be caused by an increase in 
cytoplasmic retention upon phosphorylation (Moll et al, 1991). Inhibition of protein 
phosphatase 2A resulted in reduced nuclear retention and thus efficient nuclear export of 
the shuttling glucocorticoid receptor (DeFranco et al, 1991). 
The detailed mechanism by which (de)phosphorylation influences the intracellular 
localization of proteins is not understood yet. The position of some phosphorylation sites 
near NLSs suggests that phosphorylation might modulate the activity of an NLS. The 
same could be true for phosphorylation sites in the neighbourhood of an NES. Similarly, 
phosphorylation and dephosphorylation might also negatively or positively influence 
nuclear and/or cytoplasmic retention of proteins. Consistent with this idea is the finding 
that phosphorylation of both the yeast transcription factor SW15 and the X. laevis xnf7 
protein leads to cytoplasmic retention (Moll et al, 1991; Li et al, 1994). The very 
efficient nuclear retention of La in X. laevis oocytes could be explained by assuming that 
specific (de)phosphorylation steps are necessary before La is released. 
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The use of X. laevis oocytes for localization studies 
One striking difference observed between X. laevis oocytes and other cell types is that in 
X. laevis oocytes La is not associated with Ro RNPs in the cytoplasm (Chapter 2), while 
in both human and mouse somatic cells La is a stable component of cytoplasmic Ro RNPs 
(Peek et al, 1993; Boire and Craft, 1990). A different behaviour between X. laevis 
oocytes and somatic cells has also been observed for nuclear import of Ul sriRNPs, 
which are RNA-protein complexes involved in pre-mRNA splicing. In X. laevis oocytes 
Ul RNA import is dependent on the presence of a trimethyl cap (m3GpppG) present on 
the 5' end of the molecule, while in somatic cells (even those originating from X. laevis) 
Ul snRNP import is m3G-cap independent (Marshallsay and Luhrmann, 1994; Fischer et 
al., 1994a). This might be explained by assuming that there are profound differences in 
the cellular composition between cells originating from different tissue and/or different 
species. These differences could be the complete absence or presence of certain 
components or a variation in the concentration or activity of the same component in 
different cells. A comparison between the X. laevis and human Y RNAs, for example, 
reveals that mature X. laevis Y RNAs (also from somatic cells) do not contain a 
functional the La-binding site at their 3' ends. This phenomenon is most likely related to 
the absence of La in cytoplasmic Ro RNPs of X. laevis oocytes. Cell-type-specific 
differences are, of course, not restricted to X. laevis oocytes, but inherent to every assay 
in which (specific) cells are used. This implies that one should always keep in mind that 
results obtained in a certain cell type might be cell-specific and that care should be taken 
in generalization of such results. Nevertheless, X. laevis oocytes have been shown in 
many studies to be very useful for obtaining further and better insight into the 
intracellular localization and trafficking of proteins and RNAs (Simos and Hurt, 1995; 
Izaurralde and Mattaj, 1995; Gerace, 1995). 
Bipartite NLSs 
In the amino acid sequence of the La protein three sequence elements, similar to the 
bipartite NLS consensus proposed by Dingwall and Laskey (1991), can be discerned. 
According to this consensus a bipartite NLS is characterized by two basic amino acids, 
followed by a spacer of 10 random amino acids and a second cluster of basic amino acids 
in which three out of five amino acids should be basic. The first element in La (amino 
acids 191 to 208), which has a spacer of 11 amino acids, and the second element (amino 
acids 316 to 332), which completely corresponds to the consensus, appeared not to be 
involved in the nuclear uptake of La. The most C-terminal element from amino acids 383 
to 400 does not perfectly match to the consensus, but nevertheless was shown to be 
responsible for nuclear import of La (Chapter 3). The functional NLS in La does not 
match the consensus in that it contains a spacer region of 12 amino acids and only two 
basic amino acids in the C-terminal cluster. The consensus bipartite NLS was based on 
only a limited number of experimentally established NLSs and on the observation that 
many nuclear proteins carry a putative bipartite consensus NLS. For the La protein, 
however, we were able to show that an element that perfectly matches this consensus is 
not necessarily involved in nuclear import (Chapter 3). To test the validity of the 
consensus sequence for the bipartite NLS, a new sequence comparison of all 
experimentally established bipartite NLSs was carried out. For all of these NLSs, listed in 
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Table I, the involvement of two clusters of basic amino acids has been demonstrated. The 
involvement of each individual basic amino acids in these clusters has only been tested in 
a limited number of cases. 
The N-terminal basic cluster of all identified bipartite NLSs indeed consist of at least two 
flanking basic amino acids. Only in case of protein VirE2 of Agrobacterium tumefaciens 
(Citovsky et al., 1992) and the foamy virus Bell protein (Lee et al., 1994) the two basic 
amino acids are not direct neighbours, but interrupted by one non-basic amino acid. 
The length of the spacer region does not appear to be very strict. The spacers seem to 
vary in length from 4 to 18 amino acids. An extremely long spacer region of 34 amino 
acids was observed in the case of human interferon gamma (Bader and Weitzerbin, 1994). 
A minimal length of 9 amino acids appears to be required for the spacer region. Spacer 
insertion and deletion mutagenesis data already indicated that relatively large deletions in 
the spacer are not tolerated, while insertions in the spacer appear to have no or hardly 
any influence on nuclear import (Robbins et al., 1991; Schreiber et al., 1992; Fischer et 
al., 1994b; Schmolke et al., 1995). In conclusion, although a bipartite spacer of 10 amino 
acids is most prevalent, this length is not an absolute requirement. 
Consistent with the previously proposed consensus sequence, the C-terminal basic cluster 
contains in most cases at least three basic amino acids. However, the NLSs in the human 
heat shock factor 2 (Sheldon and Kingston, 1993), the herpes simplex virus regulatory 
protein ICP27 (Mears et al., 1995) and the human La protein (Chapter 3) contain only 
two basic amino acids in their C-terminal basic cluster. 
Based on these observations we propose a somewhat modified bipartite consensus NLS 
which contains at least two N-terminal basic amino acids, a spacer region of at least nine 
random amino acids and a C-terminal basic cluster in which two out of four amino acids 
or three out of five amino acids are basic. According to this newly defined bipartite NLS 
consensus, the La protein is a real member of the bipartite NLS family. 
The observed acidic nature of the spacer sequence in the La protein (Chapter 3) appears 
to be a more general feature of bipartite NLSs. About 75% of the NLSs have one or 
more acidic amino acids in their spacer region. These spacer regions contain on average 3 
acidic amino acids with the highest content in the human NSR1 protein in which 10 out of 
15 amino acids are acidic (Yan and Melese, 1993). Furthermore, the spacers of bipartite 
NLSs appear to have a rather high content of serines and threonines: 16% of all amino 
acids in the spacer consists of serines and threonines. The number of serines and 
threonines in the spacers varies from 0 in the human poly(ADP-ribose) polymerase 
(Schreiber et al., 1992), Χ. laevis xnf7 (Li and Etkin, 1993) and the human foamy virus 
Bell protein (Lee et al., 1994) to 9 (out of 12) in the case of the papillomavirus LI 
protein (Zhou et al., 1991). Consistent with the fact that a number of these proteins have 
been shown to be phosphorylated, some serines and threonines in the spacer regions are 
potential phosphorylation sites. However, until now only in the case of the yeast SW15 
protein (Moll et al., 1991), the serine in the spacer was shown to be phosphorylated (by 
CDC28 HI kinase) which leads to increased nuclear retention. However, modulation of 
NLS activity by phosphorylation might be a much more general phenomenon in view of 
the high percentage of phosphorylatable residues near charged residues, which is 
characteristic for many recognition sites for protein kinases. 
Already in 1989 it was reported that the C-terminal part of the La protein contains a 
PEST region (Chan et al., 1989), which later on turned out to co-localize with the 
bipartite NLS (Chapter 3). PEST domains are found in proteins with short half-lives and 
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are enriched in proline (P), acidic residues (D and E) and hydrophilic residues (S and T) 
(Rogers et al., 1986; Chevaillier, 1993). Interestingly they are often flanked by clusters 
of basic amino acids. In addition to the high frequency of D, E, S and Τ in the spacer 
Table I Sequence comparison of functional bipartite NLSs 
Proteins ' NLS sequence b 
X. l a e v i s N l l 
Influenza virus PB12 
X. laevis Nucleoplasmin3 
Adenovirus AdPol4 
Yeast SWI55 
Papillomavirus Lls 
A. tumefaciens VirD2' 
A. tumefaciens VirE2e 
Human PARP' 
Maize 0210 
Human pllORBl11 
Newcastle disease virus M: 
Human HSF2" 
Human HSF213 
Human androgen receptor14 
Parvovirus NS11S 
Epstein-Barr virus EB1" 
Human c - J u n 1 6 
X. laevis x n f 7 " 
Chicken nucleolin18 
Human NSR11' 
Foamy virus Bell20 
Bovine PAP21 
Bovine PAP21 
Human B-myb" 
Mouse Kinl723 
Human I FN-gamma24 
Cytomegalovirus pp6525 
Herpes simplex virus ICP27" LGARRPSCSPERHGGKVARLQP 
Human SRY27 VQDRVKRPMNAFIVWSRDORRKMAL 
Human La28 GPVKRAREETDKEEPASKOOKTEN 
* References: ' Kleinschmidt and Seiter, 1988; 2 Nath and Nayak, 1990; 3 Robbins et al, 1991; 
4
 Zhao and Padmanabhan, 1991; 5 Moll et al, 1991; 6 Zhou et al, 1991; ' Howard et al, 1992; 
' Citovsky et al., 1992; ' Schreiber et al, 1992; 10 Varagona et al, 1992; " Zacksenhaus et al, 1993; 
12
 Coleman and Peeples, 1993; 13 Sheldon and Kingston, 1993; 14 Jenster et al, 1993; '5 Nuesch and 
Tattersall, 1993; l 6 Mikaelian et al, 1993; " Li and Etkin, 1993; " Schmidt-Zachmann and Nigg, 
1993; " Yan and Melese, 1993; » Lee et al, 1994; 21 Raabe et al., 1994; n Takemoto et al., 1994; 
23
 Mazin et al., 1994; u Bader and Weitzerbin, 1994; H Sclmwlke et al., 1995; M Mears et al, 1995; 
r
 Poulat et al, 1995; a Simons et al, 1996. 
ь
 Basic amino acids in the two basic cluster of the bipartite NLS are idicated in bold and underlined. 
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HLVRKKRKTEEESPLKDKDAKKSKOEP 
HFORKRRVRDNMTKKMVTORTIGKRKORLNK 
KAVTCRPAATKKAGOAKKKKLPK 
OAHRARRLHAEAPDSGDOPPRRRVROOP 
SGGKKYENWIKRSPRKRGRPRKDGT 
TLGKRKATPTTS STSTTAKRKKRKL * 
VLSKRPREDDDGEPSDRKRERDER 
RNYKLRPEDRYIQTEKYGKKEIQ 
SEGKRKGDEVDGVDEVAKKKSKKEKDKDSK 
TEERVRKRKESNRESARRSRYRKAAH 
RVLKRSAEGSNPPKPLKKLRFDI 
TVDKKGKKVTFDKLERKIRRLDL 
ENIKRKVSSSKPEENKIRQED 
VSLKRKRPLLLNTNGAOKKNLF 
PSCRLRKCYEAGMTLGARKLKKLGN 
KOTKKDYTKCVLFGNMIAYYFLTKKKIST 
LEIKRYKNRVASRKCRAKFKQLL 
KAERKRMRNRIAASKCRKRKLER 
TPQKRKIEEPEPEPKKAKVEE 
APGKRKKEMANKSAPEAKKKKTET 
NNDKKRKSEDAEEEEEDEESSNKKOKNEE 
EGPKPRPRHDPVLRCDMFEKHHKPROKRPRRRSID 
MHVKRKOLHOLLPSHVLOKKKKHST 
VGVKRTSSPHKEESPKKTKTEE 
RPEKOKRKPGLRRSPIKKVRKSLA 
ASGKRKESSOSSAOPAKKKKSALD 
NSNKKKRDDFEKLT-X„-PAAKTGKRKRSOM 
PKRRRHRODALPGPCIASTPKKHRG 
regions of NLSs, also the frequency of prolines in the spacer is rather high (10%). As a 
consequence, the spacer region of many bipartite NLSs meet the criteria for a PEST 
region, as indeed is the case for the La protein. The physiological meaning of this 
phenomenon is not clear yet. 
Conclusions and perspectives 
The micro injection studies performed with X. laevis oocytes have increased our 
knowledge on the intracellular localization and trafficking of Ro RNP components. After 
transcription in the nucleus Y RN As are transported to the cytoplasm. For nuclear export, 
binding of the R06O protein to the Y RNAs is absolutely necessary, while La protein 
binding appeared to retard export. This strongly suggests that R06O plays an active role in 
the export process, which makes R06O the most obvious molecule to look for an NES 
involved in Y RNA export. Another challenge will be to identify and to characterize a 
(NES) receptor involved in Y RNA export that might interact with R06O and to 
investigate whether this (NES) receptor is also involved in the export of tRNA and 
possible other RNA polymerase Ш transcripts as well. 
Mutant analyses revealed that the La protein possesses a bipartite NLS and a nuclear 
retention element. Furthermore, some data point to the presence of an NES in La as well. 
This NES can be mapped and the retention element can be characterized in more detail by 
using additional La mutants. Eventually, the component(s) interacting with these 
element(s) can be determined. The observed shuttling ability of the La protein allows a 
further study on the modulation of the activities of the NLS, of the nuclear retention 
element and of the putative NES. In view of the fact that La is a multiphosphorylated 
protein it will be useful to identify and locate the phosphorylation sites in the protein. 
Although the localization and assembly studies described in this thesis clearly 
demonstrated that the Ro RNPs exert their major function in the cytoplasm, the 
elucidation of this function still remains a major challenge for Ro RNP research. 
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SUMMARY 
Ro RNPs (Ro ribonucleoprotein particles) are complexes composed of RNA and proteins. 
The RNA moiety of Ro RNPs consists in human cells of one of four Y RN As, called 
hYl, hY3, hY4 and hY5 RNA. These RNAs are complexed with at least three proteins: 
La, R06O and Ro52. Autoantibodies directed to the Ro RNPs are frequently found in sera 
from patients with the systemic autoimmune diseases systemic lupus erythematosus (SLE) 
and Sjogren's syndrome. Autoantibodies are antibodies produced by these patients which 
are targeted to "self" components. Although Ro RNPs could be detected in every cell 
studied so far, no function has been assigned to these complexes yet. To obtain more 
insight into the characteristics of these Ro RNPs their intracellular localization, transport 
and assembly were studied. 
Chapter 1 provides a general introduction in which our knowledge concerning the 
molecular structure and characteristics of Ro RNPs and its components is summarized. 
In Chapter 2 the subcellular distribution of the different components of Ro RNPs is 
addressed. Microinjection studies with Xenopus laevis oocytes show that all three Ro RNP 
proteins are able to enter the nucleus, although their equilibrium distribution among 
nucleus and cytoplasm is different. The hY RNAs are quantitatively exported to the 
cytoplasm after injection into the nucleus. Both nuclear import of the proteins and nuclear 
export of the RNAs appear to be energy-dependent processes. Immunoprecipitation 
studies showed that initially both La and R06O are bound to hYl RNA in the nucleus. 
However, after or during export the association with La is lost and as a result R06O was 
found to be associated with hYl RNA in the cytoplasm. 
Consistent with the energy requirement, import of the La protein was shown to be 
mediated by a (bipartite) nuclear localization signal (NLS), which was mapped at the 
extreme C-terminus of the protein (Chapter 3). After import, human La is very efficiently 
retained in the X. laevis nucleus. For nuclear retention elements in the central part of the 
protein are required. Export of La mutants which are retention- and re-import-defective, 
appeared to be energy-dependent, suggesting that La in addition to an NLS and a nuclear 
retention element also contains a nuclear export signal (NES). 
Because the La protein seems to have functions in the nucleus as well as in the cytoplasm, 
the ability of La to shuttle between nucleus and cytoplasm was tested. The results in 
Chapter 4 show that in spite of the strong nuclear retention of La in X. laevis oocytes, 
human La was able to leave the human nucleus and enter the mouse nucleus in 
human-mouse heterokaryons, strongly suggesting that La indeed is a nucleocytoplasmic 
shuttling protein. 
In Chapter 5 the nuclear export process of hYl RNA was studied in more detail. By 
using hYl RNA mutants it was shown that the binding of R06O to hYl RNA is a 
prerequisite for nuclear export. Binding of the La protein, however, was not necessary for 
export, but instead led to a (transient) nuclear retention of hYl RNA in X. laevis oocytes. 
Injections of increasing amounts of hYl RNA into the nucleus showed that export was 
saturable. The nuclear export of both hYl RNA and tRNA appeared to be dependent on 
at least one common factor, as shown by cross-competition studies. Export of hYl RNA 
and tRNA was not dependent on a НГ -1 Rev protein-like nuclear export signal (NES), 
since high amounts of the HIV-1 Rev-NES sequence did not compete for export of these 
RNAs. 
In Chapter 6 the combined data obtained by the studies described in this thesis are 
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discussed. The results are integrated into a general model in which the assembly of 
Ro RNPs is described. Furthermore, the shuttling ability of the La protein is discussed in 
more detail and a sequence comparison of all bipartite NLSs identified to data is 
presented. 
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SAMENVATTING 
Ro RNP's ("Ro ribonucleoprotein particles") zijn complexen, die zijn opgebouwd uit 
RNA en eiwitten. In humane cellen wordt het RNA gedeelte van Ro RNP's gevormd door 
één van de vier Y RNA's: hYl, hY3, hY4 of hY5 RNA. Deze RNA's zijn geassocieerd 
met tenminste drie eiwitten: La, R06O and Ro52. Autoantilichamen, die gericht zijn tegen 
Ro RNP's, worden gevonden in het bloed van patiënten met systemische 
autoimmuunziekten, zoals Systemische Lupus Erythematosus (SLE) en Sjogren's 
syndroom. Autoantilichamen zijn antilichamen, die geproduceerd worden door deze 
patiënten en zijn gericht tegen lichaamseigen componenten. Hoewel Ro RNP's voorkomen 
in elke tot nu toe bestudeerde cel, kan tot op heden nog geen enkele functie toegeschreven 
worden aan deze complexen. Om meer te weten te komen is in dit proefschrift de 
intracellulaire lokalisatie, het transport en de assemblage van deze Ro RNP's bestudeerd. 
Hoofdstuk 1 geeft een algemene inleiding, waarin de kenmerken en de moleculaire 
structuur van Ro RNP's en hun componenten zijn samengevat. 
In Hoofdstuk 2 is de subcellulaire distributie van de verschillende componenten van 
Ro RNP's bestudeerd. Microinjectie studies met Xenopus laevis oöcyten laten zien dat de 
drie Ro RNP eiwitten in meer of mindere mate de kem in gaan. De h Y RNA's worden na 
injectie in de kern volledig geëxporteerd naar het cytoplasma. Zowel kern import van de 
eiwitten als kem export van de RNA's blijken energie-afhankelijke processen te zijn. 
Immuunprecipitaties laten zien dat zowel La als R06O oorspronkelijk gebonden zijn aan 
hYl RNA in de kern. Ná of tijdens export echter, is de associatie met La verloren gegaan 
en is in het cytoplasma alleen R06O nog geassocieerd met hYl RNA. 
In overeenstemming met de energie behoefte, bleek import van het La eiwit te worden 
bewerkstellig door een (tweedelig) kern lokalisatie signaal (NLS), dat aanwezig bleek te 
zijn in het uiterste C-terminale gedeelte van het eiwit (Hoofdstuk 3). Na import wordt 
humaan La zeer efficiënt vastgehouden (geretendeerd) in de X. laevis kem, waarvoor 
aminozuur-sequenties in het centrale deel van het eiwit noodzakelijk zijn. De export van 
La mutanten die retentie- en re-import-defect zijn, bleek energie-afhankelijk te zijn, 
waardoor La naast een NLS en een kem retentie element ook een kem export signaal 
(NES) lijkt te bezitten. 
Omdat het La eiwit functies lijkt te hebben in zowel de kem als het cytoplasma, is 
onderzocht of La de eigenschap bezit tussen kem en cytoplasma te pendelen. De 
resultaten in Hoofdstuk 4 laten zien dat ondanks de sterke kem retentie van La in 
X. laevis oöcyten, humaan La in staat is de humane kem te verlaten en de muizenkern 
binnen te gaan in mens-muis heterokaryons. Dit suggereert dus sterk dat La inderdaad een 
kern-cytoplasmatisch pendel eiwit is. 
In Hoofdstuk 5 is het kem export proces van hYl RNA in detail bestudeerd. Door 
gebruik te maken van hYl RNA mutanten is aangetoond dat binding van R06O aan 
hYl RNA noodzakelijk is voor kem export. Binding van het La eiwit echter, was niet 
noodzakelijk voor export, maar veroorzaakte zelfs een (tijdelijke) kem retentie van 
hYl RNA in X. laevis oöcyten. Door toenemende hoeveelheden hYl RNA in de kem te 
injecteren is aangetoond dat export verzadigbaar is. Kem export van zowel hYl RNA als 
tRNA bleken afhankelijk te zijn van tenminste één algemene factor, zoals bleek uit 
kruislingse competitie studies. hYl RNA en tRNA export waren niet afhankelijk van een 
HIV-1 Rev eiwit-gelijkend kem export signaal (NES), omdat grote hoeveelheden van de 
HIV-1 Rev-NES sequentie export van deze RNA's niet competeerde. 
113 
In Hoofdstuk 6 worden de verkregen resultaten, zoals beschreven in dit proefschrift, 
bediscussieerd. De resultaten worden gebruikt voor het maken van een algemeen model 
waarin de assemblage van Ro RNP's wordt getoond. Verder is het pendel karakter van 
het La eiwit uitvoerig bediscussieerd en is een sequentie vergelijking van alle tot nu toe 
geïdentificeerde tweedelige NLS's uitgevoerd. 
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